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Abstract
Radiotherapy uses x-ray beams to deliver prescribed radiation doses that con-
form to target anatomy and minimise exposure of healthy tissue. Accuracy of
dose delivery is essential, thus verification of dose distributions in vivo is desirable
to monitor treatments and prevent errors from compromising patient outcomes.
Electronic portal imaging devices (EPIDs) are commonly used x-ray imagers,
however their non water-equivalent response complicates use for dosimetry. In
this thesis, a Monte Carlo (MC) model of a standard EPID was developed and
extended to novel water-equivalent configurations based on prototypes in which
the high atomic number components were replaced with an array of plastic scin-
tillator fibres. The model verified that full simulation of optical transport is not
necessary to predict the standard EPID dose response, which can be accurately
quantified from energy deposited in the phosphor screen. By incorporating com-
puted tomography images into the model, its capacity to predict portal dose
images of humanoid anatomy was also demonstrated.
The prototype EPIDs water-equivalent dose response was characterised ex-
perimentally and with the MC model. Despite exhibiting lower spatial resolution
and contrast-to-noise ratio relative to the standard EPID, its image quality was
su cient to discern gross anatomical structures of an anthropomorphic phan-
tom. Opportunities to improve imaging performance while maintaining a water-
equivalent dose response were identified using the model. Longer fibres increased
e ciency and use of an extra-mural absorber maximised spatial resolution. Op-
tical coupling between the scintillator fibres and the imaging panel may further
improve performance.
This thesis demonstrates the feasibility of developing a next-generation EPID
for simultaneous imaging and dosimetry in radiotherapy. Such a detector could
monitor treatment deliveries in vivo and thereby facilitate adaptations to treat-
ment plans in order to improve patient outcomes.
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1
Introduction
Modern radiotherapy is one of the most commonly used techniques for treating
cancer. It has been estimated that approximately 52% of new cancer cases are in-
dicated for external beam radiotherapy(EBRT) at least once during their course
of treatment [1]. EBRT involves the use of a medical linear accelerator to gen-
erate beams of high-energy x-rays that penetrate through the patient, targeting
the solid tumour. Owing to the highly proliferative nature of cancer cells and
their higher sensitivity to radiation damage compared to healthy cells, EBRT
has proven to be an e↵ective means of controlling tumour growth. Through
the development of new technologies and improved x-ray beam delivery tech-
niques, radiotherapy has evolved through several generations. Earlier methods
including 3D conformal radiotherapy (3DCRT) are being replaced by more re-
cently developed techniques including intensity-modulated radiotherapy (IMRT)
and image-guided radiotherapy (IGRT). These modern techniques enable the de-
livery of beams that are both dosimetrically precise and capable of conforming
spatially to complex target geometries. For instance, current ICRU guidelines for
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IMRT recommend that in low dose gradient regions at least 85% of the target
volume receives an absorbed-dose within 5% of prescription [2].
Electronic portal imaging devices (EPIDs) are flat-panel x-ray detectors that
are frequently used for patient imaging in modern radiotherapy owing to their
high spatial resolution and real-time readout capabilities. Most linear accelerator
vendors now supply EPIDs as fully integrated systems that come fixed to the
accelerator’s gantry, greatly facilitating their routine clinical use. EPIDs can be
used either with the megavoltage (MV) therapy beam or, for improved image
contrast, with an on-board kilovoltage (kV) x-ray tube. EPIDs are most com-
monly used to verify patient setup prior to treatment by acquiring portal images
in cases where bony landmarks serve as suitable surrogates for tumour position [3].
If significant changes in patient anatomy are observed, new treatment plans may
be generated to adapt therapy accordingly. More recently, use of implantable
fiducial markers has enabled EPIDs to image tumour motion in patients in real
time using the therapy beam [4].
Despite the current ability to deliver highly conformal MV x-ray beams and
guide treatment using modern imaging technologies, there are still uncertain-
ties arising in the radiotherapy process that limit the ability to predict patient
outcomes. Arguably one of the largest uncertainties is the current inability to
quantify the actual dose delivered to the patient. Variations in patient position
and internal anatomy can have an important impact on the dose delivered to
the tumour and surrounding healthy tissues [5]. There is also growing evidence
showing that the quality of radiotherapy delivered may a↵ect patient outcomes,
including local control, toxicity rates and overall survival [6,7]. Owing primarily
to a lack of suitable commercially available dosimeters, in vivo dosimetry is not
routine clinical practice in most centres and real-time dose monitoring is limited
almost exclusively to single point skin and intracavitary measurements. The abil-
ity to perform routine in vivo patient dosimetry in two or even three dimensions is
highly desirable as it will verify correct treatment delivery, detect harmful treat-
ment errors that may otherwise go undetected and identify patients that may
benefit from treatment adaptations [8,9].
Interest in using EPIDs for radiotherapy dosimetry has been growing since
their clinical inception in the 1990s [8–10]. However their design – which as pre-
2
viously mentioned has been optimised for imaging applications – has severely
limited their routine clinical use as dosimeters. Several groups have investigated
the use of EPIDs for dosimetry, either by developing methods to adapt currently
available detectors for this purpose or by designing novel detectors specifically to
act as dosimeters rather than imagers. The former scenario typically necessitates
a complex detector characterisation and calibration scheme along with custom
software to convert portal images into dose images. The latter scenario has seen
detector prototypes that, while capable of performing accurate patient dosimetry,
su↵er from decreased x-ray detection e ciency thus inhibiting their use for imag-
ing. In both cases, proposed detectors have not been suitable for applications in
both imaging and dosimetry. Furthermore, lack of a user friendly, commercially
available product precludes these methods from being implemented routinely in
clinical practice for most centres.
This thesis presents work on the development of a next-generation EPID de-
signed for simultaneous imaging and dose verification applications in radiother-
apy. Monte Carlo (MC) simulations of radiation transport were used to develop
several di↵erent detector models. Experimental measurements were also con-
ducted with research prototypes and clinical MV radiotherapy photon beams to
validate the MC models and assess imaging and dosimetry performance. A MC
model of the currently available standard clinical EPID was first developed and
the di↵erent physical processes operating within the detector were characterised.
This model was later extended to novel configurations based on experimental
prototypes designed by our research group. The novel prototypes replaced the
high atomic number materials within the standard EPID with an array of plastic
scintillator fibres to make the detectors more suitable for dosimetry. By optimis-
ing specific geometrical and material properties of the plastic scintillator array,
the novel EPID’s detection e ciency and spatial resolution may be comparable to
that of current detectors optimised for imaging. This work therefore demonstrates
the feasibility of developing a next-generation EPID for simultaneous imaging and
dosimetry in radiotherapy, which would enable the measurement of dose being
delivered to patients in vivo. This information could then be used as a quality
assurance tool to monitor treatment accuracy and make necessary adaptations to
the treatment plan in order to improve patient outcomes.
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Literature Survey
This literature survey discusses the topics forming the foundation upon which
the work presented in this thesis is based. The most important developments
in these disciplines are summarized with relevant studies referenced throughout.
This chapter is organised into five sections, each of which is further divided into
relevant subsections. Section 2.1 concerns radiotherapy within the broad con-
text of cancer therapy and includes an overview of the history and technological
progression of this field. Section 2.2 provides an overview of electronic portal
imaging technology, beginning with a discussion of the earliest detectors and pro-
gressing towards the latest, most novel designs. Radiation dosimetry is discussed
in Section 2.3, including the range of detectors related to this work and their com-
mon clinical applications. Section 2.4 gives a technical overview of the principles
behind Monte Carlo simulation techniques and specifically their applications in
radiation transport physics. Finally, Section 2.5 concludes this literature sur-
vey by providing the motivation behind this work and the primary aims in the
individual studies making up the subsequent chapters of this thesis.
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2.1 Radiotherapy in cancer treatment
2.1.1 History of external beam radiotherapy
Many are familiar with Wilhelm Ro¨ntgen’s famous 1895 paper in which he de-
scribed, for the first time, a new kind of ray that he discovered incidentally while
operating a Crooke’s tube [1]. Despite having covered the Crooke’s tube in opaque,
black cardboard, the “X-rays” (as Ro¨ntgen called them, for the sake of brevity)
were capable of passing through an assortment of objects and inducing florescence
on a nearby florescent screen. The first ever x-ray radiograph – an image Ro¨ntgen
took of his wife’s hand (see Figure 2.1) – was published in this famous paper. As
a result of his discovery, Ro¨ntgen earned the first ever Nobel Prize in Physics in
1901.
Ro¨ntgen’s findings were the first of several important discoveries made in
radiation physics over an exceptionally short period of time. Also in 1895, Bec-
querel discovered radioactivity [2] and by 1898 Pierre and Marie Curie reported
the discovery of radium [3,4]. Even throughout this early period of discovery, the
biological e↵ects of radiation were of major interest [5]. In fact, a woman with
breast cancer was reportedly treated with x-ray radiation as far back as 1896 [4,6].
Now, over 100 years later, these invisible rays serve several crucial roles within
the medical fields of diagnostic radiology and radiotherapy.
While the earliest radium therapy trials date back to the early 1900s – not
long after x-rays and radium were even discovered – the birth of modern mega-
voltage (MV) radiotherapy took place several decades later [7]. The high cost and
limited availability of radium at that time resulted in a much slower development
of radium therapy relative to kilovoltage (kV) therapies using x-ray tubes. How-
ever as a direct consequence of the lower kV x-ray energies, it was eventually
realised that radium o↵ered a more practical means of treating deep-seated tu-
mours owing to its greater depth dose. To improve depth dose further it became
common practice to increase the distance between the radium source and the
patient [8] – a practice that led to the development of teleradium machines (the
prefix tele- roughly translates to mean ‘at a distance’). The paper “The Race For
Megavoltage” by Robison gives a more detailed account of these technological
8
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Figure 2.1: The first x-ray radiograph reported in W. Ro¨ntgen’s 1895 paper “On
a New Kind of Rays” showing the bones of his wife’s hand. Note the ring worn
on her third finger [1].
advances, including a list of some of the earliest teleradium units installed across
several institutions throughout the first half of the 20th century [7].
In 1946, Canadian physicist Harold E. Johns attended a lecture series given
by Professor William V. Mayneord in which Mayneord suggested the possibility
of using radioactive cobalt-60 (Co-60) in place of radium [7,9]. The suggestion
came following extensive research throughout the 1930s and 1940s at Princeton
and Berkeley on the neutron capture of Co-59 to yield the Co-60 isotope. The
physical properties of Co-60 are well-suited to radiotherapy, with a strong activity
of 1.17 and 1.33 MeV x-rays and half-life of 5.261 years [9]. Later, on October 27th,
1951 the first patient was treated with a Co-60 teletherapy machine in London,
Canada that was developed by Johns’ group [10].
Particle accelerators evolved along roughly the same timeframe as the early
9
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radium and later cobalt teletherapy machines, and eventually surpassed Co-60
machines as the most widely used form of modern radiotherapy [11]. When clin-
ical linear accelerators (linacs) were first developed (the earliest was an 8 MV
accelerator in 1952 at the Hammersmith Hospital in London [12,13]), they promised
several advantages over radioactive isotopes, including the ability to control the
beam energy and delivery rate. The first clinical accelerator in the U.S.A. was
developed at Stanford University, installed in the Stanford Department of Radiol-
ogy in 1954 and treated its first patient in January 1956 [11,13]. Several companies
began building commercial linacs and production accelerated throughout the sec-
ond half of the 20th century – one major manufacturer reportedly built over 3,200
accelerators between 1962 and 1999 [11]. In most developed countries, modern
clinical accelerators have increasingly replaced older Co-60 machines. Several re-
views, including those written by Farmer (1962), Karzmark (1984) and Thwaites
& Tuohy (2006) detail the evolution of the modern clinical linear accelerator [13–15].
2.1.2 Modern external beam radiotherapy
Linear accelerators, of the kind used in modern radiotherapy, comprise several
interconnected systems [11]. While the following description is a drastic oversimpli-
fication of the modern MV accelerator design, such accelerators typically consist
of (see Figure 2.2):
• a charged particle source (e.g. an electron gun)
• a radiofrequency (RF) system (including a RF power source, accelerating
waveguide and pulsed modulator)
• a beam transport system (including focussing coils and bending magnets)
• a collimation and monitoring system (including the target, primary, sec-
ondary and multi-leaf collimators, flattening filter and monitor ionization
chamber(s))
A more detailed description of the design of MV linacs may be found, for example,
in Van Dyk’s The Modern Technology of Radiation Oncology [11].
Electrons ejected from the electron gun are accelerated down the accelerating
waveguide to energies between 4 – 25 MeV, depending on the accelerator. The
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use of a variable, non-conservative electric field originating from the RF power
source with a loaded waveguide that contains periodic perturbations along its
length allows the electrons to be accelerated to such high energies. Once the
accelerated electrons reach the end of the waveguide, magnets bend and focus the
electron beam onto a tungsten target, thereby generating a bremsstrahlung x-ray
beam (or an electron beam produced without the target in place). X-ray beams
generated with nominal waveguide voltages of 6, 10 and 18 MV are commonly
used in modern practice, resulting in beams with mean energies typically much
higher than those achievable using radioactive isotopes.
Figure 2.2: Schematic of the key components of a modern linear accelerator
(figure reproduced from p1073 of Podgorsak (ed. J. Van Dyk), 1999 [11].)
The overarching goal of modern radiotherapy is, of course, to maximize the
dose of radiation being delivered to the target (e.g. tumour) whilst minimiz-
ing the dose delivered to surrounding healthy tissues and organs at risk (OAR).
The degree to which this goal may be achieved using external beam radiotherapy
(EBRT) has improved in part through the evolution of modern 3D imaging and
beam delivery techniques. So-called “conventional” 2D treatment planning was
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the standard approach prior even well after the advent of commercially available
CT around 1972 [16]. This process typically involved taking a small number of
planar radiographs for diagnostic and tumour localization purposes, and treat-
ments were largely delivered using only rectangular, coplanar fields (e.g. parallel-
opposed lateral fields). As a consequence of the limitations imposed by 2D imag-
ing and such simple beam geometries, conventional treatments typically did not
conform to the target shape and the dose delivered to the tumour was restricted
by the relatively large amount of normal tissue within the treated volume.
Several technological advances throughout the 1970s and 1980s paved the way
for 3D Conformal Radiotherapy (3D-CRT) to supersede conventional therapies.
Key amongst these included, as previously mentioned, the commercial availability
of 3D imaging systems including CT, along with the necessary advances in com-
putational e ciency to facilitate 3D dose calculations and treatment planning [16].
Furthermore, the ability to shape therapy beams into geometries that more pre-
cisely conformed to the target volume was made possible through widespread use
of the multileaf collimator (MLC). The MLC consists of an opposing pair of thick,
tungsten jaws mounted to the head of the linear accelerator, each comprising a set
of thin interlocking leaves that move linearly in one dimension (see Figure 2.3).
Being able to control the position of each individual leaf in real time during beam
delivery allows the creation of highly complex beam shapes, thereby improving
the ability to spatially conform therapy beams to the target. One of the earliest
MLCs was described by Brahme (1987) [17].
Up to this point in time, treatment planning was typically performed in a
forward manner – that is information about the patient and planned beam geom-
etry were used to calculate the expected dose delivery to the target. An optimal
plan that best met criteria specified by the radiation oncologist was then selected
manually from several forward-planned dose distributions [16]. However, with the
advent of the MLC – which o↵ered many more degrees of freedom for treatment
plan optimization than conventional rectangular fields – and modern computa-
tional e ciency, a new approach to treatment planning was suggested by Brahme
in 1988 [18]. The technique, which later came to be known as inverse planning,
essentially begins with the desired patient dose distribution and uses a computer-
based optimization algorithm to calculate the beam shapes and intensities to best
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achieve this distribution [16,18,19].
Intensity-modulated radiotherapy (IMRT) improves upon 3D-CRT most no-
tably by using the MLC to modulate both the shape and intensity of the therapy
beam. Typically, the beam intensity may be increased in areas containing the
target volume and decreased in areas containing healthy tissues and OAR [18,20].
To compensate for regions that may be over- or under-dosed as a result of this
intensity modulation, beams may be delivered from several di↵erent gantry an-
gles (see Figure 2.4). The technique was first described [21] by Brahme et al. in
1982 and was largely pioneered by Steve Webb [22]. Several historical reviews have
been written about IMRT, including those by the IMRT Current Working Group
(2001) [23], Webb (2003, 2005) [24,25] and Bortfeld (2006) [20]. IMRT, combined with
inverse treatment planning, is now one of the more commonly used methods of
EBRT in current clinical practice [20]. It is clear to imagine the advantages of
IMRT over 3D-CRT, particularly when considering how the MLC is well suited
to shielding healthy tissues. Several studies have quantified the improvements ob-
served in dose distributions resulting from the use of IMRT over 3D-CRT [26–28].
2.1.3 Advanced radiotherapy techniques
While perhaps not used as frequently overall as either IMRT or 3D-CRT, there
exist several advanced radiotherapy techniques that are commonly used to treat
specific subgroups of patients.
Although EBRT has generally evolved beyond the use of radioisotopes such as
radium and Co-60, certain radioisotopes are well established for use in brachyther-
apy – a therapy that uses small implantable radioisotope seeds to treat tu-
mours internally (common radionuclides include Co-60, Cs-137 and Ir-192) [29].
Brachytherapy o↵ers the advantage of delivering very high doses in a conformal
manner, albeit using an invasive procedure. Though not limited to these sites, it
is most commonly used for certain prostate [30], gynaecologic and breast cancers.
In some cases, it may be desirable to combine the use of brachytherapy with
EBRT, such as in the case of a primary solid tumour with metastatic lymph node
involvement, whereby seeds may be implanted within the primary tumour and
distant metastases may be more e↵ectively treated using EBRT. A historical re-
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Figure 2.3: Photo of a multileaf collimator (MLC) that is capable of forming
complex beam shapes. Moving individual leaves dynamically during treatment
facilitates intensity modulation of the beam (figure reproduced from p.R369 of
Bortfeld, 2006 [20].)
view of brachytherapy technology and physics practice is given by Williamson [31].
Other advanced EBRT techniques, including intensity modulated arc ther-
apy (IMAT) and helical tomotherapy (HT) have extended the basic principles
of IMRT to more novel therapies. IMAT is a form of IMRT that continuously
delivers the therapy beam while rotating in an arc around the patient. Whereas
traditional IMRT delivers the treatment beam from several discrete gantry angles
(usually from 5 – 9), IMAT may o↵er an added advantage by further spreading
out the low dose radiation [32]. IMAT is also commonly referred to as volumetric
modulated arc therapy (VMAT) [33]. Some studies have shown that IMAT can
result in even more conformal treatment deliveries than conventional IMRT, ow-
ing to the increased number of control points available during the treatment plan
optimization process [26]. HT was first described by Mackie et al. in 1993 and, as
the name implies with the prefix tomo- translating to mean ‘slice’, it combines
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the principles of IMRT and CT by using a MV fan beam to treat patients in
a series of slices [34]. With the patient lying on the treatment table and moving
slowly through the bore of the CT-like gantry, the therapy fan beam irradiates
the target in a helical manner. The fan beam’s intensity may still be modulated
using a binary MLC (i.e. leaves are either ‘open’ or ‘closed’). A more in depth
description of HT is given by Olivera et al. [35] and a historical review is given by
Mackie (2006) [36].
Figure 2.4: IMRT treatment plan for a patient with prostate cancer. The colour
overlay illustrates the spatial variation in planned absorbed dose (as a percentage
of the prescribed dose) resulting from the intensity modulation of beams incident
from five gantry angles (image courtesy of Varian Medical Systems, Inc.)
Image-guided radiotherapy (IGRT) is an umbrella term used to describe ad-
vanced EBRT techniques that integrate various modern imaging technologies with
radiotherapy planning and delivery. Within IGRT, pre-treatment imaging is typ-
ically used to monitor patient setup with the goal of improving the accuracy of
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treatment delivery [37]. If using image guidance reduces the geometrical uncer-
tainties associated with target localization, then it may be possible to reduce the
margin of healthy tissue being treated around the clinical target volume [38]. Sev-
eral radiation-based and non radiation-based imaging systems are currently used
in IGRT. Electronic portal imaging devices (EPIDs) are a type of radiation-based
imaging system that may use either the MV therapy beam or a gantry-mounted
kV x-ray source to acquire images. These images may then be used in real time
to guide treatment delivery for a patient or may be reviewed o✏ine at a later
time [39]. EPIDs are discussed more thoroughly in Section 2.2 of this chapter and
have been studied in depth throughout this thesis. MV and kV cone-beam CT
(CBCT) is a technique that utilizes gantry-mounted flat panel imagers opposite
the x-ray source to acquire open-field images while rotating about a patient or
phantom (an object designed to mimic the radiation absorption and scattering
properties of a patient [40]). Acquiring these projections enables 3D volumetric
images of internal anatomy to be reconstructed and has set a new standard for
imaging in IGRT [41,42]. A recent review of these and other image guidance sys-
tems, including non radiation-based systems based on ultrasound and optical
imaging, was published by De Los Santos et al. (2013) [37].
Hadrontherapy is an advanced form of radiotherapy that uses hadrons, instead
of photons or electrons, to deliver a dose of radiation to the target volume. The
most common type of hadrontherapy is proton therapy (a historical review is given
by Smith (2006) [43]) and it o↵ers certain dosimetric advantages over standard MV
x-ray EBRT. Charged particles are directly ionizing and therefore have a much
higher linear energy transfer (LET) than photons. As a consequence, charged
particles tend to deposit most of their energy in matter at a very well defined
depth known as the Bragg Peak, after Sir William Henry Bragg who discovered
this phenomenon in 1904 [44]. By modulating the energy of charged particles,
a so-called Spread Out Bragg Peak may be generated that delivers a uniform
dose to the target along the beam axis while minimizing the dose to tissues in
front of and behind the target volume. One significant drawback to hadronther-
apy, however, is its cost and as a consequence it is currently only available in a
relatively small number of facilities worldwide (at present, there are no hadron-
therapy facilities in Australia). As such, hadrontherapy is typically reserved for
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a specific subset of patients requiring highly conformal treatments. As an exam-
ple, paediatric patients receiving radiotherapy may have an increased likelihood
for developing secondary malignancies later in life because of their young age.
The delivery of highly conformal treatments to spare healthy tissues is therefore
especially critical in these patients. A natural extension to hadrontherapy is ion
therapy, whereby ions with higher atomic numbers may be used for therapy. The
Heidelberg Ion Therapy Centre in Germany is one facility that o↵ers ion therapy
with species ranging from protons to oxygens [45]. A recent review by Suit et al.
(2010) compares proton and carbon ion beams [46].
2.2 EPID imaging in radiotherapy
EPIDs are flat panel x-ray detectors that have developed into essential tools for
modern radiotherapy, so much so that it has become standard for linear accelera-
tor vendors to supply retractable EPIDs directly mounted to their linac gantries.
Their most common application is for on-line pre-treatment verification of patient
setup [37]. Portal images acquired using EPIDs may be registered with reference
digitally reconstructed radiographs (DRRs) derived from treatment plans, which
record the intended patient position [47]. Discrepancies between the portal image
and DRR may then be used to correct patient position. More contemporary
EPID applications include intra-fraction imaging for patient position verification
and real-time tumour tracking in 4D radiotherapy [48], pre-treatment and in vivo
dosimetry [49–51] and linac quality assurance (QA) [52–55]. The following subsections
describe in detail the first clinical EPIDs, followed by the more recent direct- and
indirect-detection active matrix flat panel imager (AMFPI) EPIDs, and finally
several novel EPIDs currently under investigation for potential future applications
in radiotherapy.
2.2.1 First clinical EPIDs
The ability to capture an image of a radiation field, or “port”, prior to or dur-
ing therapy has long been recognized as an important means to verify correct
treatment delivery. Portal images acquired prior to therapy may be used to
17
2. Literature Survey
verify patient positioning and target alignment with the beam. Images acquired
throughout treatment may be used to monitor treatment progression, and observe
such processes as intra-fraction motion. Traditionally the most commonly used
technology for acquiring portal images was a film cassette containing a thin radio-
graphic film sandwiched between metal plates and/or phosphor screens. While
films had a number of advantages, including high spatial resolution and sensitiv-
ity to low doses of radiation, one significant limitation was in their need to be
processed before any useful information could be obtained from them. This time
delay between acquiring a portal image and being able to use it motivated the
development of an electronic means for acquiring portal images to be viewed, in-
terpreted, and used to make clinical decisions in real time. EPIDs were therefore
developed largely as an alternative technology to film casettes, having similar ben-
efits to film including a high spatial resolution and convenience, while improving
upon film’s most significant limitation of the need for processing.
Prof. Larry Antonuk, who is one of the pioneers credited with the development
of the modern AMFPI EPID, published an excellent historical review of EPIDs in
2002 [56]. Early development of electronic portal imaging technologies dates back
to the 1950s, with more widespread commercialization occurring throughout the
late 1980s and early 1990s. Of the di↵erent early technologies developed, only
two categories were in widespread clinical use over a significant period of time.
These are the camera-mirror-lens based EPIDs and the scanning matrix ionization
chamber EPIDs.
2.2.1.1 Camera-mirror-lens based EPID
A schematic depicting the typical configuration for a camera-mirror-lens based
EPID is shown in Figure 2.5. The basic principle involves the use of a metal
plate/phosphor screen (typically gadolinium oxysulfide, Gd2O2S:Tb) to convert
x-rays transmitted through the patient into an optical wavelength signal. With a
combination of mirrors and lenses, this optical signal is directed onto a camera,
giving rise to the projected image. To protect the camera and its electronic
components from the damaging e↵ects of the primary radiation beam, it is placed
outside of the primary field and a mirror angled at approximately 45  is used to
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reflect the optical signal towards it.
Although this EPID’s large area design enables large radiation fields to be
imaged, only the emerging optical signal that falls within the small, projected
area of the camera lens is actually captured. As a result, only ⇡ 0.01 – 0.1% of the
light emerging from the converter actually reaches the camera, thereby limiting
its detection e ciency [56,57]. A second important disadvantage occurs from light
that reflects o↵ the mirror, re-scatters from the converter and eventually reaches
the camera. This long range optical glare degrades spatial resolution and can
make up more than 25% of the detected signal [56]. While significant e↵orts have
gone into improving the e ciency of this design, the maximum reported detective
quantum e ciency (DQE) for camera-mirror-lens based EPIDs using a metal
plate/phosphor screen are ⇡ 1 – 3% [56,58].
Figure 2.5: Schematic illustrating the design of the camera-mirror-lens based
EPIDs (figure reproduced from pR41 of Antonuk, 2002 [56]).
2.2.1.2 Scanning matrix ionization chamber EPID
The scanning matrix ionization chamber EPID o↵ers certain advantages over the
camera-mirror-lens based EPIDs, including a more compact design and avoidance
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of the geometrical distortions resulting from long range optical glare [56]. This
type of EPID is constructed as a 2D area detector, with two planes of electrodes
separated by a small gap filled with a liquid ionization chamber (e.g. 2,2,4-
trimethylpentane) [59]. While each electrode plane contains a series of parallel
wires, orienting the planes perpendicularly to each other gives rise to an e↵ectively
pixelated area detector.
The detector readout is performed in a linearly scanning fashion by applying
a high voltage to each of the electrodes in succession and recording the resulting
signal. Since only a single electrode is read out at a time, one disadvantage to this
system is that the full number of detected x-ray quanta does not contribute to
the measureable signal. The result is a reduced DQE, which is typically reported
as being ⇡ 0.5% in these detectors [56].
2.2.2 Direct detection a-Si EPIDs
Direct-detection AMFPI EPIDs are commercially available for diagnostic imaging
and several authors have reported on their use in kV [60–63] and MV portal imag-
ing [64–67]. Similar to the indirect-detection AMFPI EPIDs described in the follow-
ing subsection, direct-detection AMFPI EPIDs employ a pixelated array of a-Si
photodiodes on a glass substrate as a means of storing and reading out trapped
charge to form a 2D digital image. Rather than using a metal plate/phosphor
screen to convert incident x-rays into an optical signal, direct-detection EPIDs
use a continuous layer of photoconductive material, such as amorphous selenium
(a-Se). Each pixel within the matrix comprises a collection electrode and storage
capacitor that lies underneath the layer of continuous photoconductive material.
X-rays interacting within the build-up layers and a-Se generate secondary elec-
trons which, in turn, cause the creation of electron-hole pairs within the a-Se [67].
The freed electrons and holes then propagate under an applied bias electric field
to opposite surfaces of the photoconductor. The holes are collected by the col-
lection electrodes, which leads to a buildup of charge on individual pixels and
thereby forms an x-ray image. Depending on the thickness of the photocon-
ductive layer, DQE between approximately 1–3% have been estimated in early
studies investigating 1,000 µm of a-Se for a 6 MV photon beam [56,64,65].
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2.2.3 Indirect detection a-Si EPIDs
Following extensive research and development throughout the 1990s directed
largely by Larry Antonuk’s group in Michigan [68–79], the first generation of the
now standard amorphous silicon (a-Si) AMFPI EPID became commercially avail-
able in the year 2000 [56]. Owing to the important applications for a-Si EPIDs in
patient imaging, the American Association for Physicists in Medicine (AAPM)
published a set of clinical guidelines for portal imaging in radiotherapy not long
after their commercial inception [80]. As described by Antonuk, the distinguish-
ing feature of the AMFPI EPIDs is the panel’s array of a-Si photodiodes and
electronics deposited on a 1 mm thick glass substrate using plasma enhanced
chemical vapour deposition techniques [56]. Each pixel typically consists of a thin-
film transistor element coupled to a capacitor for storing detected charge. The
conductivity of the transistor switches is controlled by the voltage applied along
the Gate Control lines to render the pixels either conducting or non-conducting.
The ability to read out the charge stored within each pixel is governed by the volt-
age applied to the Data Lines. For the greatest spatial resolution, one data line is
read out at a time and reading out each line of pixels simultaneously reinitializes
them. A schematic detailing the pixelated structure and electronic components
is shown in Figure 2.6.
Standard, commercially available EPIDs employ an indirect-detection config-
uration. That is, a metal plate and phosphor screen are placed directly above the
a-Si array to act as a conversion layer, transforming the incident x-ray signal into
an optical signal. Individual photodiodes absorb these optical photons, creating
electron-hole pairs within the capacitor and leading to a build up of charge. The
metal plate serves both to convert incident x-rays into an electronic signal that
deposits energy within the phosphor, as well as to filter out low energy x-rays
that would otherwise contribute towards system noise. Energy deposited in the
phosphor induces scintillation events such that hundreds or thousands of optical
photons may be created (in proportion to the amount of energy deposited) for a
single electronic event.
This generation of a-Si AMFPI EPIDs o↵ered several advantages over the
earlier camera-mirror-lens based and scanning matrix ionization chamber EPIDs.
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Figure 2.6: Schematic illustrating the pixelated design and electronic components
of modern a-Si based AMFPI EPIDs (figure reproduced from pR49 of Antonuk,
2002 [56]).
Coupling the AMFPI array directly to the x-ray converter layers results in a
flat, compact design that is more portable than the camera-mirror-lens based
EPIDs. Similarly, a much greater proportion of the generated optical signal
is captured and used in this configuration. The detectors have a high spatial
resolution and can produce images in near real-time, in both radiographic (single
frame) and fluoroscopic (frame sequence) readouts. The photodiodes and thin
film transistors themselves are highly resistant to radiation-induced damage, and
with proper shielding of the external electronics these detectors can withstand
very high doses – in excess of 104 Gy per year [68,81,82]. Another practical advantage
of these detectors is their ability to be manufactured in large sizes, with current
commercially available detectors typically measuring 41⇥ 41 cm2 in area.
The image quality of these detectors is frequently reported as being supe-
rior to many alternative EPID designs and is even comparable with that of film.
They o↵er x-ray quantum-limited imaging and the DQE of early prototypes us-
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ing a 133 mg cm 2 phosphor screen was estimated to be slightly above 1% for
a 6 MV photon beam [66,83] as well as for a 15 MV photon beam [66]. For thicker
phosphors, however, it has been shown that direct detection EPIDs actually have
a greater DQE for the same mass thickness of the active photoconductive layer
as a result of the Lubbert’s e↵ect present in indirect detection systems [64,66,84].
The amount of image processing required for AMFPI EPID images is typically
minimal, with the standard corrections applied consisting of an o↵set correction
to account for dark current e↵ects and a gain correction to account for varia-
tions in pixel sensitivity [85–87]. Even in their early stages, EPIDs have also been
demonstrated as potentially suitable dosimeters [88–92] and interest in using these
detectors for dosimetry applications has grown in recent years (a recent review of
EPID dosimetry has been published by van Elmpt et al. (2008) summarizing their
clinical applications [49]). However, use of high-Z components including the Cu
plate and Gd2O2S:Tb screen causes standard EPIDs to respond in a non water-
equivalent manner – a characteristic that is not ideal for clinical dosimetry. While
attempting to improve upon the imaging and/or dosimetric response of standard
EPIDs, several groups have investigated more novel detector configurations and
these are summarized in the following subsection.
2.2.4 Novel detector configurations
Much work continues to be directed towards both improving the current stan-
dard a-Si EPID and developing novel technologies. Some of these developments,
along with their respective advantages and disadvantages, are highlighted and
summarized below.
2.2.4.1 Modified indirect-detection configuration
In an attempt to improve upon the dosimetric response of standard EPIDs, sev-
eral studies by Vial (2008, 2009), Gustafsson(2009, 2011) and Sabet (2010, 2012)
et al. investigated modified forms of the standard indirect-detection EPID where
materials above the photodiode array were replaced with water-equivalent buildup
material (see Figure 2.7) [93–98]. Standard EPIDs over-respond to low energy ra-
diation relative to water, an e↵ect that is attributable to the high-Z components
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within which photoelectric absorption events dominate [86,91,99–102]. Their hypoth-
esis was that by removing the high-Z components and replacing them with water-
equivalent material, the EPID’s response should be closer to water-equivalent –
a desirable characteristic for dosimetry applications.
In an initial study, measurements including linearity of response, relative
dose profiles, field size factors, tissue-maximum ratios (TMRs), spatial resolu-
tion and image quality were taken using the standard EPID and its modified
direct-detection form [93]. Results were also compared to a standard ionization
chamber. It was found that the sensitivity of the modified direct-detection EPID
was reduced relative to the standard configuration by a factor of approximately
8, although the response in the modified configuration was still su cient for all
measurements. When measured at depth of dose maximum (dmax), profiles, field
size factors and TMRs taken with the modified EPID were in excellent agreement
with the water-equivalent ionization chamber, whereas those measured using the
standard EPID exhibited the predicted over-response to low energy radiation. At
greater depths, the modified direct-detection EPID response can di↵er from the
ionization chamber measurements.
In a follow up study, the authors investigated applications using the mod-
ified direct-detection EPID for clinical IMRT dosimetry [94]. In doing so, they
first established which configuration of buildup and backscatter material resulted
in a direct-detection response that best agreed with water-equivalent measured
dosimetry data. This ideal configuration was found to use a thickness of dmax solid
water buildup without any additional backscatter. To investigate the suitability
of this modified direct EPID configuration for IMRT dosimetry, the modified
EPID was used to measure the dose distribution at dmax for a head and neck
IMRT field. Generally excellent agreement with the treatment planning system
(TPS) was found with 98.4% of pixels meeting  -index criterion [103] of 3%/3mm.
When comparing the quality of images measured using the modified EPID to
those measured using the standard EPID, it was found that for su ciently high
doses the direct-detection image quality was su cient to visualize fiducial mark-
ers within a test phantom. However whereas the standard EPID could acquire
high quality images with as little as 1 MU, the direct-detection EPID required
significantly higher doses to achieve comparable image quality. The main con-
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Figure 2.7: Experimental setup of an a-Si EPID modified into a direct-detection
configuration using solid water buildup and backscatter (figure reproduced from
p.4363 of Vial, 2008 [93]).
clusions drawn from these studies were that it is possible to modify the standard
EPID to obtain a water-equivalent dose response, however the trade o↵ in sen-
sitivity results in a drastic reduction in image quality, particularly for low dose
imaging [93,94,97,98].
2.2.4.2 Thick, segmented phosphors
Sawant et al. (2003, 2005a) have proposed a method to improve upon the low
quantum e ciency of standard EPIDs by using micro-electro-mechanical sys-
tem (MEMS) fabrication techniques to construct a 2D cell-like structure up to
2 mm tall and precisely aligned with the photodiode pixels of an underlying
AMFPI [104,105]. This matrix of cells is then filled with a scintillating material to
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take advantage of the high detection e ciency obtained with a thick phosphor
while maintaining good spatial resolution (see Figure 2.8). Three di↵erent con-
figurations were investigated experimentally with varying scintillator thicknesses
and packing densities. The scintillator being investigated was Gd2O2S:Tb, the
same granular phosphor that is used in standard EPID phosphor screens. Imaging
metrics including the detector sensitivity, modulation transfer function (MTF),
noise power spectrum (NPS) and DQE were measured for each prototype.
Figure 2.8: (a) Schematic and (b) physical prototype of a MEMS-fabricated thick,
segmented phosphor scintillator. The cells in (b) have a pitch of 508 µm (figures
reproduced from p.554-556 of Sawant, 2005 [105]).
Results suggested that it was possible to improve the quantum e ciency by at
least a factor of three over standard EPIDs using this design. Furthermore, com-
parable or even improved spatial resolution was measured using the segmented
phosphors. The downside to this design appears to result from the highly depth-
dependent light escape e ciency when using thick phosphors, resulting in high
levels of Swank noise within these initial prototypes [106]. With the increased
Swank noise, the overall DQE for the segmented phosphor systems was less than
that of the standard EPID across all spatial frequencies. One proposed solution
to the increased Swank noise was to replace the phosphor segments with more
optically transparent materials, such as thallium-doped cesium iodide (CsI:Tl)
or bismuth germanium oxide (BGO) crystal scintillators [104,105]. Another disad-
vantage to this approach is that the use of such thick, high-Z materials will not
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improve upon the non-water-equivalent response of current EPIDs and, conse-
quently, their suitability for portal dosimetry.
2.2.4.3 Thick, segmented crystals
Following their study of segmented phosphor scintillators, Sawant et al. (2005b)
investigated the theoretical gains in DQE resulting from the use of thick, seg-
mented crystal scintillators as the x-ray converter in a standard indirect-detection
AMFPI EPID [107]. This study investigated CsI:Tl and BGO crystal scintillators
and Monte Carlo (MC) simulations were performed to estimate the signal proper-
ties, MTF, NPS and DQE for di↵erent crystal thicknesses, septal wall materials,
and septal wall thicknesses. The authors’ main conclusion was that improvements
in the EPID DQE up to a factor of 50 should be possible depending on the design
specifications being considered.
Figure 2.9: Physical prototype of an array of thick, CsT:Tl crystal scintillators
(figure reproduced from p.1055 of Sawant, 2006 [108]).
In a follow up experimental investigation by the same group, a prototype
CsI:Tl array with crystals 40 mm thick (see Figure 2.9) was incorporated into
an AMFPI EPID and measurements were performed to calculate the prototype’s
sensitivity, MTF, NPS and DQE [108]. This prototype exhibited a zero-spatial
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frequency DQE of approximately 22% relative to just 1% when using a standard
EPID. Despite this large increase in DQE, results were still lower than theoretical
upper limits calculated using MC simulations, indicating the presence of Swank
noise [106]. The authors report that with further optimization of the detector
design, it may be possible to improve the DQE up to ⇡ 50% [107]. Despite their
immense potential for high DQE imaging, however, the proposed designs will
retain the non-water equivalent response of current EPIDs owing to their high-Z
components.
2.2.4.4 Segmented plastic scintillator
With the aim of improving both the quantum e ciency and water-equivalence
of current EPIDs, Teymurazyan and Pang (2012) proposed a modified indirect-
detection EPID that employs an array of plastic scintillator fibres in place of the
metal plate and phosphor screen in standard EPIDs [109]. Using MC simulations,
they predicted that such an EPID could achieve a theoretical DQE of 37% for a
6 MV beam with fibers 30 cm in length. Other properties including the detection
e ciency and MTF were also quantified. Unfortunately, however, the use of such
thick (and consequently heavy) scintillators poses certain mechanical di culties
that may complicate their clinical practicality. Another important conclusion
was that using plastic scintillator in place of the standard high-Z x-ray converter
materials results in a water-equivalent dose response, which would potentially
render this design suitable for portal dosimetry. A significant limitation of this
study, however, is that the authors did not report any experimental data against
which to validate their model.
2.2.4.5 Anti-scatter detector
Teymurazyan and Pang (2012, 2013) have also reported a particularly novel ap-
proach to improving EPID image quality, which involves replacing the metal plate
and phosphor screen with a segmented array of optical fibers coupled to individ-
ual photodiode pixels [110,111]. Rather than indirectly-detecting the incident x-ray
beam by means of scintillation events, this detector builds upon a previously pro-
posed Cˇerenkov detector [112]. MV x-rays inducing Cˇerenkov events within the
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optical fibers generate optical photons that propagate down the fibers and are
subsequently detected (see Figure 2.10). Since the Cˇerenkov photons are gener-
ated at well-defined angles with respect to the incident x-ray trajectory and as
a function of the x-ray energy, low energy scattered x-rays will tend to generate
optical photons outside of the acceptance angle of the optical fibers. Higher en-
ergy primary x-rays will therefore be preferentially detected, reducing the overall
contribution of low energy scatter to the image signal. Using MC simulations,
the authors found that 20 cm long fibers reduces the contribution of scattered
x-rays to the total signal by as much as 50% relative to standard EPIDs and the
di↵erential signal to noise ratio may be improved by up to 30%. Once again,
however, the bulkiness of this geometry may complicate its practical clinical use.
Furthermore, because this detector relies on the generation of Cˇerenkov radiation,
it is inherently insensitive not only to low energy scattered x-rays but low energy
primary x-rays as well [111].
Figure 2.10: Schematic of a proposed Cˇerenkov radiation portal imaging de-
vice using silica optical fibres (figure reproduced from p.1480 of Teymurazyan,
2013 [111]). Note that the authors’ proposed segmented plastic scintillator array
comprised a similar geometry to that shown here, however the silica cores were
replaced with plastic scintillator [109].
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2.3 Dosimetry in radiotherapy
Radiation dosimetry involves the practices of measuring and calculating the dose
delivered by a beam of ionizing radiation. Its primary clinical uses include en-
suring the correct operation of all radiotherapy equipment, monitoring health
workers’ incidental radiation exposure and verifying the correct dose delivery to
patients. As such, performing accurate dosimetry is of critical importance within
the field of radiation oncology. Current ICRU guidelines for IMRT recommend
that in low dose gradient regions at least 85% of the target volume should receive
an absorbed-dose within 5% of prescription and in high dose gradient regions
at least 85% of the absorbed dose should be within 5 mm of the intended posi-
tion [113]. However, accuracy requirements are specific to each patient and clinical
scenario and will, in general, vary depending on the dosimeter being used and the
motivation for performing dosimetry in the first place. For example, the accuracy
required to detect gross dosimetric errors may not be as high as that required
to detect slight deviations from the treatment plan due to changes in patient
anatomy.
The technological development of novel dosimeters combined with the publi-
cation of protocols to facilitate widespread standardization of dosimetry practices
remain active areas of research. Only a brief overview of commonly used detec-
tors, with a more specific focus on dosimetry using EPIDs and plastic scintillators,
is given in the following subsections. For more in-depth information on topics
pertaining to radiation dosimetry and detector physics, the reader is referred to
several key resources including the classic textbooks by Johns and Cunningham
(1983) [114] and Attix (1986) [115], and more recent books by Williams and Thwaites
(2000) [116], Metcalfe, Kron and Hoban (2007) [117] and Khan (2010) [118].
2.3.1 Overview and commonly used detectors
As outlined throughout section 2.1.2, modern linacs are capable of delivering
geometrically complex and spatially precise radiation beams. However, linacs
must also deliver accurate and precise quantities of radiation to the target volume.
Often, the absorbed dose within a patient or phantom is the quantity of interest
and is defined as the amount of energy absorbed per unit mass from ionizing
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radiation. Absorbed dose is measured in units of Gray (Gy, where 1 Gy = 1
J/kg).
There are several clinical situations that warrant routine dosimetry in radio-
therapy and published, standardized guidelines exist for most common proce-
dures. Examples include the calibration and quality assurance of photon and
electron beams [40,119–123], personal radiation monitoring for occupational radia-
tion exposure [124], pre-treatment validation of TPS dose calculations [125,126] and
verification of the dose delivered at the patient level (in vivo) [92]. The ability to
monitor dose delivery in vivo is clearly a useful means of ensuring patient safety
and is especially useful in situations where it is critical to limit radiation expo-
sure, for example when treating near a radiosensitive organ at risk or implantable
device (see, for example, Studenski et al. (2012) [127]).
Dosimetry may be broadly classified into two categories: absolute dosimetry
and relative dosimetry. Absolute dosimetry is commonly performed when cali-
brating the radiation output of a linac under reference conditions and allows one
to convert between machine settings (such as monitor units (MU)) and absolute
dose in Gy [40,119,120]. Comparing dose measurements under non-reference condi-
tions to the absolute standard is known as relative dosimetry. Examples of relative
dosimetry include the measurement of percent depth dose (PDD) curves, relative
dose profiles or output factors. Measurements of this kind were frequently per-
formed throughout this work to characterize detector performance and validate
the response predicted using MC simulations.
There exist a wide range of dosimeters, each with their own advantages and
disadvantages, available for use in modern clinical practice. Examples include ion-
ization chambers [128], gafchromic film [129–131] and solid-state dosimeters, [132–135]
which include thermoluminescent dosimeters (TLDs) [136], EPIDs (discussed fur-
ther in Section 2.3.2) and plastic scintillators (described further in Section 2.3.3).
Only those dosimeters, including ion chambers and calorimeters, whose response
can be converted to absolute dose from first principles may be used for abso-
lute dosimetry [40]. These absolute dosimeters are typically calibrated against a
primary standard – in Australia, primary standards are maintained at the Aus-
tralian Radiation Protection and Nuclear Safety Agency (ARPANSA). Other rel-
ative dosimeters can only measure dose via cross-calibration against a calibrated
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absolute dosimeter.
2.3.2 EPID dosimetry
While EPID dosimetry is still not in routine practice, there are several arguments
to support ongoing development in this field. It has long been recognized that
EPIDs o↵er several advantages over alternative 2D dosimeters, including:
• Ready accessibility, frequently provided by linac vendors
• High spatial resolution (typically 0.4 mm – greater than modern ion cham-
ber/diode arrays)
• Real-time readout capabilities
• Linear dose response
• Dose response independent of dose rate
The primary drawback acting to complicate the use of standard EPIDs for
dosimetry is their over-sensitivity to low energy radiation relative to water – the
medium to which dosimeters are typically calibrated [86,91,99–102,137]. This comes
as a result of the high-Z components making up the active region of the detector
including the metal plate (usually copper (Cu)) and phosphor screen (usually
Gd2O2S:Tb). As a consequence of di↵erences between the mass attenuation coef-
ficients of x-rays in water and Gd2O2S:Tb (see Figure 2.11(a)), low energy x-rays
interacting in EPID phosphor screens have a much higher probability of undergo-
ing photoelectric absorption relative to water. EPID response is therefore highly
sensitive to factors that change the incident x-ray spectrum, such as the detector’s
position away from the beam central axis (beam softening) and the presence of
a patient or phantom in the beam (beam hardening) [49,87,101,138–142]. As a result,
the EPID response must either be calibrated for dosimetry based on the specific
procedure and geometrical configuration being used or a model-based approach
must be taken to predict the detector’s response to an incident beam.
Physicists at the Netherlands Cancer Institute have been especially productive
in establishing and demonstrating procedures to use current metal plate/phosphor-
based EPIDs for accurate 2d dosimetry [50,143–147]. As an example of the dosimet-
ric accuracy that may be achieved using current EPIDs for pretreatment IMRT
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verification, greater than 99% of the EPID dose image pixels in a 14 ⇥ 14 cm2
region encompassing the target volume satisfied   < 1 (2%/2 mm criteria) when
compared to film, the de facto gold standard for 2d dosimetry in many institu-
tions. [145] The authors did, however, acknowledge that the calibration processes
necessary are quite labour intensive. This may explain, at least in part, why
regular EPID dosimetry continues to be performed in a relatively small number
of centres worldwide.
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Figure 2.11: Comparison of the photoelectric (PE), incoherent scattering (Incoh)
and total mass attenuation coe cients for (a) water and Gd2O2S and (b) water
and BC430 plastic scintillator over the radiotherapy energy range (data obtained
from NIST XCOM database [148]).
A recent review by van Elmpt et al. (2008) gives an excellent overview of the
diverse applications for EPIDs in clinical dosimetry and the range of techniques
being implemented worldwide [49]. Non-transit EPID dosimetry (i.e. dosimetry
performed without a patient or phantom in the beam) is typically used as a
QA tool for factors influencing beam delivery. EPIDs have been used success-
fully in this manner for both IMRT QA [54,149–151] and VMAT QA [54,151–153]. By
detecting the therapy beam after having passed through a patient or phantom,
EPIDs may also be used for transit dosimetry. Both pre-treatment and in vivo
treatment verification may be performed by comparing the delivered dose dis-
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tribution (measured with the EPID) to the planned distribution predicted using
the TPS [50,51,145,146,151,154,155]. Each of these dosimetry methods may be further
categorized according to whether the detected fluence was reconstructed to give
calculated dose in 2D [145,151,154,155] or 3D [50,146,151].
With advanced radiotherapy techniques becoming increasingly common, treat-
ment deliveries have become highly complex and are tailored specifically to in-
dividual patients. Stringent QA methods are required now more than ever to
ensure the correct treatment delivery for each patient. Despite the lack of a
widespread, commercially available product to facilitate clinical EPID dosimetry,
some groups have developed in-house methods to use EPID dosimetry as a method
for detecting several sources of treatment error [50,51,145,146,149,151,154,155]. Some of
these errors may be detected using pre-treatment EPID dosimetry whereas others
require dosimetry to be performed in vivo. Potential errors may be categorized
into those that arise from the machine, the treatment plan or the patient. Table
4 from van Elmpt et al. (2008) provides an excellent summary of the various
sources of treatment delivery error and appropriate EPID dosimetry methods
that may detect them [49](see Figure 2.12). Presently, however, there is still no
general consensus regarding acceptance and rejection criteria for the errors in
question.
In 2010, Mans et al. published an excellent study that demonstrates the
potential for EPID dosimetry [50]. Over a period of three and a half years, their
centre performed pre-treatment or in vivo EPID dosimetry on the treatment plans
of 4,337 patients. Of these plans, 17 serious errors were detected that ultimately
led to plan intervention. Nine of these 17 errors would not have been detected with
pre-treatment verification alone, thereby demonstrating the important clinical
application of routine dosimetry performed throughout treatment delivery.
One of the primary goals for this thesis was to develop a next-generation
water-equivalent EPID that may be suitable for simultaneous imaging and dose
verification in radiotherapy. Using simulations and measurements to characterize
the dose response of standard and novel EPIDs therefore formed a significant
component of this work. The vast majority of ongoing EPID dosimetry research
focuses on modelling solutions for current generation EPIDs. The investigations
reported in this thesis therefore comprise several of only very few studies inves-
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Figure 2.12: Summary of treatment delivery errors detectable using EPID dosime-
try (figure reproduced from Table 4 of van Elmpt, 2008 [49].
tigating methods to improve this detector for dosimetry, without compromising
imaging capability. EPID dosimetry will thus remain a constant theme through-
out Chapters 4 – 8.
2.3.3 Plastic scintillation dosimetry
Plastic scintillators are one particular group of materials that have shown sig-
nificant promise in the field of radiation dosimetry [156]. The reason for this is
straightforward – since they are manufactured using low-Z materials, they have
repeatedly been shown to respond in a very nearly water-equivalent manner to ra-
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diation over the energy range typically encountered in radiotherapy [102,109,156–161].
They exhibit additional characteristics including energy independence, dose lin-
earity, resistance to radiation-induced damage and the ability to be manufactured
in very small sizes thus enabling high spatial resolution [102,156,157,161,162]. As a re-
sult of these attributes, plastic scintillation dosimeters do not require the same
correction factors as other non water-equivalent dosimeters to convert measure-
ments into absolute dose [156]. Much of the work involved in this thesis surrounds
the development of a novel radiation dosimeter that employs fibres made of plas-
tic scintillator; therefore their physical properties and related applications are
summarized here.
A significant proportion of plastic scintillators are manufactured using either
a polystyrene or polyvinyltoluene (PVT) base that is doped with organic fluors
to give them their scintillation properties. Some of the earliest reports regarding
the physical characteristics of plastic scintillating materials were published in the
early 1990s, including a pair of papers by Beddar et al. (1992a, 1992b) [157,158]
Properties including their physical and electron densities were found to be very
similar to water. By comparing the mass-energy absorption coe cients of the
plastic scintillator to those of water and noting their similarity, Beddar o↵ered
an initial demonstration of their water-equivalence (see Figure 2.11(b)). Burlin
cavity theory [163] was then used to give additional support to this claim [157].
When compared to air, lithium fluoride, and silicon (the active components of
ion chambers, TLDs and diodes, respectively), plastic scintillators were shown to
have a dosimetric response much closer to that of water.
Owing to the relative ease of manufacturing plastic scintillators, they may be
cut into a variety of custom shapes and sizes (see Figure 2.13). As a result, var-
ious prototype dosimeters using plastic scintillation detectors (PSDs) have been
reported in the literature [102,156–159,164–170]. Several of these prototype detectors
have been applied to non-transit and transit dosimetry [168,170,171], and have even
been demonstrated for potential in vivo IMRT and VMAT treatment verifica-
tion [167,172]. Additional applications to kV dosimetry [173] and brachytherapy [174]
have also been demonstrated.
The generation of Cˇerenkov light within fibre optic cables used in several
detectors to transfer signal from the irradiated scintillator to a readout device
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Figure 2.13: Assortment of plastic scintillator blocks (left) and fibres (right) that
may be used for x-ray detection (image courtesy of Saint-Gobain Crystals).
proved to be a significant source of noise in these systems. However, many tech-
niques have since been reported to correct for this phenomenon [157,160,175–177]. The
generation of Cˇerenkov light directly within the plastic scintillator is, however,
estimated to be ⇡ 3 orders of magnitude lower than that of scintillation light [109].
Plastics scintillators were studied extensively throughout this thesis while
characterizing novel water-equivalent prototype EPIDs developed by our group.
Saint-Gobain Crystals manufactured the BC430 plastic scintillator and BCF-
99-06A plastic scintillating fibres under investigation in these works. Additional
properties relevant to these specific scintillators are discussed in depth in Chapters
6 through 8, which describe our characterization of the imaging and dosimetric
capabilities of these novel EPIDs.
2.4 Monte Carlo radiation transport
The Monte Carlo (MC) method is a computational method with origins dat-
ing back to the late 1940s and originally published by Metropolis and Ulam in
1949 [178]. It is fundamentally based upon repeatedly selecting random numbers
to sample known probability distributions in order to solve problems that are
di cult or impossible to solve using analytical or deterministic methods. As
such, MC methods are especially well suited to problems that are stochastic in
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nature. While the focus on radiation transport throughout this thesis provides
an excellent example, applications for MC simulations are widespread across sev-
eral disciplines in science, engineering, statistics and finance [179]. This section
attempts to provide su cient background knowledge in MC simulations as they
apply to radiation transport physics by first describing the founding principles of
the MC method, then explaining how these principles may be used to model phys-
ical phenomena and finally extensions to specific applications in medical radiation
physics research.
2.4.1 Foundations and principles
The MC method takes advantage of modern computational capabilities by gener-
ating on the order of millions of random numbers each second. In its most basic
form, MC simulations rely on two fundamental principles: the generation of ran-
dom numbers and the sampling of known probability density functions (PDFs)
relevant to the problem being solved. These two aspects of the MC method are
explored more thoroughly in the following subsections.
2.4.1.1 Random number generators
The ability to perform MC simulations ultimately depends on the ability to gener-
ate random numbers. In principle, there are several ways to generate an infinitely
long sequence of random numbers. Examples range from the repeated roll of a
die to the measurement of radioactive decay, which is a stochastic physical pro-
cess. The downfall to these approaches is their practicality for use in modern
MC techniques that typically require one to sample millions of random numbers
within a time frame of a few seconds. While these examples are straightforward
and accurate in their ability to generate a sequence of numbers truly random in
nature, they are simply too slow to be useful for modern applications.
As a means around this issue, much e↵ort has gone into using modern com-
puters to generate sequences of random numbers that can then be applied to
numerical MC applications. While this typically resolves the time constraint for
generating large sequences of numbers, an obvious downside is that writing a
computer program to generate a sequence of random numbers will result in num-
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bers that are, by their very nature, not random. Nevertheless, there are several
algorithms in common practice today that are capable of generating sequences
of numbers that appear random, with periods (the sequence length before repe-
tition occurs) on the order of 1018 or greater [180]. Such algorithms are known as
pseudorandom number generators to reflect the fact that they approximate the
generation of truly random numbers.
While there are several di↵erent algorithms that may be used to create a
robust pseudorandom number generator, one class of algorithms most commonly
implemented is the linear congruential generator [179]. This class of generators uses
the following recursive algorithm to generate pseudorandom numbers Xt based
on integers a and c with a period up to the modulus, m:
Xt = (aXt 1 + c) mod m t = 1, 2, ... (2.1)
P. L’Ecuyer originally described a multiplicative form of the linear congruen-
tial algorithm (taking c = 0) known as the ranecu engine in his 1988 paper [180].
This pseudorandom number generator has a period of ⇡ 1018 and is one of sev-
eral engines pre-programed into the MC toolkit used throughout this thesis. The
ranecu engine was chosen because it has a large period and has been frequently
used in the literature. A recent textbook by Kroese, Taimre and Botev (2011)
provides an overview of several alternate generators as well as tests that may be
performed to evaluate their quality [179].
2.4.1.2 Probability density functions and sampling
A probability density function (PDF) is a term used to describe a function that
gives the relative probabilities for a random variable to assume a specific value.
While PDFs typically concern continuous variables, a simple example of a discrete
PDF is one that gives the relative probabilities of rolling a given number on
a standard die. Having six possible outcomes, each with an equal chance of
occurring, the discrete PDF for such a scenario would be a constant with value
1/6.
When applying the MC method to simulate a physical process, the PDFs un-
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der consideration reflect the probabilities for these physical processes to occur.
As an example, consider an x-ray with a given energy, momentum and polar-
ization in a known medium. This x-ray may undergo one of several physical
processes, although certain processes may be more likely to occur than others.
If one knows that PDF describing the relative probabilities for these processes
to occur, then a random number sampling that PDF may be used to determine
which process the x-ray undergoes. To accurately and realistically simulate such
a physical situation, one must know all the relevant PDFs for the processes under
consideration.
Most pseudorandom number generators supply numbers with uniform proba-
bility – that is, if a particular generator is constrained to returning numbers on
the interval (0, 1) then there is no preference within this range to generate any
particular subset of numbers. To generate numbers that follow known PDFs,
there are several algorithms in place to sample numbers from an inherently uni-
form pseudorandom number generator. The acceptance-rejection method is a
particularly simple algorithm which involves the uniform sampling of a pseudo-
random number and accepting it for further use only if it falls within the known
PDF [181]. If it falls outside of the PDF, this number is rejected and another
one is sampled, with the process repeating itself until a number is eventually
accepted. Using pseduorandom numbers to estimate the value of ⇡ provides a
simple demonstration of the acceptance-rejection method (see Figure 2.14). Since
the ratio of the area of a circle to that of a square with equal diameter is ⇡/4,
two pseudorandom numbers x and y may be uniformly generated in ( 1, 1) and
accepted only if x2 + y2  1. The ratio of accepted (x, y) to the total number n
generated will therefore converge to ⇡ for su ciently large n.
While the acceptance-rejection is simple to implement, it can be ine cient if sev-
eral numbers must be sampled before one is eventually accepted. The textbook
by Lemieux (2009) describes the acceptance-rejection and several alternate meth-
ods, including the inversion, composition and convolution methods, that may be
better suited to handling di↵erent PDFs [181].
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n = 100 n = 1,000 n = 10,000
Figure 2.14: Estimating ⇡ using pseudorandom number generation and the
acceptance-rejection method. The ratio of green “accepted” points to the to-
tal number of points generated, n, coverges to ⇡/4 for increasing n.
2.4.1.3 Ongoing and future developments
The MC method is very well suited for solving problems that are stochastic and
multidimensional in nature, and that may not be tackled with more conventional
means. As an inherent consequence of sampling random numbers to solve a
problem, one must ensure that apparent results arising from this method are not
attributable to random noise within the simulations. Therefore, depending on the
problem being solved and desired level of statistical uncertainty, exceptionally
large quantities of random numbers may be generated in a single simulation,
which can be very computationally intensive.
Recent and ongoing developments are attempting to mediate this problem by
optimizing the way MC simulations are performed on modern computers. One
key example uses parallel processing on multi-core and multi-threaded machines
including personal laptops, desktop computers and large-scale clusters. With each
core of a computer’s central processing unit (CPU) able to independently perform
calculations, one can take advantage of the repetitive nature of MC simulations to
break a single job into several smaller jobs that each may be executed on a single
CPU. Doing so e↵ectively shares the computational burden across several CPUs,
thereby reducing the overall time required for a simulation. Results from these
statistically independent runs may then be combined after the fact. Depending
on the specific conditions of the simulations, the total processing time may be
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linearly reduced by a factor that is approximately equal to the number of cores
being used.
More recent developments that have been shown to greatly increase the e -
ciency of performing MC simulations involve the use of graphical processing units
(GPUs) in conjunction with conventional CPUs. While modern CPUs contain
several cores to process serial computations, by delegating a small but highly
computationally intensive fraction of a MC simulation to the GPU (e.g. ran-
dom number generation), e ciency can be increased by several orders of mag-
nitude [182]. Unlike CPUs, GPUs possess hundreds to thousands of cores that
enable the simultaneous execution of simple, repetitive tasks. This particular
field of research shows incredible promise with regards to future developments of
MC simulations [183–185].
2.4.2 Radiation transport physics
Radiation transport is an inherently stochastic, multidimensional and non-linear
process and, in that capacity, is perfectly suited to MC simulations. The physics
of radiation transport is governed by the Boltzmann Transport Equation (BTE,
equation 2.2) which, when written in terms of the particle flux  (r,⌦, t) (units
of m 2 s 1 sr 1) at a position r, direction ⌦ and time t in a medium of interest,
may be written as [186]:
✓
1
c
@
@t
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 (r,⌦, t) = l 1sct
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4⇡
d2⌦0 (r,⌦0, t)P (⌦ ·⌦0) + S(r,⌦, t)
(2.2)
P (⌦·⌦0) is the probability density for a photon to scatter from an initial direction
⌦0 to a final direction ⌦, c is the speed of light, and lext and lsct are, respectively,
the extinction and scattering lengths and are properties of the medium. Equation
2.2 comprises five terms [186], the first two of which describe the leakage of photons
due to photon propagation out from a point r in direction ⌦. The third term
describes the loss of photons at r and in direction ⌦ due to interactions occuring
at that point and the fourth term represents the gain in photons at r, travelling in
direction ⌦ due to scattering at that point from all possible incoming directions
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⌦0 (hence the integral over 4⇡ steradians). Finally, the fifth term describes the
gain in photons due to a source S(r,⌦, t) at that point.
The BTE may be solved with MC methods by defining a particle source and
simulating each particle history by sampling the PDFs associated with that par-
ticle’s possible interactions. A particle’s cross section is the term used to describe
the probability for a given interaction to occur and is calculated using random
sampling of the cross section’s associated PDF. When considering radiation trans-
port, each physical process that a particle may undergo has its own cross section
that can depend on several parameters, often including at least the particle’s en-
ergy E and the atomic number Z of the medium. The total cross section,  (E,Z),
is equal to the sum of the individual cross sections for each interaction process
and represents the total probability for any interaction to occur. A summary of
the main particle transport processes simulated throughout this work is provided
in Table 2.1.
Table 2.1: Summary of the main particle transport processes.
Particle Process Cross section
X-ray Photoelectric absorption  pe
Compton scattering  kn
Pair production  pp
Electron Bremsstrahlung  brem
Mass collisional stopping power
⇣
dT
⇢dx
⌘
c
Mass radiative stopping power
⇣
dT
⇢dx
⌘
r
Optical photon Rayleigh scattering  ray
Bulk absorption –
Boundary processes –
 (E,Z) is intimately related to the particle’s mean free path (MFP),  (E),
by the relationship:
 (E) =
1P
i
[ni ·  (E,Zi)] (2.3)
where ni represents the number of atoms per unit volume of element i in a com-
pound material. While Equation 2.3 gives the MFP for a known particle, the
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actual step length simulated is sampled from a PDF of the form 1  e n  , where
n  is the total number of MFPs travelled by the particle and is a random variable
calculated from:
n  =   log ⌘ (2.4)
Here, ⌘ is a uniformly distributed random number on the interval (0, 1) [187].
The following subsections describe the most relevant x-ray (2.4.2.1 – 2.4.2.3)
and charged-particle (2.4.2.4 and 2.4.2.5) interactions in matter over the energy
range typically encountered in radiotherapy. Optical photon transport processes
are also detailed in Section 2.4.2.6 due to their relevance when modelling a-Si
EPIDs. Each gives the necessary theoretical background governing the calcula-
tion of each interaction’s cross section and explains the nature of applying these
processes within the context of MC radiation transport simulations.
2.4.2.1 Photoelectric absorption
Photoelectric absorption was first described by Einstein in 1905 and occurs when
a photon, incident upon a material, is absorbed and its energy transferred to
a bound electron (see Figure 2.15). If the energy transferred to the electron is
greater than its binding energy, the electron will be ejected from the atom with
kinetic energy equal to the di↵erence between the incident photon energy and the
binding energy.
Figure 2.15: Schematic illustrating the photoelectric e↵ect. An x-ray incident
from the left causes a K-shell electron to be ejected from the atom.
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The photoelectric absorption cross-section  pe for a photon with energy E 
and an atom with atomic number Z is given by equation 2.5:
 pe / Z
5
E7/2 
(N.R.)  pe / Z
5
E 
(E.R.) (2.5)
for incident photons in the non-relativistic range and away from absorption edges
(N.R.) and in the extreme relativistic range (E.R.) [188].
MC radiation transport codes simulate photoelectric absorption by sampling
the MFP that photons travel before undergoing photoelectric absorption, as well
as the energy and direction of the ejected electron [187]. The MC software toolkit
Geant4, used extensively throughout this thesis and discussed in depth in section
2.4.3.2, calculates the photon’s MFP using the parameterized photoabsorption
cross section proposed by Biggs et al. [187,189]:
 pe(Z,E ) =
a(Z,E )
E 
+
b(Z,E )
E2 
+
c(Z,E )
E3 
+
d(Z,E )
E4 
(2.6)
As described in the Geant4 Physics Reference Manual, the coe cients a, b,
c and d were determined using separate fits to experimental data (Grichine et
al., 1994) in several energy intervals [187,190]. Geant4 stores atomic shell binding
energies in tables and these are used to compute the ejected electron’s kinetic
energy. The ejected electron’s polar angle ✓ is sampled from the Sauter-Gavrila
distribution [191]:
d pe
d(cos ✓)
⇡ sin
2 ✓
(1    cos ✓)4
⇢
1 +
1
2
 (    1)(    2)(1    cos ✓)
 
(2.7)
where   = v/c and   = (
p
1   2) 1 are the Lorentz factors of the ejected
photoelectron with velocity v.
2.4.2.2 Compton scattering
Compton scattering occurs when a photon scatters inelastically o↵ an atomic
electron, imparting some of its energy to the electron in the process (see Figure
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2.16).
Figure 2.16: Schematic illustrating Compton scattering. An incident photon with
energy E0 inelastically scatters o↵ a free electron at an angle ✓ and with a reduced
energy E .
It is generally assumed that the electron is at rest and free. This is typically
a valid assumption since in situations where binding e↵ects would be significant
(such as high Z and low E ), photoelectric absorption events dominate (owing
to the Z5 dependence from equation 2.5). Simple kinematics therefore su ce in
the determination of the well known Compton formula [188]:
✏ =
E 
E0
=
mec2
mec2 + E0(1  cos ✓) (2.8)
where E0 and E  are the incident and scattered photon energies respectively, re is
the classical electron radius, mec2 is the rest electron mass and ✓ is the scattering
angle.
The di↵erential cross section per electron is given by the Klein-Nishina for-
mula [188,192]:
d e kn
d⌦
=
r2e
4
E2 
E20

E0
E 
+
E 
E0
  2 + 4 cos2 ✓
 
(2.9)
The total electronic cross section, which gives the probability for a Compton
scattering event between the incident x-ray and an electron, may be obtained by
integrating equation 2.9 over all ⌦.
A modified form of the di↵erential cross section per atom (note the additional
factor Z accounting for the number of electrons within the atom) is used by
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Geant4 and given by [187]:
d a kn
d✏
= ⇡r2e
mec2
E0
Z

1
✏
+ ✏
  
1  ✏ sin
2 ✓
1 + ✏2
 
(2.10)
To sample the total atomic cross section for Compton scattering events, Geant4
uses a form for a kn(Z,E ) with empirically-derived coe cients that reproduce
experimental data down to 10 keV [187]:
a kn(Z,E ) =

P1(Z)
log(1 + 2X)
X
+
P2(Z) + P3(Z)X + P4(Z)X2
1 + aX + bX2 + cX3
 
(2.11)
This empirical expression for a kn may be used to calculate the probability for a
Compton scattering event between the incident x-ray and an atom with atomic
number Z. The value of ✏ is sampled by applying combined acceptance-rejection
and composition MC methods to equation 2.9. After the successful sampling of
✏, the polar angles of the scattered photon with respect to the direction of the
parent photon are generated. The azimuthal angle,  , is generated isotropically
in 2⇡ and ✓ is calculated using equation 2.8.
2.4.2.3 Pair production
Pair production is the conversion of a photon into an electron/positron pair,
occurring most often within a Coulomb field near an atomic nucleus, and hence
is the opposite process to electron/positron annihilation (see Figure 2.17). The
laws of conservation of energy and momentum result in a lower threshold energy
for photons undergoing pair production, which is equal to two times the rest mass
energy of an electron (1.022 MeV).
The di↵erential cross section for pair production is given by the Bethe-Heitler
formula which, when corrected for the screening e↵ect and Born approximation,
takes the form [187,188]:
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Figure 2.17: Schematic illustrataing an x-ray with energy E  undergoing pair
production and converting into an e /e+ pair.
d pp(Z, ✏)
d✏
=  r2eZ [Z + ⇠(Z)]
⇢
[✏2 + (1  ✏2)]

 1( (✏))  F (Z)
2
 
+
2
3
✏(1  ✏)

 2( (✏))  F (Z)
2
  
(2.12)
Here,  (✏) is a screening variable and  1( ) and  2( ) are screening functions
that are introduced into equation 2.12 to correct for screening of the Coulomb
field by outer-shell electrons. A Coulomb correction factor F (Z) = 8/3 lnZ arises
from application of the Born approximation for E  < 50 MeV.
The total cross section per atom for the conversion of an x-ray into an e /e+
pair may be parameterized as [187]:
 pp(Z,E ) = Z(Z + 1)

F1(X) + F2(X)Z +
F3(X)
Z
 
(2.13)
where E  is the incident x-ray energy and X = ln(E /mec2). The functions
Fn(X) for n = 1, 2, 3 are a set of 5 degree polynomials in X, with coe cients
obtained from fits to data provided in Hubbell et al. (1980). [193] Geant4 uses
equation 2.13 to calculate the probability for a pair production interaction in
materials with 1  Z  100 and 1.5 MeV  E   100 GeV. Below the energy
Elow = 1.5 MeV, Geant4 uses the following extrapolation [187]:
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 pp(E) =  pp(Elow) ·
✓
E   2mec2
Elow   2mec2
◆2
(2.14)
The energies for the e /e+ pair may be sampled by using combined acceptance-
rejection and composition methods on equation 2.12. The polar angles ✓  and
✓+ with respect to the direction of the parent photon may be generated for the
e /e+ pair by sampling a PDF that approximates the energy-angular distribution
given by Tsai (1977) [187,194,195]. The azimuthal angles    and  + are generated
isotropically in 2⇡.
2.4.2.4 Bremsstrahlung
Bremsstrahlung radiation occurs when a charged particle decelerates while pass-
ing near a region of charge. A common example is that of an electron traveling
close to an atomic nucleus, such that the nucleus’ electric field alters the elec-
tron’s trajectory (see Figure 2.18). In approximately 2-3% of cases, an inelastic
interaction occurs between the charged particle and the nuclear field such that a
bremsstrahlung x-ray is emitted [115]. These x-rays may obtain up to 100% of the
charged particle’s kinetic energy, causing the charged particle to be drastically
slowed down (bremsstrahlung is the German word for “braking radiation”).
Figure 2.18: Schematic illustrating an electron passing near an atomic nucleus
and emitting a bremsstrahlung x-ray.
An expression for the di↵erential cross section for bremsstrahlung, which gives
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the probability that an x-ray quanta with energy E will be emitted in direction
✓0 relative to the direction of the incident electron and that the electron will be
scattered in a direction with polar angles ✓ and   relative to the x-ray quanta
is given by Bethe and Heitler (1934) [188]. By integrating over all angles, the dif-
ferential cross section describing the probability for generating a bremsstrahlung
photon with E may be written in a more concise form [115,188]:
d brem
dE
= 5.80⇥ 10 28BrZ
2
E
✓
T +mec2
T
◆
(2.15)
where T is the kinetic energy of the incident electron.
Extensive tables of di↵erential cross section data that are typically used by
MC codes to sample bremsstrahlung photon energies have been published by
Seltzer and Berger (1985, 1986) [187,196,197]. To sample the polar angles governing
the post-interaction particle directions, an approximation to the complex cross
sections provided by Tsai (1974, 1977) [194,195] may be given by [187]:
f(u) =
9a2
9 + d
 
ue au + due 3au
 
(2.16)
with a = 0.625 and d = 27 for the variable u = E✓/m. The polar angle ✓ may
then be sampled from f(u) using combined acceptance-rejection and composite
methods [187].
2.4.2.5 Collisional and radiative stopping power
Charged particles typically experience a very large number of interactions when
passing through matter, though they may only lose a minute portion of their
kinetic energy with each interaction. For example, a 1 MeV charged particle may
undergo ⇡ 105 interactions before losing all of its kinetic energy [115]. For this
reason, it is convenient to consider the rate of energy loss by a charged particle
with kinetic energy T per unit path length x in a medium with density ⇢, a
quantity known as the mass stopping power, dT/⇢dx.
When passing through matter, charged particles may lose energy through col-
lisions and through radiative loses (the most common being bremsstrahlung x-ray
emission as described previously in subsection 2.4.2.4). The total mass stopping
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power may be calculated as a sum of mass collision and radiative stopping powers:
dT
⇢dx
=
✓
dT
⇢dx
◆
c
+
✓
dT
⇢dx
◆
r
(2.17)
For electrons and positrons, the mass collision stopping power is given by:✓
dT
⇢dx
◆
c
= k

ln
✓
⌧ 2(⌧ + 2)
2(I/mec2)2
◆
+ F±(⌧)      2C
Z
 
(2.18)
where k ⌘ 0.1535Z/A 2, ⌧ ⌘ T/mec2,   is a density-e↵ect correction term and
C/Z is a shell correction term. The expressions for F±(⌧) are polynomials in ⌧
with the Lorentz factor   to account for relativistic e↵ects [115].
The mass radiative stopping power for electrons and positrons is given by:✓
dT
⇢dx
◆
r
=  0
NAZ2
A
(T +mec
2)Br (2.19)
where  0 =
1
137(e
2/mec2)2 is a constant, NA is Avogadro’s number and Br is a
slowly varying function in Z and T [115].
Values for mass collision and mass radiative stopping powers as function of
the charged particle energy may be found in published tables for a wide range
of materials (see, for example, the NIST estar database [198]). MC codes may
then either call upon stored look-up tables for stopping powers relevant to the
situation being simulated, otherwise they may be calculated prior to runtime for
specified media over an energy range of interest [187].
2.4.2.6 Optical processes
In the context of this thesis, optical photons are generated via Cˇerenkov radiation
and scintillation events. Once generated, they may undergo three types of pro-
cesses: elastic (Rayleigh) scattering, bulk absorption and boundary interactions
(reflection and refraction).
Geant4’s treatment of Rayleigh scattering requires users to specify the Rayleigh
scattering attenuation length for each material being considered. This scattering
length is the mean distance travelled by an optical photon before it undergoes
a Rayleigh scattering event. As an elastic scattering process, the only quantity
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sampled by Geant4 is the polar angle ✓ of the photon’s new polarization vector
with respect to its original. The di↵erential cross section for Rayleigh scattering,
d ray/d⌦, is proportional to 1 + cos2 ✓.
Simulating bulk absorption requires only that users input the bulk absorption
length (the mean distance travelled before a photon is absorbed) for each mate-
rial being considered. Modelling these events is trivial, as optical photon tracks
undergoing bulk absorption are simply terminated.
The manner in which boundary processes are handled naturally depends upon
the nature of the two materials making up the boundary. Broadly, there are two
such user-specifiable categories in Geant4:
• dielectric-metal boundary
• dielectric-dielectric boundary
In the simple case of a dielectric-metal boundary, the optical photon cannot
be transmitted and the user specifies the relative probabilities for the photon to
either be absorbed or reflected back into the dielectric.
For a dielectric-dielectric boundary, the optical photon can either be transmit-
ted or reflected. The probability for the photon to be reflected or refracted and
its respective angle of reflection or refraction depend on the indices of refraction
for the adjoining media and are governed by Fresnel’s equations [199]. More details
on the precise calculation of these quantities are given in the Geant4 Physics
Reference Manual [187].
Following Geant4’s implementation of the unified model for the treatment
of boundaries and surfaces published by Levin and Moisan (1996), users may
further customize the nature of boundaries between adjacent materials [200]. The
simple case of a perfectly smooth boundary is trivial, however there are alterna-
tive boundary descriptions that account for the existence of microfacets in the
boundary surface (see Figure 2.19). The amount of “roughness” is governed by
a user-specified parameter  ↵ such that an increased  ↵ correlates to a rougher
surface. When an optical photon reaches such a boundary, the true surface nor-
mal vector is sampled from a Gaussian distribution with standard deviation  ↵
and the angle of incidence is calculated with respect to this vector.
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Figure 2.19: Schematic illustrating the unified model’s treatment of optical
boundaries with microfacet surface structure and resulting specular spike (SS),
specular lobe (SL), di↵use lobe (DL) and back-scatter spike (BS) optical reflec-
tion and transmission distributions (figure reproduced from Levin and Moisan,
1996 [200]).
As a consequence of a rough optical surface, di↵erent types of optical reflection
may occur. These include specular spike, specular lobe, di↵use lobe and back-
scatter spike reflections, each of which may be assigned a relative probability of
occurance (Css, Csl, Cdl and Cbs respectively, as in Figure 2.19) with their sum
equalling unity. For more details, the reader is referred to the original paper by
Levin and Moisan [200].
2.4.3 Specific medical physics applications
Several MC codes are suitable for radiation transport modelling within the con-
text of medical physics. Many are freely available and open-source so that users
are made aware of the algorithms used to simulate di↵erent physical processes.
In these cases, users may also modify existing code to suit custom needs.
Two MC codes that are particularly popular within the field of medical
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physics, and which were used throughout this work, are egsnrc [201] (National Re-
search Council of Canada) and Geant4 [202,203] (CERN). While each has its own
advantages and disadvantages, both are frequently used within medical physics
research. Within the context of this work, two major uses for these tools were
to comprehensively model clinical radiotherapy photon beams and a-Si EPIDs.
Details concerning each of these broad tasks are given below, along with a brief
summary of other areas application for MC radiation transport codes.
2.4.3.1 Linear accelerator modeling with EGSnrc and BEAMnrc
Radiotherapy source models were developed throughout this work using the MC
codes egsnrc [201] and beamnrc [204]. egsnrc was written specifically for medical
physics applications and simulates x-ray, electron and positron transport within
the radiotherapy energy range. There also exist a number of freely-available user
codes that run on top of the egsnrc system [205]. beamnrc is one example and it
provides a user-friendly graphical user interface (GUI) to build models of clinical
linear accelerators. beamnrc provides a template for each component of a linac
and users simply input the relevant geometrical measurements that match the
accelerator they wish to model. It is capable of modelling both clinical photon
and electron beams and its ability to export the phase-space data of simulation
particles was frequently used throughout this work to score particles comprising
treatment beams. The output phase-space files may then be used as input into
a di↵erent simulation to, for example, model the transport of the clinical beam
within a phantom or detector. Details concerning the development and validation
of source models used in this work are given in Chapter 3.
egsnrc and beamnrc are widely used by medical physics researchers and are
frequently reported in the literature. They have become the standard tools to
generate and characterize radiotherapy source models, including both photon and
electron beams over a range of energy spectra [206–212]. An early publication by
Mohan et al. simulated clinical photon beams using egs Version 3 (a predeces-
sor to egsnrc). This frequently-cited paper simulated the energy spectra and
angular distribution of photon beams produced by a number of Varian linear
accelerators [206]. After the development of beam (a predecessor to beamnrc),
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Shiekh-Bagheri and Rogers (2002) evaluated the sensitivity of calculated depth-
dose curves and o↵-axis ratios to several incident electron beam and accelerator
mechanical parameters [207]. They further used beam to generate photon beam
energy spectra for nine MV accelerators from three di↵erent manufacturers and
then compared these to the results originally published by Mohan et al [206,208]. A
more recent study by Faddegon et al. compared the accuracy of egsnrc against
two other MC codes for modelling the electron scatter from 13 and 20 MeV
monoenergetic electron beams [211]. egsnrc has been used with alternative user
codes for detector modelling studies, including characterizing the response of a-Si
EPIDs [101,213–218]. The main drawback to using egsnrc for this application is its
inability to simulate the optical wavelength transport relevant for such scintil-
lation detectors. Alternate MC codes such as Geant4 self-consistently model
both x-ray and optical transport, and as such are better suited to these specific
applications.
2.4.3.2 Detector modeling with Geant4
Geant4 is a MC software toolkit that o↵ers a radiation transport physics plat-
form upon which users build custom applications across a range of disciplines [202,203].
By o↵ering several physics packages, Geant4 is equally applicable to the very
high energy physics studied at the Large Hadron Collider (LHC) and the lower
energy physics relevant for medical applications. Within this work, Geant4 was
used primarily to study the physics operating within a-Si EPID, however it is
often used in other areas of medical physics. Examples include kV and MV ra-
diotherapy [219–223], hadrontherapy [224–228], gel dosimetry [229], brachytherapy [230],
dose calculations [231], emission tomography [232], microbeam radiation [233] and ra-
diobiology [234] simulations. Each Geant application must contain at least a
user-defined geometry, radiation source, and physics packages. Geant4 is par-
ticularly adept at handling even highly complex geometries, such as the ATLAS
detector within the LHC (see Figure 2.20).
This work was predominantly concerned with simulating the response of an
a-Si EPID for portal imaging and dosimetry applications. A large proportion
of this involved validating models of commercial and prototype EPIDs to direct
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Figure 2.20: Geant4 visualization of the ATLAS detector at the LHC (image
courtesy of the Geant4 collaboration).
the future development of a next generation detector. Generally, one may use
MC simulations to model a detector’s response by scoring quantities such as the
particle fluence or energy deposited in a specific region. By comparing simu-
lated quantities to measured data, the model may then be validated. Geant4
was particularly well-suited to this work because, amongst other freely available
MC packages, it has the unique ability to simulate self-consistently both x-ray
and optical photon transport, relevant for indirect-detection EPIDs [202,203]. Al-
though the explicit simulation of optical transport has generally been regarded
as unimportant insofar as dosimetry simulations using standard EPIDs are con-
cerned [217,218,235], the self-consistent simulation of x-ray and optical transport had
not been modelled within standard EPIDs prior to the studies reported in this
thesis. Therefore, part of the motivation for this work (including most specifically
that reported in Chapter 4) was to use a novel model that more realistically sim-
ulated the physical processes operating within standard EPIDs to independently
validate these previous authors’ claims.
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Recently, several other groups have used Geant4 to investigate optical pho-
ton transport within phosphor screens [236], crystal scintillators [237–239] and novel
EPID designs [109–111]. Pistrui-Maximean et al. used Geant4 to model kV x-ray
and optical transport within a Gd2O2S:Tb phosphor screen and investigated their
relative contributions to the imager’s MTF [236]. Others have measured [240] and
simulated [237] light collection from BGO crystal scintillators while studying the
impact of optical reflectance on the scintillator surfaces. This study took advan-
tage of Geant4’s implementation of the unified model for optical transport [200]
and its ability to model transport based on user-specified look-up tables of mea-
sured optical reflectance angular distributions. Novel EPID designs have been
modelled by Teymurazyan and Pang using Geant4. One design incorporated
an array of plastic scintillating fibres [109] while another used an array of standard
optical fibers [111] and was based on an earlier Cˇerenkov portal imaging device [112].
2.5 Motivation and Project Aims
The overarching goal of this work is to develop a next-generation a-Si EPID that
is capable of simultaneous imaging and dosimetry in modern radiotherapy. De-
spite the rapid evolution in our ability to deliver highly conformal x-ray beams,
limitations with current detectors hinder our ability to measure dose delivery to
the patient for QA and treatment plan optimization. The availability of such
a detector would be extremely beneficial both to verify that the actual dose
delivered matches the planned dose distribution and for identifying those pa-
tients that would benefit from treatment adaptations, thus making radiotherapy
safer and more e↵ective. While current metal plate/phosphor-based EPIDs o↵er
quantum-limited imaging and may be used for dosimetry, calibration processes
are labour intensive. Consequently, their dosimetric abilities have not translated
into widespread clinical implementation. A next-generation EPID that improves
upon this limitation by, for example, o↵ering water-equivalent dosimetry would
simplify in vivo dosimetry procedures by reducing the calibration workload and,
as a result, may prove to be a more reliable measurement system. One important
hypothesis that persists throughout all investigations comprising this thesis is
that a next-generation EPID may be developed that:
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1. O↵ers imaging performance equivalent to or better than current EPIDs,
and
2. Exhibits a dose response that di↵ers by less than 2% from standard mea-
surements of radiotherapy photon beams using reference dosimeters
The first task towards achieving this goal was to develop and validate a com-
prehensive model of the standard commercially available a-Si EPID. In doing so,
a more specific aim was to characterize the relative importance of di↵erent phys-
ical processes on the detectors response. This study self-consistently simulates,
for the first time, x-ray and optical photon transport within the standard a-Si
EPID. The development and validation of the standard EPID model as applied to
non-transit dosimetry are discussed in Chapter 4. An extension of the standard
EPID model to transit dosimetry is presented in Chapter 5.
The next major task, presented in Chapter 6, was to evaluate the imaging and
dosimetry capabilities of a novel EPID designed and purchased by our group.
This EPID employed an array of plastic scintillating fibres and was designed
for simultaneous imaging and dosimetry capabilities. The study involved the
first experimental characterization of this type of detector to be reported in the
literature and demonstrated its water-equivalent response.
To aid in the characterization of our physical prototype and the future opti-
mization of its design, a model of this novel EPID was developed. The previously
validated standard EPID model was reconfigured into the novel EPID geometry
based on an updated, second-generation prototype purchased by our group. The
di↵erent fibre geometry used in this second-generation prototype was primarily
influenced by the measurements performed using the first-generation prototype
described in Chapter 6. With limited information available to describe radiation
transport within this geometry, it was necessary to first investigate how di↵erent
model parameters a↵ected the detector response. A characterization of this new
model and preliminary optimization of the novel EPID geometry is presented in
Chapter 7.
Finally, the novel EPID model was validated against experimental measure-
ments taken with the second-generation prototype. The goal was to quantify and
validate both the imaging and dosimetric response of the novel EPID model, and
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this work is presented in Chapter 8. The final, validated model of the novel EPID
represents a very useful tool that will be used to investigate aspects of the detec-
tor design that may be optimized in future generations. The main conclusions
derived throughout this work, along with considerations for future studies, are
presented in Chapter 9.
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3
Source modelling and validation
The work presented in this chapter constitutes the development, optimisation and
experimental validation of a Monte Carlo model of a clinical 6 MV x-ray photon
beam source.
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3.1 Overview of the BEAMnrc source model
The Monte Carlo radiation transport user code beamnrc is one of the most fre-
quently used MC packages within the field of medical physics [1]. It was designed to
facilitate the development of clinical linear accelerator (linac) photon and electron
beam source models and uses the egsnrc code for simulating radiation transport
within the accelerator geometry [2].
To create a linac source model, users simply build their desired accelera-
tor by combining the necessary beamnrc pre-defined component modules. The
user then specifies geometric and material parameters, most commonly accord-
ing to information provided by the linac manufacturer. Rather than relying
on manufacturer-provided values, certain parameters may instead be measured
directly and these values inputted into the beamnrc model for a more precise
detector specification [3].
The component modules specified in the linac source models used throughout
this work included a tungsten target, primary collimator, flattening filter, mon-
itor ionization chamber, mirror, multi-leaf collimator and tungsten jaws. More
details describing the various functions of each component may be found in the
original paper describing the beam system [1] as well as the user manual available
with the current version of beamnrc. A schematic illustrating the geometrical
configuration of these components in the modelled linac is illustrated below in
Figure 3.1.
As described in Section 2.1.2 of Chapter 2, to generate a clinical photon beam
of high energy x-rays, electrons are generated from an electron gun and accel-
erated along a waveguide before colliding with a high atomic number target [4].
beamnrc replaces the electron gun and waveguide with a simplified beam of elec-
trons directly incident upon the target with a user-specified energy and geometry.
When validating the source model against experimental measurements, it is com-
mon practice to adjust sensitive parameters such as the electron energy spectrum
and beam geometry, which are di cult to measure directly, when optimising
the agreement between simulated and measured data. Almberg et al. described
a multivariate source electron optimisation procedure for users desiring a sim-
ple and not time-consuming method to achieve percent-level agreement between
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Figure 3.1: Schematic of the Elekta Synergy linear accelerator photon beam
model developed using beamnrc.
simulated and measured data [5]. A summary of the optimised source electron
parameters is given below in Table 3.1.
Table 3.1: Summary of the optimised source electron beam parameters used in
the validated linac photon beam model.
Parameter Value
Electron energy (MeV) 6.55
BEAMnrc Source Number 19 (ellipse)
 x 1 mm
 y 1 mm
Mean angular spread (degrees) 1.35
To improve the simulation e ciency of a beamnrc linac model, users may
specify global electron and photon cut-o↵ energies (variables named ecut and
pcut respectively). When an electron’s energy falls below ecut, its history
is terminated and its remaining energy is deposited locally (the same occurs
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when a photon’s energy drops below pcut). Furthermore, several optional vari-
ance reduction techniques are o↵ered that users may choose to take advantage
of [1]. One such technique, known as directional bremsstrahlung splitting (DBS),
was used for all linac simulations in this study and involves the “splitting” of
bremsstrahlung photons that are aimed into a region of interest (typically a cone
described by the linac target position and a DBS radius defined at the isocentre).
When a photon is “split”, a significantly greater number of identical photons
(determined by the DBS splitting number) are generated instead, each with a
reduced weight equal to the inverse of the DBS splitting number. This technique
e↵ectively reduces the total number of primary histories that need to be simu-
lated in order to achieve a given level of statistical uncertainty in the simulation.
The cut-o↵ energies and DBS parameters used in this work are summarised in
Table 3.2. More details concerning this and other variance reduction techniques
may be found in the beamnrc manual.
Table 3.2: Summary of the radiation transport and variance reduction parameters
used in the validated linac photon beam model.
Parameter Value
ECUT 0.7 MeV
PCUT 0.01 MeV
DBS splitting number 1,000
DBS splitting radius 40 cm
Phase-space files of the 6 MV photon beam were generated using the beamnrc
source model by scoring the charge, energy, position and momenta of all particles
passing through a pre-defined plane z = 89.5 cm from the linac target. These
phase-space files were created for open field sizes ranging from 5⇥5 to 40⇥40 cm2
and were used as input to a Geant4 model of a water phantom. To validate the
linac source model, central axis percent depth dose (PDD) curves, relative dose
profiles, and field size output factors were calculated from simulations of dose
deposited in water and compared with experimentally measured values.
Validation of the original beamnrc source model, as reported in the appendix
of Blake et al. (2013) [6], is discussed thoroughly in Section 3.2. Following that
study’s publication, the source model was optimised further according to the
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method described by Almberg et al. (2012) [5] and the optimised source model
was then used in all future modelling studies [7,8]. The process of optimising the
source model is discussed in Section 3.3.
3.2 Non-transit dosimetry source model valida-
tion
The following source validation procedure and results were originally reported in
the appendix of the publication characterising optical transport within a model
of a standard a-Si EPID which is included in Chapter 4 of this thesis [6].
In order to validate the MC source model, dose in water measurements were
performed including PDD measurements, relative dose in-plane and cross-plane
profile measurements at depth of dose maximum (dmax), and field size output
factor measurements. Static open fields measuring 5⇥5, 10⇥10, 20⇥20 and 40⇥40
cm2 were used. PDD and relative dose profile measurements were performed using
a linearly scanning CC13 ionization chamber (IBA Dosimetry GmbH, Germany)
in a water tank with a source to surface distance (SSD) of 100 cm. Relative
dose profiles were also verified using film for the 5 ⇥ 5 and 10 ⇥ 10 cm2 fields
to account for volume averaging e↵ects of measurements made using the ion
chamber. Output factors were measured with the ionization chamber positioned
on the beam central axis at a depth of 10 cm in the water phantom and with a
SSD of 90 cm. All dose in water measurements were performed with irradiations
of 50 MU and a nominal dose rate of 500 MU/min, where 1 MU is defined as a
delivered dose of 1 cGy at dmax in water under reference conditions (at the center
of a 10⇥ 10 cm2 field with SSD = 100 cm).
3.2.1 Percent depth dose validation
A comparison of simulated and experimentally measured PDD curves in water for
a 6 MV photon source is shown in Figure 3.2. The energy deposited within 2 mm
of the central axis was scored in 1 mm bins along the central axis to calculate
the PDD data. The curves for the 5 ⇥ 5, 10 ⇥ 10, 20 ⇥ 20 and 40 ⇥ 40 cm2
open field sizes have been scaled by factors of 0.9, 1.0, 1.1, and 1.2, respectively,
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for improved clarity. Error bars indicating statistical uncertainties for simulation
results are smaller than the symbols representing the data points. Between dmax
and 300 mm, 99%, 99%, 100% and 100% of the MC simulated data points have
   1 (2%/2 mm) for the 5⇥ 5, 10⇥ 10, 20⇥ 20 and 40⇥ 40 cm2 open field sizes,
respectively.
3.2.2 Relative dose profile validation
Relative dose profiles in the cross-plane direction at dmax for simulated and ex-
perimentally measured data are shown in Figure 3.3. Relative dose profiles were
calculated from slices through the central axis at a depth of 15 mm in the wa-
ter phantom in 1 mm bins. Seventy-four percent, 81%, 91%, and 95% of MC
simulated data points had    1 with 2%/2 mm criteria for the 5 ⇥ 5, 10 ⇥ 10,
20⇥ 20 and 40⇥ 40 cm2 profiles, respectively. Similar agreement was obtained in
the in-plane direction (data not shown). Subsequent to this work, an improved
agreement in penumbra was determined by optimising the source electron beam
parameters following the procedure described by Almberg et al [5]. However, since
this study’s primary focus was on the e↵ects of optical transport within the EPID
model, and given the impractical time burden of repeating the modeling study,
the accuracy achieved using our original source electron beam parameters was
su cient for our purposes.
3.2.3 Field size response validation
A comparison of simulated and experimental field size output factors is shown in
Figure 3.4 with the values agreeing to within 1 SD (experimental error bars are
smaller than the corresponding points on the figure). Field size output factors
were calculated from the mean energy deposited in the central 1 ⇥ 1 cm2 at 10
cm depth in the water phantom. The largest di↵erence between simulated and
measured output factors was 1.1% and occurred for the 40 ⇥ 40 cm2 field size.
This discrepancy is most likely due to the systematic error in the source electron
beam parameters described previously for the relative dose profiles.
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Figure 3.4: Experimental (Exp) and simulation (Sim) field size output factors at
depth = 10 cm in water with SSD = 90 cm. Error bars represent a statistical
uncertainty of one SD of the MC calculated dose in water within the central 1⇥1
cm2 region.
3.3 Source electron parameter optimisation
Following publication of the initial source model described in Section 3.2, the
linac model was further optimised according to the method described by Alm-
berg et al. for optimising the source electron parameters in beamnrc [5]. Briefly,
this procedure follows a three step process whereby users tune individual source
electron parameters to determine first the optimal electron energy, second the
optimal radial electron intensity and finally the electron beam’s mean angular
spread.
The source electron energy was first optimised by comparing simulated cen-
tral axis PDD curves to experimental measurements for a 5 ⇥ 5 cm2 open field
size. The PDD curves were measured and simulated for a photon beam normally
incident on a water phantom, with the relative dose deposited calculated as a
function of depth within the phantom. Varying the source electron energy in the
linac model caused a slight change in the position of dmax, with higher electron
energies resulting in greater dmax. As such, the optimal source electron energy
was determined by observing which energy resulted in a depth dose curve that
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best matched the experimental measurements. Figure 3.5 compares several depth
dose curves simulated for monoenergetic electron energies ranging from 6.00 MeV
to 6.80 MeV against experimentally measured data for a 5 ⇥ 5 cm2 field. Given
the very slight changes observed for the series of depth dose curves, the local
percent di↵erence between the simulated and measured data was also calculated.
These di↵erences, along with lines of best fit, are illustrated in Figure 3.6. The
electron energy that resulted in a local percent di↵erence plot with minimal slope
is that which provided the best agreement with the measured data. Hence, a
monoenergetic electron energy of 6.55 MeV was the optimal value for our linac
source model and this value was used in all subsequent work.
Figure 3.5: Percent depth dose curves calculated for a series of beamnrc simula-
tions with varying source electron energy and experimentally measured data. A
subplot showing the  -index (2%/2 mm) comparing the experimental and simu-
lation curves is also shown.
Once the source electron energy was optimised, the radial intensity of the
electron beam incident upon the target was adjusted and relative dose profiles
were calculated in directions perpendicular to the beam central axis (parallel and
perpendicular to the MLC leaves). As a consequence of the non-zero radial elec-
tron beam intensity, dose profiles measured for static, open fields comprise three
regions: an in-field region, an out-of-field region and a penumbra region surround-
ing the field edges. Altering the radial intensity of the source electron beam no-
ticeably modified the shape of the profile penumbra, therefore by matching the
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penumbra shape to experimental measurements the optimal radial intensity was
determined. Experimental measurements were performed using gafchromic film
because this dosimeter o↵ers the greatest spatial resolution, critical for accurately
defining the penumbra shape. 5⇥ 5 and 10⇥ 10 cm2 dose profiles were measured
by irradiating the film with 50 MU at 6 MV in a solid water phantom setup with
9 cm of backscatter, 1.5 cm of buildup and a source to surface distance (SSD) of
100 cm.
beamnrc o↵ers users several pre-defined source electron beam shapes ranging
from the simplest point source to very complex geometries. Source 19, which is
defined as an elliptical beam with Gaussian distributions in x and y, parallel or
with radial divergence, was used for all linac source modelling in this work. When
using this source geometry, the Gaussian full width at half-maximum (FWHM,
 x and  y) defined the width of the elliptical source in the x and y dimensions,
respectively.
Figure 3.7 illustrates experimental profiles measured in directions parallel and
perpendicular to the MLC leaves for a 5 ⇥ 5 cm2 static, open field along with a
series of simulated profiles calculated with varying radial distributions, specified
using values of   ranging from 0.0 to 0.25 cm. To determine the optimised
values of  x and  y that gave the greatest agreement with the experimental data,
the root mean square (RMS) di↵erence between each simulated profile and the
experimental profile was calculated for the small regions within ±2mm of the
field edges and plotted as a function of   (see Figure 3.8). The values for  x
and  y that minimized the RMS di↵erence were therefore determined to be the
optimised values for the source electron radial distribution. Despite not giving the
minimal RMS di↵erence for profiles in the direction perpendicular to the MLC
leaves, values of 0.1 cm were used for both  x and  y in all subsequent work to
maintain radial symmetry of the source electron beam.
The final source electron beam parameter to be optimised using the method
described by Almberg et al. was the mean angular spread of the source electrons
about the beam central axis. For a parallel beam, the mean angular spread
would have assumed a value of zero. However by increasing the value of this
parameter, changes in the shape of the dose horns at distances away from the
central axis were observed in the relative dose profiles for large fields. The mean
100
3.3. Source electron parameter optimisation
Figure 3.7: Relative dose profiles calculated parallel (above) and perpendicular
(below) to the MLC leaves for a range of   compared to experimentally measured
profiles. Subplots showing the  -index (2%/2 mm) comparing the experimental
and simulation profiles are also shown.
angular spread may therefore be adjusted to improve agreement in large field
profiles without a↵ecting the response for small fields. Figure 3.9 illustrates
several relative dose profiles calculated for a 40 ⇥ 40 cm2 field size and a range
of mean angular spread values, as well as an experimentally measured profile, in
directions both parallel and perpendicular to the MLC leaves. The local percent
di↵erence between simulated and measured profiles was used to determine the
mean angular spread that minimized the di↵erence between the datasets. These
local percent di↵erences are shown in Figure 3.10. A mean angular spread of
1.35  was found to be su cient and was used throughout the remainder of this
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work. A summary of the final optimised source electron beam parameters is given
in Table 3.1.
Figure 3.8: The RMS di↵erence between each of the above relative dose profiles
and the experimental data. RMS di↵erences are plotted as a function of   for
profiles calculated in both the directions parallel and perpendicular to the MLC
leaves.
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Figure 3.9: Relative dose profiles calculated parallel (above) and perpendicular
(below) to the MLC leaves for a range of mean angular spread values compared
to experimentally measured large field (40 ⇥ 40 cm2) profiles. Subplots showing
the  -index (2%/2 mm) comparing the experimental and simulation profiles are
also shown.
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Figure 3.10: The local percent di↵erence between simulated relative dose profiles
and the experimental data. The di↵erences are shown for profiles calculated in
both the directions parallel (‘Par’) and perpendicular (‘Perp’) to the MLC leaves.
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4
Characterization of optical transport
e↵ects on EPID dosimetry using
Geant4
The work presented in this chapter constitutes the development, characterisation
and experimental validation of a Monte Carlo model of a standard amorphous
silicon electronic portal imaging device and clinical 6 MV x-ray photon beam
source.
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Abstract
Purpose: Current amorphous silicon electronic portal imaging devices (a-Si
EPIDs) that are frequently used in radiotherapy applications employ a metal
plate/phosphor screen configuration to optimize x-ray detection e ciency. The
phosphor acts to convert x-rays into an optical signal that is detected by an
underlying photodiode array. The dosimetric response of EPIDs has been well
characterised, in part through the development of computational models. Such
models, however, have generally made simplifying assumptions with regards to
the transport of optical photons within these detectors. The goal of this work was
to develop and experimentally validate a new Monte Carlo (MC) model of an a-Si
EPID that simulates both x-ray and optical photon transport in a self-contained
manner. Using this model the authors establish a definitive characterisation of the
e↵ects of optical transport on the dosimetric response of a-Si EPIDs employing
gadolinium oxysulfide phosphor screens.
Methods: The Geant4 MC toolkit was used to develop a model of an a-Si
EPID that employs standard electromagnetic and optical physics classes. The
sensitivity of EPID response to uncertainties in optical transport parameters
was evaluated by investigating their e↵ects on the EPID point spread function
(PSF). An optical blur kernel was also calculated to isolate the component of
the PSF resulting purely from optical transport. A 6 MV photon source model
was developed and integrated into the MC model to investigate EPID dosimetric
response. Field size output factors and relative dose profiles were calculated
for a set of open fields by separately scoring energy deposited in the phosphor
and optical absorption events in the photodiode. These were then compared to
quantify e↵ects resulting from optical photon transport. The EPID model was
validated against experimental measurements taken using a research EPID.
Results: Optical photon scatter within the phosphor screen noticeably broad-
ened the PSF. Variations in optical transport parameters reported in the litera-
ture caused fluctuations in the PSF full width at half maximum (FWHM) and
full width at tenth maximum (FWTM) of less than 3% and 5%, respectively, con-
firming model robustness. Greater deviations (up to 9.5% and 36% for FWHM
and FWTM, respectively) were observed when optical parameters were largely
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di↵erent from reference values. When scoring energy deposition in the phosphor,
measured and calculated output factors agreed within statistical uncertainties and
at least 94% of the MC simulated profile data points passed 3%/3mm  -index
criterion for all field sizes considered. Despite statistical uncertainties in optical
simulations arising from computational limitations, no di↵erences were observed
between optical and energy deposition profiles.
Conclusions: Simulations demonstrated noticeable blurring of the EPID PSF
when scoring optical absorption events in the photodiode relative to energy depo-
sition in the phosphor. However, modelling the standard electromagnetic trans-
port alone should su ce when using MC methods to predict EPID dose response
to static, open 6 MV fields with a standard a-Si photodiode array. Therefore, us-
ing energy deposition in the phosphor as a surrogate for EPID dose response is a
valid approach that should not require additional corrections for optical transport
e↵ects in current a-Si EPIDs employing phosphor screens.
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4.1 Introduction
Patient-specific verification of dose delivery is ever more desirable to ensure the
correct delivery of complex treatment fields in radiotherapy. By monitoring the
dose delivered to the patient throughout the treatment course, necessary adap-
tations to the treatment plan may be made (for example, in cases of changing
patient anatomy). Electronic portal imaging devices (EPIDs), which are based
on active matrix flat-panel imager technology [1], have been demonstrated to be
suitable for radiotherapy dosimetry applications due in part to their high spa-
tial resolution, real-time data acquisition capabilities, and resilience to radiation-
induced damage [2–4]. Furthermore, they have been shown to exhibit a response
that is linear with dose and independent of dose rate [2].
Despite their demonstrated dosimetric capabilities, EPIDs are primarily de-
signed for megavoltage imaging and used clinically for verifying patient position-
ing. Present commercially available EPIDs indirectly detect incident radiation
by means of a metal plate and phosphor screen (typically terbium-doped gadolin-
ium oxysulfide, Gd2O2S:Tb) that converts x-rays into optical photons which are
detected by an underlying amorphous silicon (a-Si) photodiode array. These
indirect-detection EPIDs have been shown to be input-quantum-limited at low
doses with a reported detective quantum e ciency of approximately 1% [5]. A
high atomic number x-ray converter provides e cient detection of photons suit-
able for low dose imaging in commercial EPIDs. However, such x-ray converters
present problems when using these detectors for dosimetry applications. It is
well reported [6–8] that the Gd2O2S:Tb phosphor has greater sensitivity to low
energy photons as photoelectric absorption events dominate for energies lower
than ⇡ 300 keV. This results in a nonwater equivalent dosimetric response that
complicates EPID calibration to reference dosimeters such as an ion chamber
in water. Previous studies have demonstrated the relative importance of EPID
layers to dose–response [9].
One method of performing dose verification using EPID images is to compare
portal dose images with predicted dose distributions calculated using a predictive
EPID model. A number of studies have demonstrated the ability to accurately
predict EPID dosimetric images by employing Monte Carlo (MC) simulations of
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radiation transport in EPIDs [6,10–13]. The majority of these studies have, however,
made simplifying assumptions regarding the significance and/or e↵ects of optical
photon transport in these detectors. The blurring e↵ects of optical transport have
been estimated to be less than 1 mm in a notional detector modeled by Wittenau
et al. [10] That study, however, did not explicitly model optical transport and
incorporated a relatively thin (35.7mg cm 2 Gd2O2S:Tb) phosphor screen.
A detailed MC model of a Varian aS500 EPID was developed by Siebers
et al. to compute static and IMRT portal dose images using a 6 MV photon
beam [11]. Calibrated MC-computed dose images agreed very well with measured
images, however, an empirically derived layer of backscatter material was re-
quired to match computed and measured dose profiles. While optical transport
was not modeled in this study, the authors acknowledged that the e↵ects of
optical scatter would be similar to the scattering e↵ects resulting from the ap-
plied backscatter layer, and that perhaps both backscatter and optical scatter
contributed toward signal blurring. Other studies have also reported agreement
between MC-computed and measured EPID response. Parent et al. developed
a MC model of an Elekta iViewGT EPID to investigate changes in response
for open and IMRT fields due to spectral variations occurring away from the
beam central axis [12]. Generally good agreement between simulated and mea-
sured IMRT fields was found, despite response variations of up to 29% observed
at o↵-axis field positions compared to central axis fields. Wang et al. used MC
methods to produce a series of monoenergetic EPID dose kernels for varying thick-
nesses of backscatter material [13]. The e↵ective backscatter thickness required to
match predicted and measured field size response was determined for five dif-
ferent Varian aS500/aS1000 imagers. By convolving the dose kernels with the
energy-di↵erential particle fluence at the imager plane, EPID field size response
for the five imagers was modeled to within 0.34% of measured values.
While the aforementioned studies scored the energy deposited in the phos-
phor layer to calculate portal dose images, others have used empirical [14] and MC
methods [15] to include the e↵ects of optical transport in their prediction models.
Warkentin et al. reported dosimetric IMRT verification by deconvolving EPID
images with dose deposition and optical glare kernels into primary fluence distri-
butions that were compared with measurements [14]. The optical glare kernel was
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described as a double-exponential function with parameters determined by fitting
the resulting fluence profiles to measurements. A similar deconvolution approach
was reported by Kirkby and Sloboda, however this study used MC methods to
calculate dose deposition and optical point spread functions (PSFs) [15]. These
PSFs were then combined to yield an overall kernel that was used to deconvolve
EPID images into fluence distributions. In that study, optical transport notice-
ably broadened the overall kernel.
The treatment of optical blurring in modeling EPID dose response is incon-
sistent and its importance remains unclear. The goal of this work was to develop
and experimentally validate a new MC model of an EPID that is self-contained
in its treatment of x-ray and optical photon transport. While this method in-
curs a significant computational burden associated with the individual tracking of
large numbers of optical photons, modeling EPID response in this manner o↵ers
a more physically realistic scenario of the interactions and transport e↵ects lead-
ing to image formation in current a-Si EPIDs than previously reported models
employing cascaded approaches or neglecting optical transport altogether. With
this model we may therefore provide a definitive characterisation of the e↵ects of
optical transport on the dosimetric response of a-Si EPIDs.
4.2 Methods and Materials
4.2.1 Description of the Monte Carlo model
All MC simulations were performed using a computer cluster employing 252⇥2.67
GHz CPUs. The open source message passing interface OpenMPI⇤ was employed
to automate management of batch simulations run in parallel.
4.2.1.1 6 MV photon source
The radiation transport MC code egsnrc [16] (V4 2.3.1) and user code beamnrc [17]
(V4 2.3.1) were used to model an Elekta Synergy 6 MV photon source that was
used for all EPID simulations. A detailed description of the linear accelerator
⇤http://www.open-mpi.org/
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components was provided by the manufacturer (Elekta, Crawley, UK) for input
into beamnrc. Source 19, which defines the spatial distribution of the source elec-
tron beam by an ellipse, was used with a FWHM of 0.11 cm about the central
axis in the x and y directions and zero angular spread. A Gaussian distribution
with a mean energy of 6.0 MeV and FWHM of 0.21 MeV defined the source
electron energy spectrum. Global ecut and pcut of 0.7 and 0.01 MeV, respec-
tively, were used. Finally, directional bremsstrahlung splitting with a splitting
number of 1,000 and a splitting radius of 40 cm was used when modeling all open
fields. After passing through all field-defining components of the linear accelera-
tor, particles traversing a predefined plane (z = 89.5 cm from the upper surface
of the tungsten target) perpendicular to the beam central axis were scored and
saved in an output phase-space file. It was found that 5⇥ 108 primary histories
were su cient to achieve statistical uncertainties in the EPID model of less than
1%. The history-by-history uncertainty method described by Walters et al. was
used to calculate all statistical uncertainties quoted in this study, unless otherwise
stated [18]. This method accounts for correlations that may exist between particles
in a phase-space source originating from the same primary history. Validation of
the source model is provided in the Chapter 3.
4.2.1.2 EPID geometry and electromagnetic physics
The Geant4 MC simulation toolkit [19,20] (version 9.4) was used to develop the a-
Si EPID model and was chosen for this study because of its demonstrated ability
to simulate x-ray and optical photon transport [21,22]. root [23] (version 5.28.00)
was used for the postprocessing data analysis. The model consists of a series
of uniform layers representing individual detector components. Geometrical and
material compositions were obtained from specifications supplied by the manu-
facturer of the EPID used in the validation stage of this study (PerkinElmer,
Santa Clara, CA). The EPID model (XRD 1640 AN CS) has a cross-sectional
area measuring 41⇥41 cm2 centered on, and perpendicularly oriented to the cen-
tral axis of the incident beam. A schematic of the key layers of the EPID model
is given in Figure 4.1. The modeled phosphor screen includes front and back cel-
lulose acetate protective overcoats, a reflective support layer, and a Gd2O2S:Tb
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active layer with a reduced density of 5.64 g cm 3 (calculated from manufacturer
specifications) to account for the e↵ect of the low density polyurethane binder
used to suspend the phosphor grains. The a-Si photodiode layer was modeled as
a thin (0.1mm), uniform layer of a-Si supported by a 1mm SiO2 substrate. The
pixelated structure and nonunity fill factor of the individual pixels were not ex-
plicitly modeled. Materials outside of the 41⇥41 cm2 active region of the research
EPID, such as the external electronics, were not included in the model.
Figure 4.1: Schematic of the key layers of the EPID model (not to scale).
The standard electromagnetic physics and optical physics Geant4 classes
were used to simulate radiation and optical photon transport within the EPID
model. Simulated electromagnetic processes included Compton scattering, pair
production, photoelectric absorption, impact ionization, bremsstrahlung radia-
tion, electron/positron annihilation, scintillation, Cˇerenkov radiation, and multi-
ple scattering.
A default range cut value of 1mm was specified for all Geant4 simulations.
Briefly, Geant4 tracks all particles down to zero range. However, for computa-
tional performance purposes, users may specify a range cut value that is internally
converted to an equivalent energy for each of the materials included in the sim-
ulation. When a particle’s energy drops below the range cut value for a given
material, secondary particles are no longer produced and the remaining energy
is instead deposited locally. Range cut values as low as 10µm were investigated
however there were no significant variations in quantities calculated from the
simulations.
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4.2.1.3 Optical physics
Optical physics processes that were simulated include bulk absorption, Rayleigh
scattering, and boundary processes (reflection and refraction). Optical properties
such as refractive indices n, bulk absorption lengths l, Rayleigh scattering lengths
µ and scintillation parameters (scintillation yield, SY ; resolution scaleRS; optical
emission spectra µ(E) with peak wavelength, µpeak; and time decay constant, t)
were specified for the relevant detector components and are summarized in Table
4.1. These physical properties were based on specifications provided by the man-
ufacturer (Carestream Health, Inc. Rochester, NY) where possible, or otherwise
found in the literature. Although Mie scattering would more accurately model
optical transport within granular phosphor screens, Rayleigh scattering was used
instead as it requires fewer user specified parameters and is thus more straight-
forward to implement in Geant4. A comparison of simulations performed using
isotropic, Mie and Rayleigh scattering confirmed that there were no significant
di↵erences in calculated quantities between these methods.
Table 4.1: Summary of the reference optical physics properties specified in the
EPID model.
Layer Property Value Reference
Phosphor nphos Refractive index, phosphor 2.4 [24]
lphos Absorption length, phosphor 4.0 cm [24]
µphos Scattering length, phosphor 17 µm [15]
SY Scintillation Yield (nominal) 60,000/MeV [25]
SY Scintillation Yield (actual) 1,000/MeV [26]
 (E) Emission spectrum 380 – 620 nm [27]
 peak Peak emission wavelength 545 nm [27]
t Scintillation time decay constant 1 ms [25]
Overcoat ncoat Refractive index, overcoat 1.48 [28]
Photodiode ndiode( ) Refractive index, photodiode 0.46 – 5.187 [29]
ldiode( ) Absorption length, photodiode 5.29 – 13 300 nm [29]
Boundary A  ↵,A Surface roughness 1.0 . . .
Boundary B  ↵,B Surface roughness 1.0 . . .
The parameter SY defines the mean number of optical photons generated
per unit of energy deposited during a scintillation event. The actual number of
optical photons generated is sampled from a Gaussian distribution with mean
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SY and standard deviation RS ·pSY , where RS is an intrinsic property of the
scintillating material related to impurities in doped scintillators. Di↵erent values
of RS would simply a↵ect the width of the distribution from which the number
of optical photons created for a given event is sampled. Altering this parameter
does not a↵ect the physical transport of the optical photons, hence an arbitrary
value of unity was chosen for this study. While the Gd2O2S:Tb scintillator has
a nominal SY of 60,000 optical photons per MeV of deposited energy [25], it was
found that using a decreased value of SY significantly reduced the simulation
computation time without compromising the optical response, above a minimum
threshold value. This technique of lowering SY to improve simulation e ciency
was first reported by Star-Lack et al. [26] The e↵ects of varying SY within the
context of our specific model were investigated and are detailed below in Section
4.2.2.
To allow more control over the treatment of boundaries within the layers of the
phosphor screen, a G4OpticalSurface was specified at the interface between the
reflective support and phosphor layer (hereafter referred to as boundary A) and at
the interface between the phosphor and adjacent overcoat layer (hereafter referred
to as boundary B). These G4OpticalSurfaces were characterised with a ground
finish to properly account for the existence of microfacets at these boundaries.
Geant4 provides users two options, named glisur [30] and unified [31], to model
optical boundary processes. The unifiedmodel was used in this study as it allows
the user more control over parameters governing boundary processes. Briefly,
this model allows the user to specify a parameter  ↵ which governs the degree
of boundary roughness. A given microfacet will have a normal vector forming
an angle ↵ with the average surface normal. For each optical boundary process,
the angle ↵ is sampled from a Gaussian distribution with standard deviation  ↵
which was arbitrarily taken to be 1.0 for both boundaries A and B. The e↵ect
of varying  ↵ for boundaries A and B on optical transport within the phosphor
screen was studied and is detailed in Section 4.2.2 below.
The refractive index of the reflective support was not provided by the manu-
facturer, therefore boundary A was specified with an assumed optical reflectivity
of unity. Optical properties for the photodiode are sensitive to the energy of in-
cident photons, therefore these parameters were specified as a function of  . The
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bulk absorption and Rayleigh scattering lengths of the overcoat layer were found
not to significantly a↵ect optical transport in the model and as such the same
values of 4 cm and 17µm, respectively, were used as for the phosphor layer.
Figure 4.2 illustrates a simulated event in which electronic energy deposition
occurs within the phosphor and subsequent optical photons are absorbed by the
photodiode.
Figure 4.2: (a) An x-ray incident from the left undergoes a Compton scatter-
ing event in the reflective support layer [magnified (b)]. The Compton electron
proceeds to deposit energy within the phosphor layer near boundary A, thereby
generating optical photons. Some optical photons are then absorbed by the pho-
todiode, after scattering throughout the phosphor layer. Locations of energy
deposition and optical absorption events are indicated by circular markers. Note
that for image clarity a reduced scintillation yield was used.
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4.2.2 Optical transport analysis
Many of the optical transport parameters specified for the relevant EPID compo-
nents are di cult to measure directly and may not be precisely known for a spe-
cific detector due, for example, to variations occurring during the manufacturing
process. A sensitivity analysis was therefore conducted on the optical transport
parameters from Table 4.1 to evaluate the robustness of the EPID model to the
uncertainties in these values. The chosen parameters along with the tested values
are listed in Table 4.2 (note that the parameters RS and t were not included in
this analysis because variations in these parameters would not spatially alter the
physical transport of optical photons). The analysis was performed by using a
point source to emit x-rays along a line from the point source through the center
of the EPID and normally incident on its surface. X-ray energies were sampled
from a 6 MV spectrum that was created by scoring the energies of all particles in
the source phase-space file. The simulation of 1⇥107 primary x-rays was su cient
to achieve statistical uncertainties less than 0.5% in both the dose deposited at
the center of the phosphor plane and the number of absorbed optical photons at
the center of the photodiode plane. To achieve this level of statistical uncertainty,
approximately 3,000 CPU-hours were required. For all simulations involving this
point source, the parameter SY was assigned its nominal value of 60,000/MeV
unless otherwise specified.
The EPID PSF was evaluated by calculating three di↵erent quantities: the
PSF of the detected optical photons at the photodiode (PSFTot), the PSF of the
energy deposited in the phosphor (PSFEdep), and the displacement of the optical
photons relative to their point of origin ( xopt). In this model PSFTot represents
the total image signal, PSFEdep represents the commonly used surrogate for im-
age signal (ignoring optical e↵ects), and  xopt represents the optical component
of PSFTot, quantifying the spatial distribution of EPID signal resulting purely
from the transport of optical photons. The calculation of  xopt was determined
from the frequency of optical photon absorption events in the photodiode, scored
as a function of displacement from their point of origin. The  xopt determined in
this way is analogous to previously reported optical glare or optical blur kernels
because it acts to reduce the spatial resolution of the EPID [6,14,15]. Where a dis-
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Table 4.2: Analysis of the sensitivity of the EPID model to changes in optical
transport parameters.
Property Values tested
nphos Refractive index, phosphor 2.2, 2.6 [15]
lphos Absorption length, phosphor 0.1 and 10 cm [15]
µphos Scattering length, phosphor 10, 25 [24] and 50µm
SY Scintillation Yield (actual) 1, 10, 100, 1,000 and 10,000/MeV
 (E),  peak Emission spectrum and peak wavelength Monoenergetic 545 nm
ncoat Refractive index, overcoat 1.3, 1.6
Boundary process model glisur
Boundary finish Polished
 a↵ Surface roughness 0.1, 10, 100
aApplies for unified model with ground finish only.
tinction is necessary, a superscript REF will be used to indicate PSFs calculated
using the reference optical transport parameters from Table 4.1.
All PSFs were calculated in the 2d plane containing the phosphor and photo-
diode layers. PSFs were calculated both on a 2d Cartesian grid and as a function
of radial distance from the source (PSFTot and PSFEdep) or from the point of
optical photon creation ( xopt). Cartesian scoring was performed using bins
measuring 0.4⇥ 0.4mm2 and radial scoring was performed using equally spaced
radial bins measuring 0.4mm to calculate PSFs at the same spatial resolution
as current commercial EPIDs. To account for the increasing area of consecutive
radial bins at greater distances from the origin, the energy deposition and number
of absorption events were normalized to the corresponding bin area.
4.2.3 EPID dose response
4.2.3.1 Simulation dose response
The dose response characteristics of EPIDs investigated in this study were field
size output factors and relative beam profiles. These were calculated for various
open field sizes (5 ⇥ 5, 10 ⇥ 10, and 20 ⇥ 20 cm2). The energy deposited in the
Gd2O2S:Tb phosphor layer and the number of optical photons absorbed in the
a-Si photodiode (using the reference optical transport parameters) were tallied
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independently in 2d histograms to quantify their relative contributions to the
output factors and profiles. Each histogram contained 1024 ⇥ 1024 bins, giving
an e↵ective square pixel size of 0.4 ⇥ 0.4mm2, equal to the pixel pitch of the
research EPID. The dependence of energy deposition and absorption events on
depth within the layers is beyond the scope of this study, although others have
reported on such dependencies [15].
Field size output factors were calculated from the mean response within the
central ⇡ 1 ⇥ 1 cm2 region for each 2d histogram, normalized to the response
from the 10 ⇥ 10 cm2 open field. Output factors calculated from energy depo-
sition events in the phosphor were compared to those calculated from optical
photon absorption events in the photodiode and experimentally measured val-
ues. Uncertainties in all output factor calculations are quoted as the standard
deviation of the response within the central ⇡ 1⇥ 1 cm2 region.
Dose profiles were first normalized to a central-axis response of 100%. One-
dimensional relative profiles were then obtained by extracting the response along
a 1d slice through the center of the 2d histograms in the in-plane and cross-plane
directions. Relative dose profiles obtained from histograms scoring energy depo-
sition in the phosphor were compared to those obtained from histograms scoring
optical photon absorption in the photodiode and experimentally measured values.
Agreement between simulated and measured profiles was evaluated by calculat-
ing the percentage of data points with a  -index  1 based on 3%/3mm criteria
(with dose di↵erences calculated globally relative to the dose at the central-axis
and considering only those points above a minimum threshold relative dose of
10%) [32].
Due to the high level of computational time required to simulate optical trans-
port in an event-by-event manner, the parameter SY was assigned a value of
1,000/MeV in all dose response simulations involving optical transport, unless
otherwise specified. Furthermore, it was necessary to limit the range of field sizes
investigated in this study as it would have required an impractical duration of
time to achieve the desired levels of statistical uncertainty in calculated optical
output factors and profiles for large field sizes. Therefore, statistical uncertainties
in profiles scoring the number of optical absorption events in the EPID photo-
diode for open field simulations were only achieved to levels of approximately
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2.6%, 2.5% and 2.4% for the 5 ⇥ 5, 10 ⇥ 10 and 20 ⇥ 20 cm2 fields, respectively.
Approximately 200, 400, and 1,500 CPU-hours were required for these respective
field sizes. To achieve lower levels of statistical uncertainty ( 1%) in profiles
scoring energy deposition in the phosphor, simulations were repeated without
optical transport. In this case, only approximately 36, 180, and 760 CPU-hours
were required for the 5⇥ 5, 10⇥ 10 and 20⇥ 20 cm2 fields, respectively.
4.2.3.2 Experimental dose response and model validation
Experimental measurements to validate the model were made using the research
a-Si EPID described in Section 4.2.1.2. An Elekta (Elekta, Crawley, UK) Syn-
ergy 6 MV linear accelerator with the MLCi multileaf collimator was used for
all experimental measurements. The research a-Si EPID used in this study was
manufactured by Perkin Elmer (PerkinElmer, Santa Clara, CA) and incorporates
a 1mm copper buildup layer, a 133mg cm2 Gd2O2S:Tb phosphor x-ray converter
screen (Lanex Fast Back, Carestream Health, Inc. Rochester, NY) and an a-Si
photodiode array. The copper acts as buildup for the primary beam and filters
low energy scattered photons and electrons. Energy deposited in the phosphor is
converted into scintillation optical wavelength photons which are then absorbed
by the photodiode. Thin-film transistors on the photodiode array allow one to
integrate and read out charge stored in the individual pixels. The photodiode
array comprises 1024 ⇥ 1024 pixels with a pixel pitch of 0.4mm, giving a total
active surface area of ⇡ 41⇥ 41 cm2. All images were acquired using irradiations
of 50 monitor units (MU) with the photodiode array positioned at isocenter dis-
tance. To minimize backscatter from the treatment couch, the research EPID was
positioned vertically (i.e., on its side) on the couch and centered on the collimator
axis of rotation with the gantry rotated to 90 degrees. No external buildup or
backscatter materials were used in this study.
The XIS software package (PerkinElmer, Santa Clara, CA) was interfaced
with the research EPID to collect all images. A gain setting of 4 pF with a
frame integration time of 133ms was found to provide the highest signal without
saturating any pixels. The EPID was left to warm up for 20 minutes in order to
reduce the e↵ect of fluctuating dark currents inthe photodiode prior to irradiation.
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Dark field frames were obtained by integrating the EPID signal for 30 frames
with the beam o↵, prior to collecting images. This dark field was subtracted
from subsequent open field images and was updated prior to each new open field
size series of irradiations.
A pixel sensitivity correction based on the method described by Greer [33] was
applied to all measured images using in-house code written in Matlab (version
R2011a, The MathWorks, Inc.). Whereas the traditional method of dividing raw
images by a flood-field image removes both the nonuniform pixel sensitivities and
o↵-axis response from EPID images, this method removes only the nonuniform
pixel sensitivities. The e↵ects of image lag and ghosting have been previously
reported for EPIDs [34,35]. While not explicitly investigated in this study, dark
fields were frequently updated to minimize such e↵ects on all experimental mea-
surements.
4.3 Results and Discussion
4.3.1 Optical transport analysis
Figure 4.3 shows a comparison between the 2D PSFREFEdep and PSF
REF
Tot . It is clear
that PSFREFTot is noticeably broader than PSF
REF
Edep with di↵erences attributable
to the scattering of detected optical photons within the phosphor screen. The PSF
broadening e↵ect shown here is discernible at the 0.4mm resolution of commercial
EPIDs and qualitatively agrees with results reported by Kirkby and Sloboda,
despite di↵erences in the EPID model and spatial resolution considered [15].
Di↵erences in calculated  xopt were observed when performing simulations
with variations in the optical transport parameters, as listed in Table 4.2. When
specifically investigating the use of values reported from previous studies (notably
nphos = 2.6; lphos = 10 cm; and µphos = 25µm), it was found that  xopt did not
vary significantly from  xREFopt . However, parameters that di↵ered more signifi-
cantly from the reference values resulted in noticeable changes to  xopt. Figure
4.4(a) illustrates the changes in  xopt for selected values of lphos and µphos rela-
tive to  xREFopt . Overall, variations in nphos did not greatly a↵ect  xopt whereas
decreasing lphos to 1mm narrowed  xopt as optical photons were more readily
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Figure 4.3: EPID model point spread functions (PSFs) calculated by scoring (a)
the energy deposited in the phosphor layer and (b) detected optical photons at
the photodiode. Both PSFs were calculated using the reference optical transport
parameters listed in Table 4.1.
absorbed in the phosphor. Correspondingly, decreasing µphos to 10µm narrowed
 xopt as optical photons traveled shorter distances on average between scattering
events. Increasing either of lphos or µphos acted to broaden  xopt, with greater
broadening occurring for larger values of these parameters. Figure 4.4(b) illus-
trates the changes in  xopt for the values of SY listed in Table 4.2. Overall,
decreasing SY had little e↵ect on  xopt although for values of SY  1,000/MeV
di↵erences relative to the case with SY =60,000/MeV were distinguishable. It
was therefore concluded that reducing SY to 1,000/MeV should have little e↵ect
on the physical optical transport within the EPID model, while significantly de-
creasing simulation time. As stated in Table 4.1, SY was taken to be 1,000/MeV
for all open field simulations (described below in Section 4.3.2).
Screenshots taken using the visualization functionality of the MC model were
used to discern qualitatively the e↵ects of µphos on  xopt. An example of this
is shown in Figure 4.5, where µphos was varied between 1, 17, and 50µm for the
same simulation event. It is clear that by increasing µphos the spatial distributions
of optical scattering in the phosphor and absorption in the photodiode increased
accordingly.
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Figure 4.4: Variations in calculated  xopt for (a) select values of lphos and µphos
relative to  xREFopt and (b) variations in the phosphor SY . Subplots show the
same data plotted on a linear ordinate scale for comparison.
The observed di↵erences in  xopt arising from variations in the optical trans-
port parameters generally translated to proportional di↵erences between the cor-
responding PSFTot. This was to be expected as PSFTot may be considered to
be formed from a convolution of PSFEdep, which is una↵ected by the optical
transport parameters, and  xopt [15,36]. A series of PSFTot calculated for varia-
tions in optical transport parameters selected from Table 4.2 are illustrated in
Figure 4.6, with PSFREFEdep shown for comparison. For each optical parameter
that was investigated, the full-width at half-maximum (FWHM) and full-width
at tenth-maximum (FWTM) of the resulting PSFTot were calculated. Selected
values are summarized below in Table 4.3 along with their percent di↵erences rel-
ative to the FWHM and FWTM calculated from PSFREFTot . Using the values for
nphos, lphos and µphos that were reported from previous studies resulted in PSFTot
that di↵ered only slightly from PSFREFTot , with the greatest percent deviations in
FWHM and FWTM (occurring for µphos = 25µm) being less than 3% and 5%,
respectively. Percent di↵erences in FWHM and FWTM up to 9.5% and 36%,
respectively, were observed for optical parameters that were significantly greater
or less than the reference values. Optical parameters that were investigated but
are not listed in Table 4.3 resulted in di↵erences in the FWHM and FWTM less
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Figure 4.5: Geant4 visualization of the EPID phosphor screen demonstrating the
e↵ects of increasing the scattering length in phosphor, µphos, from (a) 1µm to (b)
17µm and (c) 50µm while keeping all other parameters constant. The primary
x-ray track incident from the left undergoes a Compton scattering event in the
support layer. The secondary electron track scatters downward and deposits
energy in the phosphor layer. Optical photons are then generated and scatter
throughout the phosphor. Energy deposition events in the phosphor and optical
absorption events at the photodiode surface are illustrated by circular markers.
Note that a reduced scintillation yield was used to improve image clarity.
than 1.5% and 3.2%, respectively.
This analysis demonstrates that the dosimetric response of the EPID model
remains relatively una↵ected over a range of optical parameters reported in the
literature for Gd2O2S:Tb and at the spatial resolution of current commercial
EPIDs (0.4mm). Large deviations from  xREFopt and PSF
REF
Tot were found only
when the optical transport parameters di↵ered significantly from values reported
in the literature, confirming that optical transport would be quantitatively dif-
ferent in alternate materials. A similar analysis would be necessary in order
to validate optical transport simulations within alternative configurations em-
ploying higher resolution detectors and/or thicker x-ray converters. Under these
conditions, PSF broadening e↵ects may be more sensitive to variations in optical
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Figure 4.6: (a) PSFTot for variations in selected optical transport parameters
[magnified, with a subplot showing the same data on a linear ordinate scale for
comparison (b)].
parameters. Experimental validation of PSFREFTot , such as with the measurement
of the EPID line spread function, is beyond the scope of this work and is the sub-
ject of ongoing investigations. As an aside, it is worth commenting that although
Cˇerenkov radiation was included in the model for completeness, less than 1% of
optical photons originated from Cˇerenkov processes. The remainder originated
from scintillation events in the Gd2O2S:Tb phosphor layer.
4.3.2 EPID model dose-response
4.3.2.1 Field size output factors
Experimental and simulated EPID field size output factors are shown in Figure
4.7. Simulated output factors calculated by scoring energy deposition within the
phosphor and optical photons absorbed by the photodiode both agreed with the
experimental measurements to within 1 SD. The greatest di↵erence between the
simulated and experimental EPID output factors was 2% and was observed for the
5⇥ 5 cm2 field size. This di↵erence may be attributed to slight deviations in the
beam phase-space used for the simulations when compared to the experimental
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Table 4.3: Summary of the FWHM and FWTM for PSFREFEdep and PSFTot calcu-
lated by varying the corresponding optical transport parameter. Percent di↵er-
ences relative to PSFREFTot are given in parentheses.
Property Value tested FWHM (mm) FWTM (mm)
PSFREFTot . . . 0.915 1.82
PSFREFEdep . . . 0.807 ( 12%) 1.16 ( 36%)
PSFTot nphos 2.6 [15] 0.922 (0.82%) 1.85 (1.6%)
lphos 0.1 cm 0.828 ( 9.5%) 1.17 ( 36%)
10 cm [15] 0.932 (1.8%) 1.89 (3.6%)
µphos 10µm 0.889 ( 2.9%) 1.69 ( 7.2%)
25µm [24] 0.939 (2.7%) 1.91 (5.0%)
50µm 0.995 (8.6%) 2.23 (23%)
 ↵ 10 0.924 (1.0%) 1.86 (2.1%)
beam (see Chapter 3 and Figure 3.4). Although the largest discrepancy in output
factors calculated when validating the source was found for the 40⇥ 40 cm2 field
size, EPID output factors were not calculated for this large field due to the com-
putational demand required to achieve the desired statistical uncertainty when
modeling optical transport. The EPID model accurately reproduced the detector
response to variations in open field size. Simulated output factors calculated by
scoring energy deposition within the phosphor and optical photons absorbed by
the photodiode agreed within statistical uncertainties in the simulations.
4.3.2.2 Relative dose profiles
Experimentally measured and simulated EPID relative dose profiles are shown
in Figure 4.8 in the cross-plane direction. For the profiles calculated by scoring
energy deposition in the phosphor, 94.5%, 97.6% and 98.5% of the MC simu-
lated data points had    1 with 3%/3mm criteria for the 5 ⇥ 5, 10 ⇥ 10 and
20⇥ 20 cm2 profiles, respectively, when compared to the experimental profiles. It
should be noted that the increased percentage of passing gamma values reported
here relative to those stated in Chapter 3 for the source validation is a result of
the finer scoring grid used in the EPID simulations compared to the dose in water
simulations. The larger variations in the optical profiles are attributed to statis-
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Figure 4.7: Experimental (Exp) and simulation EPID field size output factors.
Output factors calculated from energy deposited in the phosphor (Sim–Edep) and
optical photons absorbed by the photodiode (Sim–Opt) are shown. Error bars
represent a statistical uncertainty of one standard deviation of the MC calculated
EPID response within the central ⇡ 1 ⇥ 1 cm2 region. Experimental error bars
are smaller than the corresponding points on the figure.
tical noise arising from the impractical length of time required to achieve lower
uncertainties, particularly with the larger fields. Despite the larger statistical un-
certainties present in the profiles scoring optical absorption events, 92.4%, 97.6%
and 98.2% of the MC simulated data points had    1 with 3%/3mm criteria for
the 5 ⇥ 5, 10 ⇥ 10 and 20 ⇥ 20 cm2 profiles, respectively, when compared to the
experimental profiles. These results indicate excellent agreement between sim-
ulated and experimental cross-plane profiles. In particular, the increased EPID
response o↵-axis due to the detector’s sensitivity to low energy radiation, clearest
for the 20⇥ 20 cm2 field size, was accurately reproduced with the model. Profiles
taken in the in-plane direction agreed equally well with experimental profiles.
The small di↵erences observed in penumbra shape between the simulation and
experimental profiles (most notable for the 5⇥5 cm2 field size) may be attributed
to a systematic uncertainty in the source phase-space that was similarly present
in the source validation results (see Chapter 3 and Figure 3.3). This uncertainty,
discussed in more detail in Chapter 3, resulted from a small deviation in the
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source electron beam parameters relative to more optimal values.
A comparison of the simulation profiles scoring energy deposition in the phos-
phor with those scoring optical photons absorbed by the photodiode shows that
for all field sizes investigated there are no statistically significant di↵erences be-
tween the profile shapes. This agrees with the results presented for the EPID
PSFs as di↵erences between the optical and energy deposition PSFs were only
visible below a relative response of about 10 1 on a semilog plot. At this level, the
PSFs di↵ered spatially by only a few hundred microns. These di↵erences would
be di cult to detect with a pixel size of 0.4mm, particularly when considering
the low dose gradient out-of-field EPID response present in EPID profiles at the
relative response level of 10 1.
The close agreement between the energy deposition and optical absorption
profiles within the penumbral region is consistent with the results of the optical
analysis presented in Section 4.3.1. Close agreement across all field sizes suggests
that detailed modeling of optical transport does not result in any significant
dosimetric e↵ects for commercial a-Si EPIDs with a pixel pitch of 0.4mm. It is
worth commenting that this EPID MC model was not developed for widespread
practical applications, but rather as an in-house research tool that can be used
to gain deeper insight into the relevant physical processes. This model is only
practical for those with dedicated computational resources. However, the results
of this study give confidence that for clinical dosimetry purposes involving static
open fields, modeling the standard electromagnetic transport alone should su ce
for the prediction of EPID dose response using MC methods, and this approach
does not impose nearly as great a computational burden. The extension of this
finding to modulated delivery techniques such as IMRT and VMAT has not been
tested.
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Figure 4.8: Experimental (Exp) and simulation EPID relative dose profiles for
(a) 5⇥5, (b) 10⇥10 and (c) 20⇥20 cm2 field sizes. Simulated profiles calculated
from energy deposited in the phosphor (SimEdep) and optical photons absorbed
by the photodiode (SimOpt) are shown. Subplots show the  -index (3%/3mm
criteria) for the experimental and SimEdep profiles.
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Optical transport e↵ects are expected to be more significant when using the
EPID for imaging studies (such as for modeling DQE) and for EPIDs employing
novel designs (such as di↵erent scintillator materials and thicknesses). Work is
currently underway to use this comprehensive MC model to assess the importance
of optical transport on EPID imaging performance, where the optical blurring ef-
fects demonstrated with simulations of the EPID PSF can impact on the detector
MTF and DQE. The assessment and optimization of thick segmented scintilla-
tors, where the optical e↵ects may be more complex and may not be neglected,
are another important future application for this model.
4.4 Conclusion
A comprehensive MC model of an a-Si EPID has been developed using Geant4.
The model presented here is the first to simulate both x-ray and optical pho-
ton transport in a self-contained manner within the EPID layers. Simulations
demonstrated minor but noticeable blurring of the EPID PSF when scoring opti-
cal absorption events relative to energy deposition in the phosphor. The optical
PSF was insensitive to uncertainties in optical transport parameters reported in
the literature. EPID field size output factors and relative dose profiles calcu-
lated by scoring energy deposition in the phosphor layer of the MC model agreed
with experimental measurements within statistical uncertainties. Furthermore,
despite the relatively larger statistical uncertainties in optical simulations, optical
output factors and relative dose profiles also agreed with experimental measure-
ments. Specifically, no di↵erences were observed in optical profile penumbrae
when compared to energy deposition profiles. Therefore, using energy deposition
in the phosphor as a surrogate for EPID dose response to static, open 6 MV
photon beams is a valid approach that does not require additional corrections for
optical transport e↵ects in current a-Si EPIDs employing phosphor screens.
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5
Monte Carlo simulation of the transit
dosimetric response of an a-Si EPID
The work presented in this chapter constitutes the extension of the Monte Carlo
model described in Chapter 4 to transit dosimetry and the simulation of portal
images of an anthropomorphic phantom.
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Abstract
Amorphous silicon (a-Si) electronic portal imaging devices (EPIDs) are x-ray
detectors frequently used in radiotherapy imaging and dosimetry applications.
EPIDs employ a copper plate and gadolinium oxysulfide phosphor screen with an
array of a-Si photodiodes to indirectly detect incident radiation. In this study,
a previously developed Monte Carlo (MC) model of an a-Si EPID has been ex-
tended for transit dosimetry. The Geant4 MC toolkit was used to integrate an
a-Si EPID model with two phantoms and a 6 MV x-ray source. A solid water
phantom was used to simulate EPID transmission factors, field size output factors
and relative dose profiles and results were compared to experimental measure-
ments. An anthropomorphic head phantom was used to qualitatively compare
simulated and measured portal images of humanoid anatomy. Calculated trans-
mission factors and field size output factors agreed to within 2.0% and 1.9% of
experimental measurements, respectively. A comparison of calculated and mea-
sured relative dose profiles yielded > 98% of points passing a gamma analysis
with 3%/3mm criterion for all field sizes. The simulated anthropomorphic head
phantom image shows macroscopic anatomical features and qualitatively agrees
with the measured image. Results validate the suitability of the MC model for
predicting EPID response in transit dosimetry.
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5.1 Introduction
Amorphous silicon (a-Si) electronic portal imaging devices (EPIDs) serve a num-
ber of important clinical applications in modern radiotherapy. EPIDs are rou-
tinely used to image patient anatomy and verify patient setup prior to treatment.
EPIDs are also suitable dosimeters since the pixel values of acquired images cor-
relate to the absorbed dose in the detector. One method of performing dose
verification using EPIDs is therefore by comparing portal dose images to dose
distributions predicted using an EPID model. EPID dosimetric characteristics
and their various clinical uses for dosimetry have been reviewed by van Elmpt et
al. [1]
A number of arguments support the integration of EPID dosimetry into rou-
tine clinical practice. Linear accelerator (linac) vendors typically supply a-Si
EPIDs with the necessary hardware mounted directly to the gantry, in line with
the megavoltage (MV) treatment x-ray source. This configuration provides a
readily available mechanism to detect the MV beam and enables direct monitor-
ing of both patient position and dose delivery from the beam’s-eye view. When
compared to alternative 2d dosimeters such as arrays of diodes or ion chambers,
a-Si EPIDs o↵er increased spatial resolution (typically 0.4 ⇥ 0.4mm2) and real-
time data acquisition capabilities. Additionally, EPIDs are resilient to radiation-
induced damage and respond both linearly with dose and independently of dose
rate [2,3]. One centre has reported on the routine use of EPIDs for pre-treatment
and in vivo dosimetry, including the EPID’s ability to detect errors in treatment
delivery [4].
The goal of this study is to extend the functionality of an EPID model that
we previously developed for non-transit dosimetry [5] by integrating phantom ge-
ometries into the model. In doing so, we may investigate the EPID response in a
transit dosimetry configuration that is more representative of clinical treatment
situations. Furthermore, we aim to validate the transit dosimetric response of
this model against experimental measurements.
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5.2 Monte Carlo model and detector geometry
5.2.1 6 MV photon source
The MC radiation transport code egsnrc [6] (V4 2.3.1) with user code beamnrc [7]
(V4 2.3.1) were used to create a 6 MV photon source model of an Elekta Synergy
linac (Elekta, Crawley, UK). A description and validation of the source model
has been previously reported [5]. The simulation of 109 primary histories was
performed to generate phase space files for square fields ranging in size from 2⇥2
to 9⇥ 9 cm2 (defined at the isocentre, 100 cm from the target).
5.2.2 EPID geometry and physics processes
The Geant4 MC simulation toolkit [8] (version 9.4) was previously used to de-
velop a model of an a-Si EPID and validate its dosimetric response in a non-transit
configuration [5]. A complete description of the EPID geometry may be found in
the previous study as only a brief overview is given here.
The EPID model (Figure 5.1) consists of a series of uniform slab layers with
geometries and material compositions based on specifications provided by the
manufacturer of a research EPID (XRD 1640 AN CS) used in the validation
stage of this study (PerkinElmer, Santa Clara, CA). The EPID model has a
cross-sectional area of 41 ⇥ 41 cm2 and was positioned at a source to detector
distance (SDD) of 160 cm for all simulations. It incorporates a 1mm Cu buildup
layer, a 133mg cm 2 Gd2O2S:Tb phosphor screen (Lanex Fast Back, Carestream
Health, Inc. Rochester, USA) and a 0.1mm thick layer of a-Si supported by a
1mm SiO2 substrate.
The standard Geant4 electromagnetic physics models were used to simulate
radiation transport within the MC model. The transport of optical photons orig-
inating in the phosphor screen was not explicitly simulated. We previously found
that optical transport does not significantly change calculated dosimetric quan-
tities relative to those calculated using only standard electromagnetic physics [5].
Simulated processes included Compton scattering, pair production, photoelec-
tric absorption, impact ionization, bremsstrahlung radiation, electron/positron
annihilation and multiple scattering.
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5.2.3 Phantom definitions
This study incorporated two distinct phantom geometries into the MC model to
investigate separate EPID dosimetric characteristics. The first phantom was a
simple homogeneous box of solid water with a cross-sectional area of 40⇥ 40 cm2
and a thickness along the central axis that varied depending on the quantity being
simulated. The second phantom was an anthropomorphic head that was defined
by integrating a set of CT images into the MC model using functions distributed
with the Geant4 source code. Both phantoms were centred about the isocentre
and the head phantom was oriented with its anterior-posterior (AP) axis aligned
with the beam central axis.
Figure 5.1: [Schematic of the key layers of the standard EPID model.]Schematic
of the key layers of the EPID model (not to scale).
5.3 Simulated dosimetric quantities
The EPID dose response characteristics investigated in this study include trans-
mission factors, field size output factors and relative beam profiles. An image of
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an anthropomorphic head phantom was also simulated for qualitative evaluation.
All quantities were calculated by tracking particles from the source phase space
files and scoring the energy deposited in the phosphor layer of the EPID in a 2d
histogram. Each histogram contained 1024 ⇥ 1024 bins (0.4 ⇥ 0.4mm2 pixels),
equal in number and size to the pixels of the research EPID. All MC simula-
tions were performed using a computer cluster of 252⇥ 2.67 GHz CPUs and the
open source message passing interface OpenMPI⇤ was used to facilitate parallel
processing. root [9] (version 5.28.00) was used for all post-processing analysis.
5.3.1 Transmission factors
Transmission factors were calculated by varying the solid water phantom thick-
ness from 0 to 40 cm in 10 cm increments with a fixed beam field size of 9⇥9 cm2.
The mean response within the central ⇡ 1⇥1 cm2 region of each 2d histogram was
calculated, normalized to the response for the phantom thickness of 0 cm. Un-
certainties in all output factor calculations are quoted as the standard deviation
of the response within the central region.
5.3.2 Field size output factors and relative dose profiles
Field size output factors and relative dose profiles were calculated by varying
the beam field size from 2 ⇥ 2 to 9 ⇥ 9 cm2 with a fixed solid water phantom
thickness of 20 cm. Output factors were calculated as the mean response within
the central ⇡ 1⇥ 1 cm2 region of each 2d histogram, normalized to the 9⇥ 9 cm2
field response. Uncertainties in all output factor calculations are quoted as the
standard deviation of the response within the central region.
Dose profiles were first normalized to a central axis response of 100%. 1d rel-
ative profiles were then obtained by extracting the response along a slice through
the centre of the 2d histograms in the cross-plane direction. Agreement between
simulated and measured profiles was evaluated by calculating the percentage of
data points with a  -index  1 based on 3%/3mm criteria (with dose di↵erences
calculated globally relative to the dose at the central-axis and considering only
those points above a minimum threshold relative dose of 10%) [10].
⇤http://www.open-mpi.org
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5.3.3 Projection phantom portal dose image
A static 9⇥ 9 cm2 beam field size was used to generate an AP projection portal
image of an anthropomorphic head phantom using the EPID model.
5.4 Experimental measurements and model val-
idation
Experimental measurements to validate the MC model were made using the re-
search a-Si EPID described in Section 5.2.2. An Elekta (Elekta, Crawley, UK)
Synergy 6 MV linac with the MLCi multi-leaf collimator was used for all measure-
ments. Images were acquired by averaging 50 frames when delivering a nominal
dose rate of 500MU/min. To minimize backscatter from the treatment couch,
the EPID was positioned vertically (i.e. on its side) on the couch and centered
on the collimator axis of rotation at a SSD of 160 cm, with the gantry rotated
to 90 degrees. Phantoms (as described in Section 5.2.3) positioned on the couch
were centred at the isocentre.
The XIS software package (PerkinElmer, Santa Clara, CA) was interfaced
with the research EPID to acquire all images. A gain setting of 4 pF was used
with a frame integration time of 499ms. Images acquired for validation of the
transmission factors and field size output factors were both dark-field and flood-
field corrected. Flood-field corrections were not applied for validation of EPID
relative dose profiles or the anthropomorphic head phantom image as this correc-
tion would remove the well-known o↵-axis detector response [11].
5.5 Results and Discussion
5.5.1 Transmission factors
Transmission factors calculated using the MC model and measured using the
research EPID are shown in Figure 5.2. Calculated and measured transmission
factors are in excellent agreement, with a maximum percent di↵erence of only
2.0% (occurring for the 40 cm phantom thickness).
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Figure 5.2: Measured (Exp) and calculated (Sim) EPID transmission factors.
5.5.2 Field size response
Figure 5.3 shows the calculated and measured variation in EPID response with
beam field size when a 20 cm thick solid water phantom is used. The calcu-
lated and measured field size responses are in close agreement with the greatest
di↵erence of 1.8% occurring for the 3⇥ 3 cm2 field size.
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Figure 5.3: Measured (Exp) and calculated (Sim) EPID field size output factors.
5.5.3 Relative dose profiles
Relative dose profiles calculated using the MC model and measured using the
research EPID are presented in Figure 5.4 for selected beam field sizes between
2⇥2 and 9⇥9 cm2 when a 20 cm thick solid water phantom is used. The subplot
shows the results of a   comparison between the calculated and measured profiles
for each field size using 3%/3mm criterion. 98% and 99% of profile data points
had    1 for the 2 ⇥ 2 and 3 ⇥ 3 cm2 field sizes respectively, whereas 100% of
points had    1 for the remaining field sizes. These results demonstrate excellent
agreement between the calculated and measured EPID o↵-axis response.
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Figure 5.4: Calculated relative dose profiles from the standard EPID model using
a 20 cm thick phantom of solid water (top panel) and corresponding  -values for
3%/3mm agreement with measured profiles (bottom panel).
5.5.4 Projection phantom portal dose image
Measured and calculated portal images of an anthropomorphic head phantom are
presented in Figure 5.5. A qualitative comparison of these images demonstrates
that the MC model is able to simulate spatial variations in detector response
resulting from the use of an inhomogeneous phantom representative of human
anatomy. The statistical noise present in the calculated image made it di cult
to resolve the fine anatomical structures and slight changes in relative density
within the phantom. However, macroscopic features such as the orbits and nasal
cavity are discernable in the calculated image.
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Figure 5.5: Measured (a) and simulated (b) portal images of an anthropomorphic
head phantom.
5.6 Conclusion
A Monte Carlo model of a standard a-Si EPID that was previously developed
for non-transit dosimetry has been extended to transit dosimetry applications.
Transmission factors, field size output factors and relative dose profiles were cal-
culated using the model and validated against experimental measurements with
excellent agreement. The simulation of an anthropomorphic head phantom portal
dose image provides a demonstration for applying this model to predicting EPID
images of humanoid anatomy.
Acknowledgments
Financial support was provided by the Cancer Institute NSW (Research Equip-
ment Grants 10/REG/1-20 and 10/REG/1-10), Cancer Council NSW (Grant ID
RD 11-06) and the National Health and Medical Research Council of Australia
(Project Grant ID569211). SJB acknowledges The University of Sydney and the
Institute of Medical Physics for scholarship support, as well as the Liverpool and
Macarthur Cancer Therapy Centres for additional financial support.
150
References
References
1. van Elmpt, W. et al. A literature review of electronic portal imaging for radio-
therapy dosimetry. Radiotherapy and Oncology 88, 289 – 309 (2008). URL http:
//www.sciencedirect.com/science/article/pii/S0167814008003721. 142
2. Boudry, J. M. & Antonuk, L. E. Radiation damage of amorphous silicon, thin-
film, field-e↵ect transistors. Medical Physics 23, 743–754 (1996). URL http:
//link.aip.org/link/?MPH/23/743/1. 142
3. El-Mohri, Y. et al. Relative dosimetry using active matrix flat-panel imager
(AMFPI) technology. Medical Physics 26, 1530–1541 (1999). URL http://link.
aip.org/link/?MPH/26/1530/1. 142
4. Mans, A. et al. Catching errors with in vivo EPID dosimetry. Medical Physics 37,
2638–2644 (2010). URL http://link.aip.org/link/?MPH/37/2638/1. 142
5. Blake, S. J. et al. Characterization of optical transport e↵ects on EPID dosimetry
using Geant4. Medical Physics 40, 041708 (2013). URL http://link.aip.org/
link/?MPH/40/041708/1. 142, 143
6. Kawrakow, I. Accurate condensed history Monte Carlo simulation of electron
transport. I. egsnrc, the new egs4 version. Medical Physics 27, 485–498 (2000).
URL http://link.aip.org/link/?MPH/27/485/1. 143
7. Rogers, D. W. O. et al. beam: A Monte Carlo code to simulate radiotherapy
treatment units. Medical Physics 22, 503–524 (1995). URL http://link.aip.
org/link/?MPH/22/503/1. 143
8. Agostinelli, S. et al. Geant4–a simulation toolkit. Nuclear Instruments and Methods
in Physics Research Section A: Accelerators, Spectrometers, Detectors and Asso-
ciated Equipment 506, 250 – 303 (2003). URL http://www.sciencedirect.com/
science/article/pii/S0168900203013688. 143
9. Brun, R. & Rademakers, F. ROOT - an object oriented data analysis
framework. Nuclear Instruments and Methods in Physics Research Section
A: Accelerators, Spectrometers, Detectors and Associated Equipment 389, 81
– 86 (1997). URL http://www.sciencedirect.com/science/article/pii/
S016890029700048X. 145
151
References
10. Low, D. A., Harms, W. B., Mutic, S. & Purdy, J. A. A technique for the quanti-
tative evaluation of dose distributions. Medical Physics 25, 656–661 (1998). URL
http://link.aip.org/link/?MPH/25/656/1. 145
11. Greer, P. B. Correction of pixel sensitivity variation and o↵-axis response for
amorphous silicon EPID dosimetry. Medical Physics 32, 3558–3568 (2005). URL
http://link.aip.org/link/?MPH/32/3558/1. 146
152
6
Characterization of a novel EPID
designed for simultaneous imaging and
dose verification in radiotherapy
The work presented in this chapter includes the first experimental demonstration
of a novel, first-generation prototype electronic portal imaging device employing
an array of plastic scintillating fibres.
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Abstract
Purpose: Standard amorphous silicon electronic portal imaging devices (a-Si
EPIDs) are x-ray imagers used frequently in radiotherapy that indirectly detect
incident x-rays using a metal plate and phosphor screen. These detectors may also
be used as two-dimensional dosimeters; however, they have a well-characterized
nonwater-equivalent dosimetric response. Plastic scintillating (PS) fibers, on the
other hand, have been shown to respond in a water-equivalent manner to x-rays in
the energy range typically encountered during radiotherapy. In this study, the au-
thors report on the first experimental measurements taken with a novel prototype
PS a-Si EPID developed for the purpose of performing simultaneous imaging and
dosimetry in radiotherapy. This prototype employs an array of PS fibers in place
of the standard metal plate and phosphor screen. The imaging performance and
dosimetric response of the prototype EPID were evaluated experimentally and
compared to that of the standard EPID.
Methods: Clinical 6 MV photon beams were used to first measure the detec-
tor sensitivity, linearity of dose response, and pixel noise characteristics of the
prototype and standard EPIDs. Second, the dosimetric response of each EPID
was evaluated relative to a reference water-equivalent dosimeter by measuring
the o↵-axis and field size response in a nontransit configuration, along with the
o↵-axis, field size, and transmission response in a transit configuration using solid
water blocks. Finally, the imaging performance of the prototype and standard
EPIDs was evaluated quantitatively by using an image quality phantom to mea-
sure the contrast to noise ratio (CNR) and spatial resolution of images acquired
with each detector, and qualitatively by using an anthropomorphic phantom to
acquire images representative of human anatomy.
Results: The prototype EPID’s sensitivity was 0.37 times that of the standard
EPID. Both EPIDs exhibited responses that were linear with delivered dose over a
range of 1–100 monitor units. Over this range, the prototype and standard EPID
central axis responses agreed to within 1.6%. Images taken with the prototype
EPID were noisier than those taken with the standard EPID, with fractional
uncertainties of 0.2% and 0.05% within the central 1 cm2, respectively. For all
dosimetry measurements, the prototype EPID exhibited a near water-equivalent
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response whereas the standard EPID did not. The CNR and spatial resolution
of images taken with the standard EPID were greater than those taken with the
prototype EPID.
Conclusions: A prototype EPID employing an array of PS fibers has been de-
veloped and the first experimental measurements are reported. The prototype
EPID demonstrated a much more water-equivalent dose response than the stan-
dard EPID. While the imaging performance of the standard EPID was superior to
that of the prototype, the prototype EPID has many design characteristics that
may be optimized to improve imaging performance. This investigation demon-
strates the feasibility of a new detector design for simultaneous imaging and
dosimetry treatment verification in radiotherapy.
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6.1 Introduction
Amorphous silicon (a-Si) electronic portal imaging devices (EPIDs), based on
active-matrix flat panel imager (AMFPI) technology [1], serve a number of im-
portant clinical applications in modern radiotherapy. EPIDs are routinely used
to image patient anatomy and verify patient setup prior to, and during treat-
ment. While primarily used for such imaging applications, EPIDs are also suitable
dosimeters since the pixel values of acquired images relate to the dose absorbed in
the detector. One center has reported on the use of in-house developed software
employing back-projection methods to enable routine in vivo and pretreatment
EPID dosimetry for IMRT deliveries [2–4]. Other methods for pretreatment EPID
dosimetry have been developed which include absolute dose prediction using a
modified algorithm of a treatment planning system [5] and conversion of EPID
portal dose images to dose planes in water using mathematical methods [6–9]. A
literature review summarizing EPID dosimetric characteristics and procedures
for the calibration and clinical use of EPIDs for dosimetry has been provided by
van Elmpt et al [10].
A number of arguments support the integration of EPID dosimetry into rou-
tine clinical practice. Since the early 2000s, linear accelerator (Linac) vendors
have supplied a-Si EPIDs with the necessary hardware mounted directly to the
gantry, in line with the megavoltage (MV) treatment x-ray source. This con-
figuration provides a readily available mechanism to detect the MV beam with
minimal setup required. Furthermore, this arrangement provides the only means
to directly monitor patient position and dose delivery from the beam’s-eye view.
When compared to alternative 2d dosimeters such as arrays of diodes or ion
chambers, a-Si EPIDs o↵er increased spatial resolution (typically 0.4⇥ 0.4mm2)
and real-time data acquisition capabilities [11]. Additionally EPIDs are resilient
to radiation-induced damage with a response that is both linear with dose and
independent of dose rate [12–14].
One of the main factors acting to complicate EPID uses for dosimetry is
the nonwater-equivalent response of commercially available detectors [15–18]. Such
EPIDs indirectly detect incident radiation by means of a metal plate and phos-
phor screen (typically copper, Cu, and terbium-doped gadolinium oxysulfide,
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Gd2O2S:Tb, respectively). Photon and electron interactions deposit energy within
the phosphor screen, causing the emission of scintillation optical wavelength pho-
tons that may subsequently be detected by the underlying array of a-Si pho-
todiodes. The high atomic number (Z) materials result in increased detector
sensitivity (relative to water) to lower energy x-rays where photoelectric absorp-
tion events dominate. EPIDs designed in this manner have been shown to be
input quantum limited with a detective quantum e ciency (DQE) of ⇡ 1% [19].
By removing the metal plate and phosphor layers, the EPID may be used to
directly detect incident x-rays with a near water-equivalent response [20,21], albeit
with a detection e ciency reduced by approximately 90% [12,17]. Other studies
have shown that the EPID DQE at radiotherapy energies may be significantly
increased to greater than 20% (zero spatial frequency) by replacing the phos-
phor screen with thick, segmented scintillators [22,23]. Examples include a linearly
scanning array of ZnWO4 crystals that were individually coupled to photodi-
odes and read-out electronics [24], arrays of CsI:Tl crystals incorporated into a
CCD camera-based EPID [25,26] and directly coupled to a flat panel imager [27], a
thick segmented 2d array of Gd2O2S:Tb phosphor with an underlying AMPFI
[28],
and more recently even thicker (up to 40mm) segmented arrays of CsI:Tl and
BGO coupled to an AMPFI [22,23]. The use of a thick, segmented scintillator can
greatly increase the DQE while maintaining a high spatial resolution; however
such high-Z materials will still result in a nonwater-equivalent detector response.
By replacing the high-Z scintillators in these designs with a low-Z material such
as plastic scintillator, the detector response may become almost water-equivalent
and therefore more useful for dosimetry.
The physical characteristics of plastic scintillating materials and their appli-
cations in radiotherapy have been extensively studied and reported in the litera-
ture [29–36]. These scintillators are manufactured using low-Z materials and have
been shown to respond in a nearly water-equivalent manner to both x-ray and
electron beams in the energy range relevant for radiotherapy [29,30,33,34]. In partic-
ular, plastic scintillators have a dosimetric response closer to that of water than
air, lithium fluoride, and silicon (the active components of ionization chambers,
thermoluminescent detectors, and diodes, respectively) [29,33]. These detectors
exhibit minimal temperature dependence [29], excellent resistance to radiation-
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induced damage [29] and respond in a stable and reproducible manner that is
linear with dose and independent of dose rate [30].
Various prototype dosimeters that use plastic scintillation detectors (PSDs)
have been reported in the literature [29,30,35,37,38]. Early work involving the de-
velopment of a planar detector to characterize brachytherapy dose distributions
used sheets (< 1mm thick) of plastic scintillator in alignment with an optical
image intensifier and CCD camera [39]. While the authors acknowledged that the
spatial resolution of such a system was limited by light transport throughout the
detector, it was found that plastic scintillator was potentially free from energy-
response artifacts unlike thermoluminescent and diode detectors. Other dosimeter
designs reported in the literature include small PSDs coupled to fiber optic cables
that guide scintillation light to a photo-sensitive detector, such as a photomul-
tiplier tube [29,30] or CCD camera [35,37,38]. While a significant source of noise in
these systems was the generation of Cˇerenkov light within the fiber optic cables,
many techniques have been reported to correct for this phenomenon [32] (including
background subtraction [29], temporal separation [40], and chromatic filtration [41]).
The generation of Cˇerenkov light directly within the plastic scintillator is esti-
mated to be about 3 orders of magnitude lower than that of scintillation light [42].
Therefore, by directly coupling the plastic scintillator fibers to a photo-sensitive
detector such as the photodiode array in commercial a-Si EPIDs, the contribution
of Cˇerenkov light as a source of noise may be drastically reduced.
The overall goal of this study is to experimentally evaluate the imaging per-
formance and dosimetric response of a novel prototype a-Si EPID relative to the
standard, commercially available detectors. An EPID that responds in a water-
equivalent manner would enable portal images to be used clinically not only for
monitoring patient positioning and motion but also for real time monitoring of
the dose being delivered to the patient. Such a system would enable clinicians to
acquire more information about the treatment delivery, without the use of any
additional equipment or setup time. The prototype EPID under investigation
in this study employs an array of plastic scintillator fibers coupled directly to
the photodiode array, in place of the standard metal plate and phosphor screen.
This first prototype provides a proof of principle for simultaneous imaging and
dosimetry and is hypothesized to exhibit a water-equivalent dosimetric response.
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6.2 Methods and Materials
6.2.1 Detector design and settings
All EPID measurements reported in this study were performed using 6 MV pho-
ton beams delivered by an Elekta Synergy Linac (Elekta, Crawley, UK) with
a nominal dose rate of 540 monitor units (MU) per minute. Unless otherwise
stated, all beam field sizes and positions are defined with respect to the isocenter,
located at a source-to-detector distance (SDD) of 100 cm. Both the experimen-
tal prototype and standard configurations employ the same XRD 1640 AN CS
flat panel imaging device (PerkinElmer, Santa Clara, CA). This detector, which
consists primarily of a 40 ⇥ 40 cm2 a-Si photodiode array, is used routinely as
the photosensitive component of EPIDs on medical Linacs. The array comprises
1024⇥ 1024 pixels, giving a pixel pitch of approximately 0.4mm. Thin-film tran-
sistors on the photodiodes allow integration and read out of the charge stored
in individual pixels. The XIS software package (PerkinElmer, Santa Clara, CA)
was interfaced with this research EPID to acquire all images. The EPID was
left to warm up for 20 min prior to each set of measurements in order to reduce
the e↵ect of fluctuating dark currents. Dark field corrections were obtained by
integrating the EPID signal for 30 frames with the beam o↵, prior to collecting
images. This dark field was subtracted from subsequent open field images and
was updated regularly during experiments. Flood field corrections were obtained
as a frame-averaged exposure of a region-of-interest (ROI) on the EPID to a beam
su ciently large enough to cover the ROI. For the standard EPID configuration
this ROI was the entire detector; however, for the prototype EPID configuration
this ROI was of an area slightly smaller than, and centered on, the plastic scintil-
lator array. Dark field corrected images were then divided by the flood fields to
correct for nonuniformities in individual pixel sensitivities across the photodiode.
Dead pixel corrections were applied in all measurements.
6.2.1.1 Standard EPID configuration
The standard EPID configuration consists of the research EPID setup as it is
used routinely in radiotherapy clinical practice. This design incorporates front
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and rear aluminum covers, as well as a 1mm thick copper sheet and 133mg cm2
Gd2O2S:Tb phosphor scintillator screen (Lanex Fast Back, Carestream Health,
Inc. Rochester, USA) that is coupled to the a-Si photodiode array (see Figure
6.1(a)). The copper acts as buildup for the primary beam and filters low energy
scattered photons and electrons. Energy deposited in the phosphor is converted
into scintillation optical wavelength photons, which are then absorbed by the
photodiode leading to charge integration in individual pixels. The research EPID,
when configured in this manner, shall be referred to as the “standard EPID”
throughout the remainder of this paper.
Figure 6.1: Schematic illustration of the main components of (a) the standard
clinical EPID incorporating a metal plate/phosphor screen and (b) the prototype
experimental EPID incorporating a segmented plastic scintillator array. The same
a-Si photodiode array was employed in both configurations. Schematics are not
drawn to scale and the gaps located between neighboring layers are for illustrative
purposes only.
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6.2.1.2 Prototype EPID configuration
The prototype EPID configuration utilizes a segmented plastic scintillator ar-
ray in place of the copper sheet and phosphor screen described above for the
standard EPID (see Figure 6.1(b)). The segmented plastic scintillator array was
constructed using square fibers, each having a cross-sectional area of 1 ⇥ 1mm2
and 15mm length. The fibers are oriented parallel to each other and as such
are not focused toward a particular point in space (e.g., the radiation source).
Figure 6.2 shows an image of the array. The fibers used (BCF-99-06A) are made
of a polystyrene base and are the fiber analogue of BC-430 plastic scintillator.
Each fiber was optically isolated from its neighbors by a polymethylmethacrylate
(PMMA) cladding having a thickness of approximately 4% of the fiber width
and a 10   15µm thick coating of white Extra Mural Absorber (EMA). EMA
is a coating applied to the outer surface of each fiber to minimize crosstalk be-
tween adjacent fibers by reflecting or attenuating light that escapes through the
cladding. The top layer of the array (closest to the radiation source) was also
covered with a thin film of reflective material (VikuitiTM Enhanced Specular
Reflector (ESR) from 3M, St Paul, MN). This ESR is a multilayer polymer film
that redirects light arriving at the upper surface of the plastic array back into
the fibers and toward the photodiodes. The plastic array comprised 150 ⇥ 150
such fibers, giving a total cross-sectional area of approximately 150 ⇥ 150mm2.
This prototype was constructed by Saint-Gobain Crystals (Saint-Gobain Crys-
tals, Hiram OH, USA) to our specifications. It should be noted that because the
cross-sectional area of the plastic scintillating fibers is greater than the area of
the photodiode pixels, misalignment of the fibers and photodiodes was inevitable.
To reassemble the research EPID into this configuration, the front aluminum
cover and all components above the photodiode were first removed and the seg-
mented plastic scintillator array was then placed directly on top of the photodi-
odes. When configured in this manner, the research EPID shall be referred to
as the “experimental EPID” throughout the remainder of this paper. For some
experiments it was necessary to stand the EPID on its side. In these cases, the
plastic scintillator array was also positioned on its side and was placed on top of
Styrofoam blocks to elevate it approximately to the level of the EPID’s center.
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Figure 6.2: (a) Photograph of the segmented plastic scintillator array used in the
experimental EPID. The segmented structure is clearly visible in the magnified
view (b). Each segment has a cross-sectional area measuring 1⇥1mm2, is 15mm
long, and is surrounded by an optically reflective coating.
Tape was fixed from the outer frame of the plastic scintillator array to the EPID
edges, to maintain direct contact between the plastic fibers and the photodiode
array. It should be noted that any residual air gaps between the plastic scintil-
lator array and the a-Si photodiode may a↵ect the response of the experimental
EPID. While measures were taken to minimize the occurrence of such air gaps,
a detailed investigation of their e↵ects on the detector response was beyond the
scope of this study (see also Section 8.2.3.1).
6.2.2 Detector sensitivity, linearity and pixel noise
The detector sensitivity and linearity of dose response were measured at the cen-
tral axis of a 10 ⇥ 10 cm2 field for both EPID configurations. The EPID was
placed on the treatment couch at a SDD of 100 cm with the gantry at 0 . Unless
otherwise stated, the gain and integration times were adjusted to maximize the
signal for each configuration without saturating the detector and the acquired
images were both dark field and flood field corrected. The integrated pixel re-
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sponses were recorded for exposures of 1  100MU and were calculated from the
mean pixel value sampled over the central 24 ⇥ 24 pixels. Uncertainties were
calculated as the standard deviation of the response within this region. The
detector was operated in free running mode, where each frame is acquired at a
preset frequency. An integrated image was obtained by simply summing the in-
dividual frames. The sensitivity of the experimental EPID was evaluated relative
to that of the standard EPID by comparing the integrated pixel values per MU
for each configuration. The linearity of dose response for each configuration was
calculated from the integrated pixel values per MU as a function of MU num-
ber over the range investigated. The pixel noise was calculated as the fractional
uncertainty (standard deviation divided by mean) of the central 24⇥ 24 pixels.
6.2.3 Dose response evaluation
The dose responses of the standard and experimental EPID configurations were
evaluated relative to that of an ionization chamber array in nontransit and transit
dosimetry setups. The MatriXX ionization chamber array (IBA Dosimetry Asia
Pacific, Beijing, China) was used with 1.2 cm of solid water build-up to give a
measurement depth of 1.6 cm (approximately equivalent to that of the experimen-
tal EPID). The MatriXX ionization chamber array has a dose response equivalent
to a Farmer ionization chamber in water-equivalent material for the experimental
geometries used in this study [21,43–45].
In the nontransit setup, the o↵-axis response and field size response were mea-
sured for each detector. For these measurements, each detector was positioned
on the treatment couch with the gantry at 0  and a SDD of 100 cm. The EPID
response was calculated from frame-averaged images consisting of 30 frames.
In the transit setup, square sheets of solid water were used to create a phantom
on the treatment couch, centered about the isocenter. The gantry was rotated to
90  and each detector was placed on its side on the treatment couch with a SDD
of 160 cm (couch rotated 90 ). This configuration was chosen because it provided
a simple and reproducible way to position the phantom material, EPID and
MatriXX detector. The o↵-axis response, field size response, and transmission
factors for each detector were measured. The EPID response was calculated using
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frame-averaged images with 50 frames.
For all measurements taken with the MatriXX array, the mean response was
calculated within the central 3⇥3 ionization chambers for field sizes greater than
3 ⇥ 3 cm2. For smaller fields, the response of the single central chamber was
used. The MatriXX array was aligned with one central detector located at the
central axis. For all EPID dosimetry measurements, response was calculated as
the mean pixel value within the central 24 ⇥ 24 pixels, with uncertainties taken
as the standard deviation of pixel values in this region, unless otherwise stated.
EPID gain and integration times were adjusted to maximize the signal for each
configuration without saturating the detector. Unless otherwise stated, acquired
images were both dark field and flood field corrected.
6.2.3.1 O↵-axis response
The nontransit o↵-axis dose response was measured with static 10⇥ 10 cm2 fields
centered at positions of 0, 5, 10, and 15 cm along the cross-plane collimator axis.
The transit o↵-axis dose response was measured using static 7 ⇥ 7 cm2 fields
centered at positions of 0, 5, 10, 15, and 20 cm (defined at the EPID position
with a SDD of 160 cm) along the cross-plane collimator axis with a solid water
phantom thickness of 20 cm. The o↵-axis fields were created using asymmetric jaw
settings. In both nontransit and transit configurations, the EPID was shifted in
the cross-plane direction with each field such that the same region of the detector
was being irradiated. This method was used to overcome field size limitations
due to the 15⇥ 15 cm2 square size of the segmented plastic scintillator array and
to remove any response variations due to measuring with di↵erent regions of the
detector. In order to maintain the o↵-axis response these images were not flood-
field corrected. Reference measurements were taken using the MatriXX ionization
chamber array, placed at the same positions along the cross-plane collimator axis.
Each ionization chamber measurement was taken with irradiations of 100MU. All
measured detector responses were normalized relative to the 0 cm field position
(when the 10⇥ 10 cm2 field was symmetric about the beam central axis).
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6.2.3.2 Field size response
For the nontransit field size response measurements, static square fields ranging in
size from 2⇥2 to 15⇥15 cm2 were centered on the beam central axis. For the EPID
measurement taken with the smallest field size, the response was calculated as
the mean value of the central 6⇥6 pixels. Reference measurements were taken by
delivering 100MU for each field size with the MatriXX ionization chamber array
placed at the isocenter in the same orientation as the EPID. All measurements
were normalized to the reference 10⇥ 10 cm2 field.
For the transit setup, the solid water phantom had a fixed thickness of 20 cm.
Static square fields ranging in size from 2⇥ 2 to 9⇥ 9 cm2 were centered on the
beam central axis. With the EPID positioned at a SSD of 160 cm, a field size
measuring 9 ⇥ 9 cm2 was the largest that could be used with the experimental
EPID due to size limitations of the plastic scintillator array. For the EPID mea-
surements response was calculated as described above. Reference measurements
taken with the MatriXX detector were obtained by delivering 300MU for each
field size. All response measurements were normalized to the value measured
with the 9⇥ 9 cm2 field.
6.2.3.3 Transmission factors
Transmission factors were determined using static fields measuring 9⇥ 9 cm2 and
centered on the beam central axis. Sheets of solid water were positioned on the
treatment couch to create solid water objects with thicknesses ranging from 0
to 40 cm in 10 cm increments and centered about the isocenter. For the EPID
measurements response was determined as described above. Measurements taken
with the MatriXX detector were obtained by delivering 200MU (0 and 10 cm
solid water thickness), 300MU (20 cm solid water thickness), 400MU (30 cm solid
water thickness), or 500MU (40 cm solid water thickness) and normalizing the
response to the number of MU delivered. Transmission factors were then deter-
mined by normalizing the response per MU measured with each detector to the
value obtained with no solid water in the beam.
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6.2.4 Image quality evaluation
The imaging performance of the experimental EPID was evaluated and compared
to that of the standard EPID. Imaging performance was measured using a PipsPro
QC-3V image quality phantom with associated software (Standard Imaging, Inc.,
Middleton, WI) and an anthropomorphic head phantom to acquire images with
each EPID configuration for qualitative and quantitative analysis. Unless other-
wise stated, images were acquired with the gantry rotated to 90  and with the
phantom centered on the isocenter on the treatment couch. Each EPID configu-
ration was placed on its side on the treatment couch behind the phantom (with
the couch rotated 90 ). As discussed in Section 6.2.3, this setup was the most
simple and reproducible method available. A gain setting of 4 pF and frame in-
tegration time of 133ms were used and all images were both dark field and flood
field corrected.
6.2.4.1 QC-3V Phantom
The PipsPro QC-3V image quality phantom and software were used to quanti-
tatively compare the spatial resolution and contrast-to-noise ratio (CNR) of the
standard and experimental EPIDs. The phantom was placed on its side on the
treatment couch with its upper surface located 90 cm from the source. The EPID,
also placed on its side, was located at a SDD of 100 cm.
For each EPID configuration, separate images of the phantom were acquired
using a single frame and an average of 50 frames, representing low and high dose
levels approximately equivalent to 1 and 66MU, respectively. These dose levels
represent the range of low and high dose imaging applications.
PipsPro software was used to calculate the spatial resolution and CNR for
images acquired with each combination of EPID configuration and dose levels.
The spatial resolution was calculated based on f50 and f30 (the spatial frequencies,
measured in units of lp/mm, at which the relative modulation transfer function
is equal to 50% and 30%, respectively). For details on the calculation of f50, f30
and CNR the reader is referred to Rajapakshe et al [46].
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6.2.4.2 Anthropomorphic phantom
Images of an anthropomorphic head phantom were acquired to qualitatively
evaluate the performance of the experimental EPID configuration, relative to
the standard configuration, when imaging an object representative of human
anatomy. The head phantom was positioned in an anterior-posterior orientation
on the treatment couch and was centered at the isocenter. The EPID was placed
at a SDD of 160 cm. For each EPID configuration, an image of the phantom was
acquired by averaging 50 individual frames.
6.3 Results and Discussion
6.3.1 Detector sensitivity, linearity and pixel noise
For a given detector gain and integration time setting, the sensitivity of the ex-
perimental EPID was found to be approximately 0.37 times that of the standard
EPID. This is to be expected since the Gd2O2S:Tb has a significantly higher
scintillation yield (on average 60 optical photons per keV of deposited energy [47])
than the plastic scintillator (on average eight optical photons per keV, as provided
by the manufacturer). Furthermore, the total photon cross sections and electron
linear stopping power for Gd2O2S:Tb are greater than those for the plastic scin-
tillator over the energy range relevant for radiotherapy. While these properties
are partially countered by increasing the thickness of the plastic relative to the
phosphor screen, determining the relationship between fiber dimensions and the
detector sensitivity is the subject of ongoing investigations. Uneven physical
contact between the fibers and the photodiode array may also a↵ect detector
sensitivity, as well as the mismatch between refractive indices for the plastic scin-
tillating fibers (1.6 as provided by the manufacturer) and the a-Si photodiodes
(4.6 for the peak optical emission wavelength [48]), respectively. Methods to im-
prove the optical transfer e ciency between the fibers and photodiodes are the
subject of ongoing work.
Figure 6.3 illustrates the pixel values per MU measured at the center of the
standard and experimental EPIDs for beam deliveries ranging from 1 to 100MU.
Values have been normalized to that measured with a 100MU beam delivery. It
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Figure 6.3: Pixel values per MU measured at the center of the standard and
experimental EPIDs for beam deliveries ranging from 1 to 100MU. Values have
been normalized to that measured with a beam delivery of 100MU.
was found that for deliveries greater than 8MU, the standard and experimen-
tal EPID pixel values agreed very closely with a mean di↵erence of only 0.1%.
For deliveries with fewer MU, agreement between the standard and experimental
EPIDs was still within 1.6%. Overall, both configurations exhibited a response
that was highly linear with delivered dose. The maximum deviation from unity
was 3.3% and 1.7% for the standard and experimental EPIDs, respectively, occur-
ring for a dose delivery of 3MU (taking the experimental EPID response at 6MU
as an outlier). For dose deliveries above 15MU, the normalized pixel values per
MU for both EPID configurations were all within 1% of unity. The dependence
of the measured pixel values per MU on the number of MUs delivered has been
previously reported to be a consequence of image lag and gain ghosting e↵ects
attributable to charge trapping in a-Si based EPIDs [49–51].
Images uncorrected for gain (i.e., without the application of a flood field cor-
rection) were much noisier for the experimental EPID than for the standard EPID,
with fractional uncertainties within the central region reaching 14.4% and 0.2%,
respectively. The additional noise for the prototype EPID is due to the size di↵er-
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ence between the cross-sectional area of the plastic scintillator fibers (1⇥ 1mm2)
and the area of individual photodiode pixels (0.4 ⇥ 0.4mm2). This di↵erence,
combined with the irregularities in the array construction seen in Figure 6.2(b),
results in an imperfect alignment of the fibers and detector pixels. After ap-
plying the gain correction, the pixel noise decreases to 0.2% and 0.05% for the
experimental and standard EPIDs, respectively. The generation of Cˇerenkov light
within the plastic scintillator of the experimental EPID is expected to be several
orders of magnitude smaller than the scintillation signal [42]. PSDs su↵er from
noise due to Cˇerenkov radiation generated in the optical fibers that transport the
optical signal from the scintillator to a remote light sensor [32]. The experimental
EPID detector does not involve the transport of light outside of the radiation field
to a remote light sensor and therefore does not su↵er the same problem. Work is
planned to extend a previously validated Monte Carlo model of a standard EPID
to investigate this phenomenon and its impact on the prototype EPID design [52].
6.3.2 Dose response evaluation
6.3.2.1 O↵-axis response
The detector response at positions away from the central axis of the x-ray beam
is shown in Figure 6.4 for a reference MatriXX detector and the standard and
experimental EPID configurations in nontransit and transit geometries. Note
that for this and all subsequent figures, error bars that are not visible are smaller
than their corresponding data points. At the greatest o↵-axis distance (15 cm) in
the nontransit geometry, the experimental EPID’s response is only 1.9% greater
than that of the ionization chamber, whereas the standard EPID’s response is
18% greater than that of the ionization chamber. It is well documented that
the energy spectrum of a 6 MV clinical x-ray beam becomes softer at positions
away from the central axis of the beam [53]. Given the increased sensitivity to
low energy radiation exhibited by Gd2O2S:Tb relative to water, the o↵-axis over-
response observed with the standard EPID was therefore to be expected. The
close agreement in o↵-axis response observed between the experimental EPID
and the ionization chamber provides support that the prototype EPID responds
in a more water-equivalent manner, making it more suitable for dosimetry ap-
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plications. The large o↵-axis over-response that occurs when using the standard
EPID implies that portal dose images acquired with a standard EPID must be
manipulated in order to convert the dose measured in the EPID to an equivalent
dose-in-water measurement. Using a water-equivalent dosimeter such as the ex-
perimental EPID greatly simplifies dosimetry calculations, since manipulations
to the portal dose images are not required.
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Figure 6.4: Comparison of (a) nontransit and (b) transit o↵-axis ratios measured
using the MatriXX detector (ion chamber), the standard EPID and the experi-
mental EPID.
In the transit geometry, the greatest di↵erence in response between the ex-
perimental EPID and the ionization chamber array was 1.2%, occurring at the
o↵-axis distance of 15 cm. The greatest di↵erence in response between the stan-
dard EPID and the ionization chamber array was 5.6%, occurring at the greatest
o↵-axis distance of 20 cm. These results are still consistent with a softer x-ray
spectrum at positions away from the central axis; however, the presence of the
phantom acts to change the incident beam energy spectrum by increasing the
ratio of scattered radiation to primary radiation incident on the detectors. This
causes the observed flattening of the o↵-axis ratios relative to those observed
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in the nontransit geometry. Despite the lower o↵-axis ratios measured in the
transit configuration, the experimental EPID is still seen to respond in a more
water-equivalent manner than the standard EPID.
6.3.2.2 Field size response
Figures 6.5(a) and (b) show the responses of a reference MatriXX ionization
chamber array and the standard and experimental EPIDs with beam field size,
in nontransit and transit geometries, respectively. In the nontransit geometry,
the field size response of the experimental EPID more closely matches that of the
MatriXX detector than does the response of the standard EPID. The maximum
percent di↵erences in response between the experimental EPID and the MatriXX,
and between the standard EPID and the MatriXX, were 1.2% and 6.2%, respec-
tively, across all the studied field sizes. Once again, the disagreement observed
between the response of the standard EPID and the MatriXX may be attributed
to the increased sensitivity of the standard EPID to low energy radiation. As
the x-ray beam field size increases, there is a greater proportion of low energy x-
rays within the beam spectrum which causes the standard EPID to over-respond
relative to the ionization chambers and experimental EPID.
Figure 6.5(b) shows that even in a transit dosimetry configuration, the field
size response of the experimental EPID more closely matches that of the ioniza-
tion chambers than does the field size response of the standard EPID. In this case,
the maximum percent di↵erences in response between the experimental EPID and
ionization chambers, and between the standard EPID and ionization chambers
were 1.2% and 5.0%, respectively. In both the nontransit and transit configura-
tions, the experimental EPID was therefore found to exhibit a field size response
that was water-equivalent whereas the standard EPID was not.
6.3.2.3 Transmission factors
Transmission factors measured with the reference ionization chamber array and
the standard and experimental EPIDs in a transit dosimetry configuration are
shown in Figure 6.6. The transmission factors measured with the experimental
EPID closely match those measured with the MatriXX ionization chamber array,
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Figure 6.5: Comparison of (a) nontransit and (b) transit field size output factors
measured using a MatriXX ionization chamber array, the standard EPID and the
experimental EPID.
with a maximum percent di↵erence in response of only 2.5%. Agreement between
the response measured using the standard EPID and the MatriXX ionization
chamber array was worse, with a maximum percent di↵erence in response of 13%.
Once again, the di↵erence in response between the standard and experimental
EPIDs may be attributed to the higher sensitivity of the standard EPID to the
low energy component of the x-ray beams. By increasing the thickness of solid
water in the beam, more of the low energy photons are filtered from the beam and
the standard EPID’s response becomes closer to that of the experimental EPID
and ionization chamber.⇤ However, the very close agreement observed between
the experimental EPID and the ionization chamber provides further evidence that
this prototype EPID maintains a water-equivalent dosimetric response.
⇤Further to the primary beam’s hardening as it passes through the phantom, low energy
scattered photons are also being generated in the solid water. However, this generation of low
energy photons has a much slower ‘buildup’ as compared to the total dose buildup as seen in
a classical percentage depth dose curve. These details, while not included in the published
version of this chapter [54], have been included here for completeness.
173
6. A novel EPID for imaging & dosimetry
0
0.2
0.4
0.6
0.8
1
Tr
an
sm
iss
ion
 fa
cto
r
 
 
Ion chamber
Standard EPID
Experimental EPID
0 10 20 30 400.80
0.90
1.0
1.1
Thickness of solid water (cm)E
PI
D 
/ I
on
 ch
am
be
r
Figure 6.6: Comparison of transmission factors measured using a MatriXX ioniza-
tion chamber array, the EPID in its standard configuration and the experimental
EPID with the segmented plastic scintillator.
These dose response evaluation results demonstrate that the experimental
EPID exhibits a significantly more water-equivalent response than the standard
EPID in both nontransit and transit configurations. As Linac mounted kV sys-
tems for 2d and 3d imaging become standard, the clinical demand for MV imag-
ing has reduced. Meanwhile, the justification and potential for EPID-based in
vivo dosimetry continues to grow [4,55]. It is possible that the primary function of
EPIDs will shift more towards dosimetry in the future. The prototype detector
reported in this study serves as a promising example of a water-equivalent EPID
that would be better suited for clinical dosimetry than current EPIDs.
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6.3.3 Image quality evaluation
6.3.3.1 QC-3V phantom
Figure 6.7 shows images of the QC-3V image quality phantom taken with the
standard and experimental EPIDs. The most immediately apparent observation
when comparing these images is that the image acquired using the experimental
EPID su↵ers from additional blurring relative to that taken with the standard
EPID. This blurring primarily results from the misalignment between the fibers
and photodiode pixels.
Figure 6.7: High dose (50 frame-averaged) images of the QC-3V image qual-
ity phantom (with dark and flood field corrections applied) taken with (a) the
standard EPID and (b) the experimental EPID.
Table 6.1 summarizes the quantitative comparison of the image quality ob-
tained using the standard and experimental EPIDs. Images identical to those
shown in Figure 6.7, acquired as frame-averaged images with either 1 or 50 indi-
vidual frames, were analyzed using PipsPro software to calculate their CNR and
spatial resolution (f50 and f30).
The CNR of the images taken with the standard EPID were greater than that
of the images taken with the experimental EPID. For both detectors, the CNR
increased with dose (the number of frames), as expected. The decreased CNR
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Table 6.1: Quantitative comparison of the CNR and spatial resolution of the
standard and experimental EPID configurations.
CNR Spatial resolution
EPID configuration 1 frame 50 frames f50 (lp/mm) f30 (lp/mm)
Standard 195 1269 0.41 0.70
Experimental 47.8 819 0.25 0.39
measured in images taken with the experimental EPID is consistent with this
detector’s reduced sensitivity and increased noise, as measured relative to the
standard EPID. However, the di↵erential increase in CNR with number of frames
is larger for the experimental EPID ( CNR/CNR = 16.1) than the standard
EPID ( CNR/CNR = 5.51) over the range 1–50 frames.
The spatial resolution was also better in images acquired using the standard
EPID relative to those obtained with the experimental EPID. This result agrees
with the qualitative description of the images in Figure 6.7 and again is largely a
consequence of the greater cross-sectional area of the scintillating fibers relative
to the photodiode pixels in the experimental EPID.
6.3.3.2 Anthropomorphic phantom
Anterior-posterior projection images of an anthropomorphic head phantom ac-
quired using the standard and experimental EPIDs are shown in Figure 6.8.
These images provide an example of the ability for the standard and experimental
EPIDs to visualize anatomical structures. In the image taken using the experi-
mental EPID, the structure of the plastic scintillating fiber array is manifested
as a persistent grid-like pattern overlaying the image of the phantom.
Based on these image quality results, it is hypothesized that the imaging
performance of the experimental EPID configuration may be improved by opti-
mizing certain features of the plastic scintillator array. Features including the
fiber dimensions, structural uniformity of the array, alignment of the fibers and
photodiodes, and focusing the fibers to the radiation source likely impact the
spatial resolution of acquired images. Optimization of the fiber lengths, mate-
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Figure 6.8: Anterior-posterior projection images of the anthropomorphic head
phantom (with dark and flood field corrections applied) taken with (a) the stan-
dard EPID and (b) the experimental EPID.
rial and optical matching with the photodiodes may serve to improve detector
sensitivity [42]. The relationship between these features and image quality is the
subject of ongoing investigations.
6.4 Conclusion
In this study, a prototype EPID employing an array of plastic scintillating fibers
in place of the standard copper plate and Gd2O2S:Tb phosphor screen has been
developed and the first experimental measurements have been reported. In con-
trast to the standard EPID, the prototype EPID exhibited a near water-equivalent
dosimetric response. While the imaging performance of the standard EPID was
superior to that of the prototype, there are promising opportunities for design
optimization of the prototype to improve imaging performance while maintaining
a water-equivalent dose response. Monte Carlo radiation transport simulations
will be used in future studies to quantify how features such as the dimensions of
the plastic scintillating fibers and alignment of the fibers with photodiode pixels
may improve image quality. The performance of the prototype reported in this
work demonstrates the feasibility and potential of this experimental EPID as a
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next-generation device for simultaneous imaging and dosimetry in radiotherapy.
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7
Optimisation of the imaging and
dosimetric characteristics of an EPID
employing plastic scintillating fibres
using Monte Carlo simulations
The work presented in this chapter describes the design and implementation of a
Monte Carlo model developed to optimise the prototype EPID.
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Abstract
A Monte Carlo model of a novel electronic portal imaging device (EPID) has
been developed using Geant4 and its performance for imaging and dosimetry
applications in radiotherapy has been characterised. The EPID geometry is based
on a physical prototype under ongoing investigation and comprises an array of
plastic scintillating fibres in place of the metal plate/phosphor screen in standard
EPIDs. Geometrical and optical transport parameters were varied to investigate
their impact on imaging and dosimetry performance. Detection e ciency was
most sensitive to variations in fibre length, achieving a peak value of 36% at 50
mm using 400 keV x-rays for the lengths considered. Increases in e ciency for
longer fibres were partially o↵set by reductions in sensitivity. Removing the extra-
mural absorber surrounding individual fibres severely decreased the modulation
transfer function (MTF), highlighting its importance in maximising spatial reso-
lution. Field size response and relative dose profile simulations demonstrated a
water-equivalent dose response and thus the prototype’s suitability for dosimetry
applications. Element-to-element mismatch between scintillating fibres and un-
derlying photodiode pixels resulted in a reduced MTF for high spatial frequencies
and quasi-periodic variations in dose profile response. This e↵ect is eliminated
when fibres are precisely matched to underlying pixels. Simulations strongly
suggest that with further optimisation, this prototype EPID may be capable of
simultaneous imaging and dosimetry in radiotherapy.
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7.1 Introduction
Patient-specific radiotherapy treatment deliveries are becoming increasingly com-
plex and treatment plans often involve steep dose gradients that are sensitive to
intra-fraction patient motion and inter-fraction changes in patient anatomy. Dose
verification of treatment deliveries thus presents a highly desirable means of mon-
itoring treatment progression and catching potential errors occurring throughout
the radiotherapy process.
Modern amorphous silicon (a-Si) electronic portal imaging devices (EPIDs)
are frequently used for imaging applications in radiotherapy [1]. A common ex-
ample includes verifying patient setup prior to treatment delivery [2] and they
have also been applied to real-time tracking of tumour position using fiducial
markers [3]. With such image-guided radiotherapies becoming increasingly com-
monplace, the megavoltage (MV) imaging capabilities of EPIDs have made them
indispensable devices in radiotherapy.
Interest in using modern a-Si EPIDs for dose verification continues to grow [4–6].
This is largely due to their high spatial resolution, real-time readout capabilities,
resilience to radiation-induced damage and seamless integration with modern
clinical linear accelerators [4,7,8]. The high atomic number (Z) components that
are used to optimise EPID imaging performance, however, cause a non-water
equivalent dose response that complicates the interpretation of portal images for
dosimetry [4,9,10]. While some groups have succesfully used a-Si EPIDs for pre-
treatment and in-vivo dosimetry [11], EPID dosimetry is still far from becoming
routine in clinical practice. The complex dose response presents a major challenge
for the development of standardized commercial software support.
The detective quantum e ciency (DQE) of an imaging system is a widely
accepted measure of the e ciency with which a detector converts incident x-rays
into an image signal [1]. Novel EPIDs have been developed that exhibit DQEs
significantly greater than those of standard EPIDs. Examples include EPIDs
using thick, segmented phosphors [12] and crystal scintillators [13,14] in place of the
standard metal plate and phosphor screen. Using an array of CsI:Tl crystals
40 mm thick, Sawant et al. reported zero spatial frequency DQEs up to 22%
relative to ⇡ 1  3% for standard EPIDs [14]. The authors proposed that a DQE
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up to 50% may be achievable with further optimisation. Prototypes employing
thick CsI:Tl, BGO and LYSO crystal scintillators have also been characterised
and applied to low-dose MV cone beam CT imaging [15,16]. However while these
various prototypes drastically improve upon the current DQE, they do not o↵er
detectors with water-equivalent responses.
Our group has previously characterised a novel, first-generation prototype
EPID utilising an array of plastic scintillator fibres in place of the metal plate
and phosphor screen of standard EPIDs for simultaneous imaging and dosime-
try in radiotherapy [17,18]. Plastic scintillators respond linearly to dose and inde-
pendently of dose rate, are resilient to radiation-induced damage and exhibit a
water-equivalent dose response [19,20]. A range of plastic scintillation dosimeters
have been developed for radiotherapy applications to take advantage of these
characteristics [21,22]. One study modeled a similar plastic scintillator fibre EPID
and reported zero spatial frequency DQEs between 4 – 37% at 6 MV depend-
ing on fibre length [23]. While our first-generation prototype exhibited a reduced
sensitivity and spatial resolution relative to standard EPIDs, it exhibited a water-
equivalent dose response and many aspects of the prototype were identified for
future optimisation of imaging performance [17].
In this study we develop a MC model of a novel a-Si EPID employing a plastic
scintillator fibre array (PSA) based on a second-generation prototype designed
and recently purchased by our group. This second-generation prototype is hy-
pothesised to exhibit a water-equivalent response because it utilises the same
plastic scintillator material as previously studied with the first generation proto-
type, albeit with a di↵erent physical geometry. With this model, we investigated
the e↵ects of varying the detector geometry and optical transport parameters on
its response, specifically to characterise the prototype’s imaging and dosimetry
capabilities. The ultimate goal of this work was to determine the set of param-
eters that will optimise the detector response and to quantify the sensitivity of
the response to sub-optimal parameter values.
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7.2 Methods and Materials
7.2.1 Monte Carlo source model and EPID geometry
All MC simulations were performed on a computer cluster comprised of 252 ⇥
2.67 GHz CPUs, with parallel processing implemented using openmpi. ⇤.
A MC source model of a 6 MV photon beam was used to generate phase space
files for the di↵erent field sizes investigated (3 cm ⇥ 3 cm to 10 cm ⇥ 10 cm). A
detailed description of this source model may be found in earlier publications [24,25].
Briefly, egsnrc (V4 2.3.1) [26] was used with user code beamnrc (V4 2.3.1) [27] to
build a model of an Elekta Synergy 6 MV photon beam. The source model was
used to generate a phase space file for each beam field size by scoring all particles
that traversed a plane 89.5 cm from the target. These files were then used as
input for a Geant4 MC model of the PSA-EPID. The distance from the target
to the PSA-EPID photodiode plane was fixed at 100 cm.
The PSA-EPID model was developed using the Geant4 MC toolkit (version
9.6 patch 02) [28,29] and was based on a previously validated model of a standard
EPID that was also developed using Geant4 [24,25]. The standard EPID model
comprised a series of uniform layers representing the individual detector compo-
nents and was based on the 2D PerkinElmer flat panel imager XRD 1640 AN CS,
which has a cross-sectional area measuring 41 cm⇥41 cm and 0.4 mm pixel pitch.
The key components of the standard EPID model were the copper buildup layer,
Gd2O2S:Tb phosphor screen and array of a-Si photodiodes. Geometrical and
material compositions were based on manufacturer specifications (PerkinElmer,
Santa Clara, CA). The array of a-Si pixels was modeled as a uniform, 0.1 mm
thick layer of a-Si supported by a 1 mm SiO2 substrate. The pixelated structure
and nonunity pixel fill factor were not explicitly modeled.
The standard EPID model was modified into the PSA-EPID configuration
by replacing all layers above the a-Si photodiode array, including the Cu plate,
Gd2O2S:Tb phosphor screen and aluminum cover, with a 2d array of plastic scin-
tillator fibres. The photodiode layer and all downstream components remained
as previously defined in the standard EPID model. The geometry of the PSA
⇤(http://www.open-mpi.org/)
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Figure 7.1: Schematic (not to scale) of the PSA-EPID MC model. (a) Beam’s-eye
view of a polystyrene fibre with PMMA cladding surrounded by an EMA. Dashed
lines delineate the outer edges of the fibres. (b) A simulated event. Green x-ray,
blue electron and magenta optical photon tracks propagate through the PSA-
EPID.
was based on a physical prototype currently under experimental investigation by
our group, with a total cross-sectional area measuring 15 cm⇥ 15 cm (see Figure
7.1).
Several di↵erent fibre geometries were simulated in this study to investigate
the impact of fibre geometry on imaging performance and dosimetric response.
Fibres in the PSA were square in shape and were composed of a scintillating
polystyrene core surrounded by a 20µm thick PMMA cladding and a 15µm thick
layer of extra-mural absorber (EMA) that was used to prevent optical cross-talk
between neighboring fibres (see Figure 7.1). Details of the fibre materials and
their physical properties were provided by the manufacturer (Saint-Gobain Crys-
tals, Hiram OH, USA) and are listed in Table 7.1. Throughout the remainder
of this paper, the term “reference parameters” refers to the use of simulation
parameters with values listed therein. On the other hand, “non-reference param-
eters” refers to the use of alternate values (listed in Table 7.2) that were chosen to
investigate how variations in certain geometrical and physical parameters would
a↵ect simulated PSA-EPID imaging and dosimetric response.
The reference fibre length of 30 mm was chosen to match the length of fibres in
our physical prototype. Additional fibre lengths of 15 and 50 mm were simulated
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for comparison. The reference fibre cross-sectional area (including the cladding
and EMA layers) measured 0.4mm ⇥ 0.4mm as this represented an idealised
geometry where the individual fibres were precisely aligned to the underlying a-
Si photodiode pixels. It was hypothesized that this configuration would optimize
spatial resolution. However, because the cross-sectional area of fibres in the
physical prototype measured 0.5mm ⇥ 0.5mm, a PSA geometry with this fibre
area was simulated for comparison.
For greater control over the optical processes occurring between the cladding
and EMA layers, a Geant4 G4OpticalSurface was defined at this interface for
each fibre. A G4OpticalSurface is used to empirically specify surface characteris-
tics that a↵ect the nature of incident optical photon absorption and scattering,
such as surface reflectivity or roughness. Since the purpose of the EMA is to ab-
sorb incident optical photons and thus prevent them from being transmitted into
neighbouring fibres, the G4OpticalSurface was defined as a perfect absorber. The
boundaries between the fibre core/cladding and cladding/EMA were assumed to
be smooth, which is valid assumption for fibres with diametres > 0.1mm [23,30].
The impact of the EMA layer on the detector’s response was investigated by
performing simulations with and without this G4OpticalSurface present.
7.2.2 Simulated physics processes
The standard Geant4 electromagnetic physics classes with a range cut of 1 mm
were used for all PSA-EPID simulations (decreasing this parameter to 0.01 mm
had a negligible e↵ect on the resulting line spread function (LSF)).
Optical photons were generated in the fibre cores via scintillation and Cˇerenkov
radiation. These photons may undergo boundary processes (reflection and refrac-
tion), incoherent (Rayleigh) scattering and bulk absorption. The refractive index
n, scattering length µ and absorption length l were specified for each medium
and the scintillation yield SY with optical emission spectrum  (E) (for photon
energy E and with peak wavelength  peak) was specified for the scintillator core.
These optical transport parameters and reference values used in this study are
summarised in Table 7.1.
Optical properties for the plastic scintillator were obtained from the PSA
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Table 7.1: Summary of the reference properties of the PSA-EPID fibres and
photodiodes used in the MC model. Unless otherwise stated, values were provided
by the manufacturer (Saint-Gobain Crystals, Hiram OH, USA). Properties listed
in parentheses had no information provided.
Property Value
Fibre length 30 mm
Fibre cross-sectional area 0.4mm⇥ 0.4mm
Core material Polystyrene
Core density 1.06 g/cm2
Cladding material PMMA
Cladding density 1.20 g/cm3
(EMA material) Water
(EMA density) 1.00 g/cm3
Cladding refractive index, nclad 1.49
Core refractive index, ncore 1.60
Core absorption length, lcore 3.5 m
(Core scattering length, µcore ) 2.0 cm
Core scintillation yield, SY 7,100 photons/MeV
Optical emission spectrum,  (E)  (E) =  peak = 580 nm
Photodiode refractive index, ndiode( ) 0.46 – 5.187 a
Photodiode absorption length, ldiode( ) 5.29 – 13,300 nm a
aValues obtained from [31].
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Table 7.2: Analysis of the sensitivity of the PSA-EPID model to changes in
geometric and optical transport parameters.
Property Values tested
µcore 1.0, 5.0, 10, 50 mm
EMA G4OpticalSurface Present, absent
Fibre length 15, 50 mm
Fibre area 0.5mm⇥ 0.5mm
prototype manufacturer (Saint-Gobain Crystals, Hiram OH, USA). Material in-
formation for the EMA was not provided and was therefore specified as water-
equivalent. This is a valid assumption given that we have previously demonstrated
experimentally that the fibres comprising the PSA respond in a water-equivalent
manner [17].
Optical parameters including µ and l are di cult to measure directly and
may not be precisely known due to, for example, variations in the PSA’s manu-
facturing process. One aspect of this study thus involved varying select optical
transport parameters to observe any e↵ects on the calculated quantities described
in Section 7.2.3. The values of n, which are well known, and lcore, which has a
nominal value more than two orders of magnitude greater than the fibre dimen-
sions, were not included in this analysis. Information for µcore was not provided
therefore a reference value of 2 cm was assigned and several alternate values were
investigated. The e↵ects of varying geometrical parameters including the fibre
length and cross-sectional area were also investigated. Table 7.2 includes the dif-
ferent optical transport and geometrical values that were utilised in addition to
the reference values listed in Table 7.1.
7.2.3 Simulated imaging and dosimetric quantities
2d histograms scoring the spatial distribution of optical absorption events in the
photodiode layer were created using root (version 5.28.00) data-analysis soft-
ware and were used to evaluate the imaging and dosimetric performance of the
196
7.2. Methods and Materials
PSA-EPID. This scoring was performed in 0.4mm ⇥ 0.4mm bins to match the
pixel pitch of the physical detector. Histograms were then analysed and post-
processed using root or Matlab (version R2011b). For simulations using a
monoenergetic x-ray pencil beam, 106 incident x-rays resulted in ⇡ 0.4% sta-
tistical uncertainty (the fractional uncertainty in the number of optical photons
detected in the photodiode per incident x-ray). Those involving open field beams
required 5 ⇥ 107 incident x-rays to achieve ⇡ 1% statistical uncertainty. Un-
less otherwise stated, the following quantities were calculated using the reference
values (Table 7.1) and non-reference values (Table 7.2).
7.2.3.1 Imaging performance evaluation
The detection e ciency, ⌘(E ), is the probability for an incident x-ray with en-
ergy E  to generate at least one optical photon in the PSA that is absorbed
by the photodiode layer. The detector sensitivity, ⇠(E ), is defined as the mean
number of optical photons absorbed by the photodiode layer per incident x-ray as
a function of E . To calculate ⌘(E ) and ⇠(E ), pixel-sized monoenergetic pencil
beams with energies from 0.2 to 6 MeV were normally incident on the central
fibre. The fraction of incident x-rays that were subsequently detected and the
mean number of optical photons absorbed per incident x-ray were scored.
An imaging detector’s modulation transfer function (MTF) characterises its
spatial resolution and may be calculated from the 1d LSF [32,33]. One method of
calculating a detector’s LSF uses the angled slit technique [34]. This was imple-
mented in the model by sampling x-rays from a 6 MV spectrum derived from
the source model. The Geant4 General Particle Source was used to create a
50mm⇥0.08mm beam normally incident on the PSA-EPID and angled by ⇡ 2.5 
with respect to the pixel columns. The 2d spatial distribution of optical photons
absorbed by the photodiode layer was scored and the MTF was calculated from
the modulus of the Fourier transform for the normalised LSF.
7.2.3.2 Dose response evalation
The PSA-EPID’s dosimetric response was evaluated by comparing simulated field
size factors and relative dose profiles to those simulated in a water phantom. The
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6 MV photon beam model described in Section 7.2.1 was used with square field
side lengths ranging between 3 and 10 cm. The spatial distribution of optical
photons absorbed in the photodiode layer was scored in a 2d histogram as this
represents the true physical processes leading to image formation.
Field size factors were calculated from the mean response within the central
1 cm ⇥ 1 cm for each field size normalised to the response for the 10 cm ⇥ 10 cm
field. Uncertainties were calculated as the standard deviation in the response
within the central 1 cm⇥ 1 cm. 1d relative dose profiles were extracted from the
2d histograms through the PSA-EPID’s central axis in the cross-plane direction,
with the response normalised to that simulated at the central axis.
To confirm the PSA-EPID’s water-equivalent response, field size factors and
dose profiles were similarly calculated in a water phantom measuring 41 cm⇥41 cm
and 40 cm depth. Energy deposited at a depth of 30 mm in water (100 cm from the
target in the source model) was scored to ensure similar conditions of electronic
equilibrium and build up between the PSA and the phantom.
7.3 Results
Aside from µcore, which did not significantly a↵ect the PSA-EPID’s dosimetric
response, the parameters investigated uniquely a↵ected each of the calculated
quantities.
7.3.1 Detection e ciency
The variations in detection e ciency with fibre length, cross-sectional area, µcore
and EMA G4OpticalSurface are presented in Figures 7.2(a), (b), (c) and (d)
respectively. Subplots show the ratio between e ciencies calculated using non-
reference and reference values. E ciency typically decreases with increasing en-
ergy. This is a consequence of the reduced interaction probability and increased
range for higher energy x-rays and secondary electrons, respectively, in the plastic
scintillator.
The detection e ciency increases with increasing fibre length for all incident
x-ray energies, which is consistent with longer fibres having greater sensitive
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volumes. The x-ray energy resulting in peak detection e ciency shifts from 0.2
MeV to 0.3 MeV and finally 0.4 MeV for the 15, 30 and 50 mm long fibres,
respectively. This is because low energy x-rays tend to interact at shallower
scintillator depths. Increasing fibre length may increase the probability of optical
absorption within the scintillator, thus decreasing x-ray detection probability for
these energies.
Increasing the fibre area and removing the EMA G4OpticalSurface similarly
increased the detection e ciency for x-rays energies < 1MeV. This is intuitive
since increasing the fibre area reduces the probability that optical photons within
the fibres will refract through the cladding and be absorbed by the EMA. Simi-
larly, removing the EMA increases the number of optical photons that reach the
photodiode layer.
The detection e ciency tends to decrease with decreasing µcore, though this
e↵ect was most significant for µcore = 1mm. Increasing µcore increases the aver-
age distance traveled by an optical photon between Rayleigh scattering events.
Therefore, on average more optical photons reach the photodiode when the prob-
ability for optical Rayleigh scattering is reduced. This e↵ect is greatest for the
low energy x-rays because the range of µcore values tested is on the order of the
fibre length (30 mm). Varying µcore therefore preferentially a↵ects those optical
photons generated at shallower depths in the plastic.
7.3.2 Detector sensitivity
Variations in detector sensitivity with fibre length and µcore are shown in Figures
7.3(a) and (b), respectively. Subplots show the ratio between non-reference and
reference value detector sensitivities. Sensitivity increases continuously with in-
creasing x-ray energy for all cases investigated. This is likely a consequence of
two independent factors. Firstly, higher energy x-rays tend to interact deeper in
the PSA and generate optical photons closer to the photodiode. Secondly, higher
energy x-rays produce more optical photons on average when they interact and
thus create a greater signal when detected.
Increasing the fibre length decreases sensitivity across all x-ray energies and
this stems from the greater probability for optical absorption in longer fibres.
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Figure 7.2: X-ray detection e ciency as a function of energy for varying (a)
fibre length, (b) fibre cross-sectional area, (c) µcore and (d) EMA optical surface.
Subplots show the ratio of the detector e ciency relative to that calculated using
reference parameters.
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Figure 7.3: Detector sensitivity as a function of incident x-ray energy for varying
(a) fibre length and (b) µcore. Subplots show the ratio of the detector sensitivity
relative to that calculated using reference parameters.
Varying the fibre area and EMA G4OpticalSurface had a negligible e↵ect on the
detector sensitivity (data not shown). Interestingly, decreasing values of µcore
resulted in increased sensitivity to low energy x-rays. One explanation is that as
µcore approaches the fibre width, fewer optical photons reach the EMA and are
absorbed.
7.3.3 Modulation Transfer Function
The variations in the PSA-EPID MTF for di↵erent fibre lengths, cross-sectional
areas, µcore and EMA G4OpticalSurfaces are shown in Figures 7.4(a) – (d). A
greater MTF over higher spatial frequencies corresponds to improved spatial res-
olution.
Increasing fibre length decreases the MTF across all spatial frequencies as
longer fibres o↵er a greater volume for x-ray and secondary electron scatter. Op-
tical photons may thus be generated farther away from the x-ray source, degrad-
ing spatial resolution. These results agree with those of other studies reported
in the literature [23]. Similarly, increasing the fibre cross-sectional area decreased
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the MTF at spatial frequencies above ⇡ 0.2mm 1. By increasing the fibre area
optical photons are spatially less confined and, in the case of photodiode pixels
being smaller in area than the fibres, may be incident upon multiple pixels despite
propagating along a single fibre. The MTF is less sensitive to variations in µcore.
Across the midrange spatial frequencies, increasing µcore increased the MTF only
slightly.
Removing the EMA surrounding each fibre had the most significant impact
on the PSA-EPID’s MTF and greatly decreased its spatial resolution across all
spatial frequencies. Removing the G4OpticalSurface allowed optical photons to
interact with the EMA as any other dielectric medium. Therefore, they were able
to refract through the EMA into neighbouring fibres, which constituted optical
cross talk and thus degraded spatial resolution.
7.3.4 Field size response
Figure 7.5 compares field size factors calculated for the PSA-EPID using reference
parameters and a water phantom. All field size factors agree within statistical
uncertainties with a maximum di↵erence of 1.1% occurring for the 3 cm ⇥ 3 cm
field size. These results demonstrate the PSA-EPID’s water equivalent response.
Variations in optical transport parameters from Table 7.2 did not result in any
significant changes to the reference field size factor calculations.
7.3.5 Relative dose profiles
Relative dose profiles calculated for the PSA-EPID and water phantom models
are compared in Figure 7.6(a). For clarity, the 3 cm⇥ 3 cm, 5 cm⇥ 5 cm, 7 cm⇥
7 cm and 10 cm ⇥ 10 cm profiles have been vertically shifted by 0, 10, 20 and
30 arbitrary units, respectively. Comparing the PSA-EPID and water phantom
profiles demonstrates very close agreement for all field sizes studied.  -index
analysis [35] using 3%/3mm criteria yielded   91% of data points passing above a
dose threshold of 10% (data shown for 3 cm⇥ 3 cm and 10 cm⇥ 10 cm field sizes
only). Above this threshold, a minimum of 89 data points (3 cm⇥3 cm field size)
were compared for each profile in the  -index analysis. Note that the sudden
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Figure 7.4: PSA-EPID MTF as a function of spatial frequency for varying (a)
fibre length, (b) fibre area, (c) µcore and (d) EMA optical surface.
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drop in response occurring near ±75mm corresponds to the outer edges of the
scintillator array.
Figure 7.6(b) compares relative dose profiles using 5 cm ⇥ 5 cm and 10 cm ⇥
10 cm field sizes for the PSA-EPID with variations in EMA G4OpticalSurface
and fibre area. As demonstrated in Figure 7.4(d), removing the EMA degrades
spatial resolution and when simulating open field beams, this manifests as severe
profile rounding.
An interesting e↵ect was observed for PSA-EPID profiles calculated with a
fibre cross-sectional area of 0.5mm⇥0.5mm. Increasing the fibre area eliminated
the precise matching of individual fibres and photodiode pixels so that optical
photons confined to a single fibre were incident upon multiple pixels. This resulted
in quasi-periodic variations in the dose profiles most noticeable in the in-field
region. A  -index analysis using 3%/3mm criteria yielded only 73% and 41% of
data points from the 5 cm ⇥ 5 cm and 10 cm ⇥ 10 cm profiles, respectively, with
0.5mm⇥ 0.5mm fibre area agreeing to the reference profile above a 10% relative
dose threshold.
7.4 Discussion
The results obtained provide valuable insight into factors a↵ecting the PSA-EPID
response and how it may be optimised. Simulating the detection e ciency, sen-
sitivity and MTF quantified the detector’s imaging performance while field size
factors and relative dose profiles characterised its dose response relative to water.
The PSA-EPID’s detection e ciency was most sensitive to fibre length, with
an increase from 30 to 50 mm (⇡ 2/3) producing an increase in peak e ciency of
⇡ 43%. However, increasing fibre length also caused an approximately constant
decrease in sensitivity of 30%, which may act to reduce the contrast of images ac-
quired using a thicker scintillator. The continuously increasing sensitivity across
0.2 – 6 MeV for all fibre lengths agrees with results published by Teymurazyan et
al.. Because of its water-equivalent response, the PSA-EPID does not exhibit the
over-response to low energy radiation characteristic of standard EPIDs [23]. Sim-
ulation results published by Cremers et al. for a copper plate/phosphor screen
instead showed a peak in sensitivity for x-ray energies less than ⇡ 2MeV owing
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Figure 7.6: (a) Relative dose profiles calculated using the PSA-EPID model with
reference parameters are compared to dose profiles calculated in a water phantom.
The 3 cm⇥ 3 cm, 5 cm⇥ 5 cm, 7 cm⇥ 7 cm and 10 cm⇥ 10 cm profiles have been
shifted vertically by 0, 10, 20 and 30 respectively for clarity. The subplot shows a
 -index analysis (3%/3mm). (b) Relative dose profiles calculated using reference
and non-reference EMA and fibre cross-sectional area for the 5 cm ⇥ 5 cm and
10 cm⇥ 10 cm field sizes. The 10 cm⇥ 10 cm profiles have been shifted vertically
by 20.
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to the large cross-section of the high-Z components [36]. One potential method
to further increase e ciency is by using an optical coupling agent to increase
transmission between from the PSA fibres to the photodiodes. This will be the
subject of future investigation.
Simulations of the detector MTF quantified the loss in spatial resolution that
occurs for scintillators of increasing thickness. Moreover, these simulations have
demonstrated the importance of an e↵ective EMA surrounding each fibre to main-
tain spatial resolution and the impact of element-to-element mismatch between
fibres and the underlying photodiode pixels. This latter result is an important
demonstration of the improvements in spatial resolution that may be realised by
optimising the physical dimensions of our prototype and matching them to the
photodiode pixel pitch. The variation in MTF for di↵ering µcore is also important.
Since information concerning this parameter is not precisely known, µcore may be
considered a “free” model parameter that may be determined empirically by com-
paring simulated MTFs to experimental measurements. This process, which may
aid in validating the model, is currently under investigation.
Di↵erences in the 6 MV energy spectra occurring for photon beams with
di↵erent field sizes causes variation in field size and o↵-axis dose profile response.
The increases in these quantities relative to water observed with standard EPIDs
have been greatly reduced with the PSA-EPID, further demonstrating its water-
equivalent response.
Dose profile results suggest that a quasi-periodic variation in response may be
observed experimentally using the PSA-EPID prototype. Others have reported
similar misalignment issues while investigating thick, segmented crystal scintilla-
tors [14,15]. El-Mohri et al. proposed a novel binning technique to minimise the
undesirable e↵ects of detector misalignment, however it was most e↵ective when
applied to scintillators exhibiting mechanical hardness, high density and high re-
fractive index [16]. Investigating the misalignment e↵ect and correction methods
experimentally is the subject of future investigation.
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7.5 Conclusions
This study reports on a Monte Carlo investigation of the imaging and dosimetry
performance of a novel a-Si EPID employing an array of plastic scintillating fi-
bres (PSA) in place of the standard EPID metal plate and phosphor screen. We
have found that the increase in the PSA-EPID’s detection e ciency with fibre
length is partially o↵set by a reduction in sensitivity to x-rays, which decreases
with increasing fibre length. The energy at which x-ray detection e ciency peaks
was found to increase with fibre length, from ⇡ 0.2MeV for 15 mm length to
⇡ 0.4MeV for 50 mm length. Our results suggest that self-absorption of opti-
cal photons in the fibres becomes important for lengths approaching 50 mm and
therefore that the optimum fibre length is less than 50 mm. The MTF is acutely
sensitive to the presence of extramural absorber (EMA), which prevents optical
crosstalk between the fibres. The trade-o↵ between improving detection e ciency
while decreasing spatial resolution when using thicker scintillators is well known.
Based on these results, however, the use of an absorbing EMA and scintilla-
tor core with increased Rayleigh scattering length are recommended to maximise
both detection e ciency and spatial resolution. The optical transport parameters
studied did not significantly influence the PSA-EPID’s water-equivalent dose re-
sponse, which is important so that we may continue to optimise the PSA-EPID’s
imaging performance without a↵ecting its water-equivalency. However, the align-
ment of the PSA fibre cross-sectional area with the photodiode pixel size a↵ects
the profile shape within the open field region. This is an important consideration
for experimental prototype development as performance is optimised when the
fibres are precisely aligned to the underlying imaging pixels. Future work will
involve validating our model against experimental measurements so that it may
be used to optimise the design of a next-generation EPID capable of simultaneous
imaging and dose verification in radiotherapy.
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8
A next-generation EPID for simultaneous
imaging and dosimetry in radiotherapy
The work presented in this chapter includes the experimental demonstration and
model validation of the second-generation prototype EPID employing plastic scin-
tillating fibres.
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Abstract
Background and Purpose: This study reports the first experimental measure-
ments of a novel, second-generation prototype water-equivalent electronic portal
imaging device (EPID) designed for simultaneous imaging and dose verification in
radiotherapy. Measurements were performed both to characterise the detector’s
performance and empirically validate a Monte Carlo (MC) of the prototype that
will be used for ongoing detector optimisation.
Materials and Methods: The prototype EPID utilises an array of plastic
scintillating fibres in place of the metal plate/phosphor screen used in standard
amorphous silicon EPIDs and the MC model, developed using Geant4, is based
on its design. Experiments were performed using a clinical 6 MV photon beam to
measure the prototype’s modulation transfer function (MTF), field size output
factors and relative dose profiles for static, open fields. These quantities were
likewise simulated using the MC model and comparison with measured results
empirically validated unknown model parameters.
Results: Field size factor and profile measurements demonstrated the prototype
EPID’s water-equivalent response. Dose profiles exhibited quasi-periodic varia-
tions resulting from element-to-element mismatch between the scintillating fibres
and underlying photodiode pixels. The presence of a thin air gap between the
scintillator and photodiode plane caused a more rapid fall o↵ of the MTF relative
to an idealised configuration without an air gap.
Conclusions: A novel water-equivalent EPID has been characterised experimen-
tally for imaging and dosimetry applications in radiotherapy. A MC model has
also been validated and simulation results suggest that further improvement in
spatial resolution may be realised through ongoing detector optimisation.
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8.1 Introduction
Improvements in our ability to modulate the shape and intensity of high-energy
x-ray beams in modern radiotherapy enable clinicians to o↵er highly conformal
and patient-specific therapies. However, the increasing prevalence of steep dose
gradients in modern therapies places a high level of importance on ensuring cor-
rect patient positioning and monitoring of intra-fraction motion [1]. The ability
to perform routine in vivo patient dosimetry would give clinicians a means to
verify that treatments are delivered as intended and would serve as a useful tool
to catch errors in dose delivery and identify those patients that may benefit from
adaptations to their treatment plan. This study proposes a novel detector based
on modern amorphous silicon (a-Si) electronic portal imaging devices (EPIDs)
that may be used for simultaneous imaging and dose verification in radiotherapy.
Megavoltage (MV) a-Si EPIDs are based on active matrix flat panel imag-
ing (AMFPI) technology and first became commercially available in the year
2000 [2,3]. Since their commercial inception, a-Si EPIDs have evolved to become
one of the most frequently used imagers in radiotherapy clinics, finding applica-
tions in image-guided radiotherapy [4,5], linear accelerator (linac) quality assurance
(QA) [6,7] and in vivo patient dosimetry [8,9]. There are also several features that
make a-Si EPIDs ideally suited for routine in vivo dosimetry; they are readily
supplied by linac vendors, are typically mounted to the gantry directly opposite
the primary MV therapy beam, o↵er real-time readout capabilities, respond lin-
early to integral dose and independently of dose rate and are highly resistant
to radiation-induced damage [10–16]. The primary drawback to using modern a-Si
EPIDs for dosimetry applications is their well-characterised non water-equivalent
response, which complicates the calibration of these detectors against reference
water-equivalent dosimeters [12,14,17–19]. Their non water-equivalent response stems
primarily from the high atomic number (Z) metal plate and phosphor screen com-
ponents, which causes them to over-respond to low energy radiation relative to
water.
An x-ray imager’s detective quantum e ciency (DQE) is a measure of how
well it transfers an input x-ray signal into an output image. A theoretically perfect
imager with a DQE of 100% would process an input signal without degradation
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such that the resulting image’s quality is dependent solely on characteristics of the
input signal [3]. Several studies have shown that modern a-Si EPIDs have DQEs
on the order of 1-3% [3,20,21], therefore significant e↵ort has gone into developing
novel EPIDs with improved DQE. Several such high-DQE EPID prototypes have
been reported in the recent literature, most of which are based on the principle of
replacing current metal plate/phosphor screen components with thick, segmented
scintillators [22–29]. These designs drastically increase the detector sensitivity rel-
ative to standard EPIDs that employ thin phosphor screens while striving to
maintain high spatial resolution. The segmented scintillator design, however, in-
troduces an imaging artifact that stems from an inevitable misalignment between
the individual segments of the scintillators and the imaging pixels of the under-
lying detector [25,30,31]. Depending on the specific geometry under consideration
and the pixel pitch of the detector being used, this element-to-element mismatch
can significantly degrade image quality. At present, one group has presented
novel post-processing binning algorithms to minimise the loss in image quality
resulting from this geometrical mismatch [31]. Another disadvantage to the thick,
segmented scintillators proposed by these groups is that they do not improve
upon the current non water-equivalent response of standard EPIDs since they
too employ high-Z materials.
Plastic scintillators have been well characterised with respect to their water-
equivalent dosimetric response and have frequently been used in clinical dosimetry
applications. Several di↵erent prototype dosimeters employing plastic scintillator
have been reported in the literature [32–40]. Teymurazyan and Pang (2012) pro-
posed a novel water-equivalent EPID employing plastic scintillating fibres and
used Monte Carlo (MC) simulations to characterise both its water-equivalent re-
sponse and its imaging performance in terms of the modulation transfer function
(MTF) and zero spatial frequency DQE [41]. Based on their model, they predicted
the water-equivalent EPID to have a higher DQE and better energy response than
current copper plate/phosphor screen EPIDs. The EPID’s water-equivalent re-
sponse eliminates the over-sensitivity to low energy x-rays. However, their model
predicted the spatial resolution to be worse than that of the standard EPID and
they commented that the increased thickness of the plastic scintillator would
make such proposed detectors heavier and bulkier than standard EPIDs.
219
8. A next-generation EPID: measurements & model validation
The previous characterisation of the imaging and dosimetry performance of
our first-generation prototype EPID employing plastic scintillation fibres repre-
sents the first experimental validation of such a thick, segmented plastic scintil-
lator in the literature [42]. The primary advantage to the prototype EPID design
over that of standard a-Si EPIDs and those proposed for high-DQE imaging is
its demonstrated water-equivalent response. The plastic scintillating fibres of
the second-generation prototype array reported in this study were fabricated us-
ing the same materials as those in the first-generation prototype. Therefore, it
is hypothesized that this second-generation prototype will continue to exhibit a
water-equivalent response.
The principal aim of this study was to characterise the imaging and dosime-
try performance of a second-generation prototype of a novel EPID employing an
array of plastic scintillating fibres (PSA). Experiments were performed to eval-
uate the water-equivalent response of the prototype EPID and to quantify the
detector’s line spread function (LSF) and MTF. These measurements were also
used to validate a previously developed MC model of the prototype EPID [43]. By
validating a MC model of the PSA-EPID against our physical prototype, we will
be able to further quantify the detector response and investigate potential con-
figurations to further optimise its overall performance in simultaneous imaging
and dosimetry.
8.2 Methods and Materials
8.2.1 Description of the prototype detector
The scintillation detector investigated in this study is a second-generation proto-
type that is based on an earlier design previously characterised by our group [42].
It comprises an array of plastic scintillating fibres constructed by and purchased
from Saint-Gobain Crystals (Saint-Gobain Crystals, Hiram OH, USA) that is
used with a standard configuration a-Si EPID purchased specifically for research
purposes. The research a-Si EPID was a PerkinElmer XRD 1640 AN CS flat
panel imaging device (PerkinElmer, Santa Clara, CA) that was previously used
to characterise our group’s first PSA prototype [42]. It employs a 1024 ⇥ 1024
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array of a-Si photodiode pixels each having a pitch of 0.4 mm and total com-
bined area measuring ⇡ 41⇥41 cm2. As a research detector, the front aluminium
cover of the a-Si EPID may be taken o↵ and the underlying copper sheet, optical
filter and gadolinium oxysulfide phosphor screen removed to expose the array of
photodiode pixels.
A photo of the PSA along with a schematic illustrating its structure and di-
mensions are shown in Figure 8.1. The array comprises square plastic scintillating
fibres measuring 0.5⇥0.5mm2 in cross-sectional area and 30 mm in length. Each
fibre comprising the array is identical and consists of a polystyrene scintillating
core doped with organic fluors surrounded by a PMMA cladding. A thin extra-
mural absorber (EMA) is painted on the outer surface of the cladding and acts to
absorb optical photons refracting through the cladding to prevent optical cross
talk between fibres. The array contains 300 ⇥ 300 parallel fibres, which results
in a total area of approximately 150⇥ 150mm2. A rigid, plastic frame surrounds
the array and o↵ers structural support. For comparison, the first generation pro-
totype previously characterised by our group contained fibres with an identical
chemical and structural makeup, however measuring 1⇥ 1mm2 in cross-sectional
area and with a length of 15 mm.
Figure 8.1: (a) Photo of the second-generation prototype array of plastic scintil-
lating fibres. The individual fibre components and dimensions are illustrated in
the schematic, (b).
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As described further in Section 8.2.3, experiments were performed with the
aluminium cover, copper sheet, optical filter and phosphor screen of the standard
configuration a-Si EPID removed and replaced by the PSA. The PSA was placed
in direct contact with the photodiode panel such that the combined PSA-EPID
constituted an indirect x-ray detection configuration. X-rays and secondary elec-
trons interacting within the scintillator produce optical photons that are chan-
neled along individual fibres via total internal reflection. Those optical photons
reaching the photodiodes may generate electron-hole pairs within the a-Si, lead-
ing to a build up of charge that may be integrated and subsequently read out to
form a digital image.
8.2.2 Overview of the Monte Carlo model
A MC model of the PSA-EPID was developed using Geant4 and is shown in
Figure 8.2. While a detailed description and characterisation of this model has
been described in another paper [43], an overview is presented here for complete-
ness. Geant4 was chosen for the modeling component of this study because
of its ability to self-consistently simulate both x-ray and optical photon trans-
port relevant for such indirect-detection imagers. Several others have similarly
used Geant4 to study optical transport within phosphor screens [44,45], crystal
scintillators [46,47] and plastic scintillators [41].
A previously validated model of a standard a-Si EPID was modified by re-
placing all components upstream of the photodiode plane with an array of plastic
scintillating fibres [42]. The PSA model was based on the physical prototype de-
scribed in Section 8.2.1 with material properties for the fibres and cladding pro-
vided by the manufacturer (Saint-Gobain Crystals, Hiram OH, USA). The square
fibres were modeled as previously described with a PMMA cladding thickness of
20 µm and EMA thickness of 15 µm. Geometrical and material properties for the
a-Si photodiode array and all underlying components that comprised the research
EPID were also provided by the manufacturer (PerkinElmer, Santa Clara, CA).
The a-Si photodiodes were modeled as a uniform 1 mm thick layer of a-Si with
a 1 mm SiO2 substrate.
The standard electromagnetic Geant4 physics classes were used to simulate
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Figure 8.2: Geant4 model of the plastic scintillating fibre array and underlying
a-Si EPID (not to scale). For clarity, only the photodiode array and substrate
are shown.
photoelectric absorption, Compton scattering, pair production, bremsstrahlung
radiation, impact ionisation, electron/positron annihilation, scintillation and Cˇerenkov
radiation. Optical physics classes were used to simulate optical boundary pro-
cesses (reflection and refraction), incoherent (Rayleigh) scattering and bulk ab-
sorption. To properly simulate optical transport, the correct optical properties
must be assigned to the relevant materials. These include the refractive indices
n, Rayleigh scattering lengths µ and bulk absorption lengths l for all materials
that optical photons propagate through. In addition, the scintillation yield SY
with optical emission spectrum  (E) (for photon energy E with peak wavelength
 peak) must be specified for the scintillator. Unless otherwise stated, all surfaces
were treated as specular optical photon reflectors. Where possible, these optical
properties were obtained from the manufacturer otherwise values were obtained
from the literature. A summary of all relevant material and optical transport
parameters and the values used throughout this study is listed in Table 8.1.
Material information was not provided for the EMA layer, therefore its ma-
terial was simply assigned as water. Its function to absorb optical photons that
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Table 8.1: Summary of the reference properties of the PSA-EPID fibres and pho-
todiodes used in the MC model. Unless otherwise stated, values were provided by
the manufacturer. Properties listed in parentheses had no information provided.
Property Value
Fibre length 30 mm
Fibre cross-sectional area 0.4⇥ 0.4mm2
Core material Polystyrene
Core density 1.06 g/cm2
Cladding material PMMA
Cladding density 1.20 g/cm3
(EMA material) Water
(EMA density) 1.00 g/cm3
Cladding refractive index, nclad 1.49
Core refractive index, ncore 1.60
Core absorption length, lcore 3.5 m
(Core scattering length, µcore ) 2.0 cm
Core scintillation yield, SY 7,100 photons/MeV
Optical emission spectrum,  (E)  (E) =  peak = 580 nm
Scintillation time decay constant, t 16.8 ms
Photodiode refractive index, ndiode( ) 0.46 – 5.187 a
Photodiode absorption length, ldiode( ) 5.29 – 13,300 nm a
aValues obtained from [48].
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are transmitted through the cladding layer and thereby prevent optical cross
talk between fibres was treated by assigning a G4OpticalSurface to the interface
between the cladding and EMA layers. Geant4 allows users to specify such sur-
faces to have more control over the types of optical boundary processes taking
place. This G4OpticalSurface was therefore defined to absorb all incident optical
photons. The impact of using this G4OpticaSurface on the resulting detector ef-
ficiency, sensitivity and modulation transfer function was previously investigated
in a separate study [43]. Briefly, the G4OpticaSurface was found to increase the
detector e ciency for x-ray energies below ⇡ 1 MeV and was shown to be crucial
in maintaining high spatial resolution.
8.2.3 Experimental measurements
Measurements were performed using the PSA-EPID to both characterise its re-
sponse and quantify its performance for imaging and dosimetry. These measure-
ments also provided a series of data against which to validate the MC model. The
following subsections describe the experimental procedures followed to measure
the detector LSF, MTF, field size output factors and relative dose profiles. The
LSF and MTF are commonly used metrics for quantifying the spatial resolution
of imaging systems whereas the field size response and relative dose profiles are
used to investigate the variations in the detector’s response with incident x-ray
energy spectra.
A 6 MV Elekta Synergy linac (Elekta, Crawley, UK) was used to generate
photon beams for all measurements. Unless otherwise stated, all beam field sizes
and positions are defined with respect to the isocentre, located at a distance of 100
cm from the target. The PerkinElmer software package XIS (PerkinElmer, Santa
Clara, CA) was interfaced with the research EPID to facilitate image acquisition.
To minimise the fluctuations in residual dark current, the EPID was left to
warm up for approximately 20 minutes prior to each set of measurements. Dark
field images were acquired by integrating the EPID signal for 30 frames with
the radiation source o↵ and were updated after each portal image was acquired.
When necessary, flood field images were acquired as frame-averaged exposures
of a region on the EPID using an open field larger than the measurement area
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of interest. For a given measurement, dark field images were subtracted from
the raw image and the result was divided by the flood field to correct for non-
uniformities in pixel response. Dead pixel corrections were also applied to all
corrected images.
8.2.3.1 Line spread and modulation transfer functions
The angled-slit technique was used to measure the PSA-EPID’s LSF [49–52]. This
method has previously been used by others to measure the LSF of MV imagers in-
cluding standard EPIDs [20,51] and novel EPIDs employing thick, segmented phos-
phor and crystal scintillators [23,52]. Measuring the LSF involves the generation
of a photon beam incident on a closely spaced pair of thick, tungsten blocks to
form a narrow beam of radiation with sub-pixel width. Since the MTF may be
calculated by taking the Fourier transform of the LSF, the following procedure
describes the experimental determination of the LSF.
To measure the detector LSF, it was necessary to rotate the linac gantry and
the treatment couch to 90  and 270 , respectively. The treatment couch was
retracted and a portable cart supporting two machine-polished tungsten blocks
on a translation stage was positioned near the isocentre. Each block measured
17.5 ⇥ 11.5 ⇥ 8 cm3 (thickness ⇥ height ⇥ width) with the largest dimension
oriented parallel to the linac beam central axis. A piece of paper was placed
between the blocks and a clamp was used to press the blocks together, forming a
slit approximately 0.08 mm wide. The width of the slit was verified with a series
of metal shims with known thicknesses. The translation stage was used to rotate
and translate the blocks such that the linac beam’s central axis was centred on
and oriented parallel to the slit opening, using the in-room lasers for guidance.
The translation stage itself was slightly elevated on one side to allow the slit to be
slightly angled (⇡ 4  with respect to vertical) to obtain a sub-pixel sampled LSF.
The research EPID, with all components above the a-Si photodiodes removed
(including the aluminium cover, copper sheet, opaque optical filter and phosphor
screen), was then placed on its side facing the linac target and in line with the
blocks and the beam central axis. Relative to the linac target, the proximal face
of the blocks were positioned at a distance of 110 cm and the EPID was positioned
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at 143 cm. A clamp was used to secure the EPID to the couch in this orientation.
Finally, the PSA was placed on its side on top of a Styrofoam support and
was positioned against the photodiodes. Individual fibre axes were therefore
perpendicular to the surface of the photodiode plane and parallel to the beam
central axis. An attempt was made to ensure good contact between the scintillator
and photodiode surfaces by fixing tape from the edges of the PSA to the outer
frame of the research EPID. While alternative methods may have resulted in
improved contact between the PSA and the photodiodes (such as the use of an
optical coupling agent), these may have also had an unintended and permanent
e↵ects on the detector and hence were not investigated. Finally, all light sources
within the linac bunker were turned o↵ and the entire PSA-EPID apparatus was
covered with an opaque sheet to prevent any residual ambient light from a↵ecting
the detector’s signal. A schematic illustrating this experimental setup is shown
in Figure 8.3.
Figure 8.3: Diagram of the experimental setup used to measure the PSA-EPID
LSF using the angled slit technique. (a) side-on view and (b) beam’s-eye view.
To calculate the detector LSF a set of three di↵erent images was acquired.
Image acquisition was repeated several times to ensure measurement consistency.
First, the raw LSF images were obtained by irradiating the tungsten blocks with
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a vertically oriented 5 ⇥ 2 cm2 open x-ray field, centred on the narrow spacing
between the blocks. The narrow beam of radiation that passed between the blocks
and was incident on the PSA-EPID constituted the angled slit that generated
the raw LSF image. A second image was then acquired after slightly rotating the
translation stage that supported the tungsten blocks in the plane of the floor so
that the angled slit was no longer in line with the beam central axis. The same 5⇥
2 cm2 field was used to irradiate the blocks, however with the slit out of alignment
no primary signal was measured with the PSA-EPID. These “background” images
were used to subtract any background signal from the raw LSF images that
may have resulted from x-ray scatter and transmission. Finally, the blocks were
completely removed from the linac beam and a flood field correction image was
acquired by irradiating the PSA-EPID geometry with a larger, 7 ⇥ 7 cm2 open
field. The raw and background images were independently dark field and flood
field corrected before the background image was subtracted from the raw image.
Finally, a dead pixel correction was applied.
All image processing was performed using Matlab (version R2011b) and in-
house code was written to calculate the detector’s LSF. The slit angle ✓slit relative
to the vertical columns of image pixels was first determined by sampling pixels
with peak responses from the corrected image. Each horizontal row in the image
was then shifted by a distance yi tan ✓slit where yi is the vertical distance between
row i and the row passing through the centre of the slit. A 1d sub-sampled LSF
was finally calculated by summing along the resulting column vectors. The MTF
was then calculated from the modulus of the Fourier transform for the normalized
LSF by using Matlab’s built-in Fast Fourier Transform (FFT) algorithm.
8.2.3.2 Field size output factors
Field size output factors were measured both for the PSA-EPID and a MatriXX
2d array of ionisation chambers (IBA Dosimetry Asia Pacific, Beijing, China) by
placing the detectors on the treatment couch and rotating the linac to a gantry
angle of 0 . The detectors were centred on the beam central axis and the source to
detector distance (SDD) was fixed at 100 cm. The detector plane was considered
to be at the position of the photodiodes for the PSA-EPID and at the indicated
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position of the ion chambers for the MatriXX.
The PSA-EPID field size response was measured by using the PSA-EPID to
acquire a series of static, open field images for varying field size. Images for square
fields ranging from 2⇥2 to 15⇥15 cm2 were acquired and the mean response within
the central 1 ⇥ 1 cm2 of the open field region was calculated. Field size output
factors were then determined by normalising the response for each field to that
measured with the reference 10⇥10 cm2 field size and measurement uncertainties
were taken as the standard deviation in the response within the central region of
interest.
To evaluate the water-equivalency of the PSA-EPID’s response, field size out-
put factors were also measured using a MatriXX array of ion chambers with 27
mm solid water buildup – a configuration that has previously been shown to be
water-equivalent [42]. The MatriXX was slightly o↵set to align a single ionisation
chamber with the beam central axis and a series of three measurements were taken
by delivering 100 monitor units (MU) for each field size. The mean response and
standard deviation were then calculated for each field size and field size output
factors were determined by normalising measurements to that measured with the
10⇥ 10 cm2 field size.
8.2.3.3 Relative dose profiles
A set of open field images for the 5 ⇥ 5 and 10 ⇥ 10 cm2 field sizes were also
acquired using the PSA-EPID to calculate relative dose profiles. Profiles were
extracted from the 2d images along a 1d slice in the cross plane direction through
the centre of the open field. Each profile was then normalised to the response
measured at the central axis. The profiles were measured to investigate any
changes in PSA-EPID response at distances away from the central axis and to
investigate the profile penumbra shape measured for several field sizes using a
segmented detector.
An artifact arises in the dose profiles measured with the PSA-EPID owing to
a mismatch between individual scintillating fibres and the underlying photodiode
pixels. This mismatch has been previously reported for other prototype EPIDs
using segmented scintillators [25,30,31] and is largely due to the 0.5⇥0.5mm2 cross-
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sectional area of the scintillating fibres being greater than the 0.4 mm a-Si pixel
pitch. In an idealised geometry, each fibre would be precisely matched to a single
a-Si to maximise the detector’s spatial resolution. An initial attempt to remove
this artifact from the dose profiles was taken by applying flood field corrections
to the PSA-EPID images. Others have reported alternative methods to minimise
the e↵ect of the mismatching artifact, however the application of these methods
was beyond the scope of the current study [31].
8.2.4 Simulated quantities
The MC model was used to simulate the same quantities described throughout
Section 8.2.3 and measured experimentally using the physical PSA-EPID proto-
type. A previously validated source model of a 6 MV Elekta Synergy (Elekta,
Crawley, UK) linac was used for all simulations [42]. The spatial distribution of
optical photons that reached and were absorbed by the photodiodes was scored
in 2d histograms using root (version 5.28.00) data-analysis software to quan-
tify the PSA-EPID response. The histogram bin size was 0.4 mm to match the
spatial resolution of the physical a-Si photodiode array. These histograms were
then analysed and post-processed using in-house code developed in root and
Matlab (version R2011b).
8.2.4.1 Line spread and modulation transfer functions
The LSF and MTF were simulated using the Geant4 General Particle Source
class to define a geometrical x-ray source with the same physical dimensions as
the experimental angled slit (50⇥0.08mm2 at an angle of ⇡ 2.5 ). X-ray energies
were sampled from a 6 MV clinical spectrum and were normally incident on the
PSA-EPID’s surface. The simulation of 107 primary histories was su cient to
achieve a statistical uncertainty less than 1% in the number of optical photons
absorbed per incident x-ray at the beam central axis.
The 2d histogram scoring optical photon absorption events in the photodiode
was analysed using the same process described in Section 8.2.3.1 for the exper-
imental LSF images. Once the sub-sampled 1d LSF was calculated, a Fourier
transform was used to generate the simulated MTF.
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Owing to the di culty of ensuring good optical contact between the PSA
and photodiodes when performing the LSF measurement (as described in Section
8.2.3.1), the detector LSF was also simulated with a thin, uniform air gap present
between the PSA and the photodiode layer in the MC model. The air gap was
specified to have an arbitrary uniform thickness of 0.5 mm as this was believed to
be a good estimate of the maximum possible spacing that may have been present
in the experimental setup. The LSF and MTF that were simulated with the 0.5
mm air gap were then compared to those simulated without any air gap present
to quantify the gap’s impact on these imaging metrics.
8.2.4.2 Field size output factors
Field size output factors were simulated using static, open fields measuring 3⇥3,
5⇥5, 7⇥7 and 10⇥10 cm2. Clinical open field x-ray beams were generated using
egsnrc and beamnrc and saved as output phase space files. These files were then
read into the Geant4 model of the PSA-EPID.
In a manner similar to that performed experimentally, the mean number of
optical photons absorbed within the central 1⇥ 1 cm2 region of the 2d histogram
was calculated for each field size. Field size output factors were then determined
by normalising these values to the response simulated with the 10 ⇥ 10 cm2 ref-
erence field size. Uncertainties were calculated as the standard deviation in the
response within the central region for each field size.
8.2.4.3 Relative dose profiles
Relative dose profiles were simulated using the same static, open 5 ⇥ 5 and
10 ⇥ 10 cm2 field size phase space files previously described for the field size
output factor calculations. The simulation of 5⇥ 107 primary histories was su -
cient to achieve a statistical uncertainty of ⇡ 1% in the number of optical photons
absorbed per incident x-ray at the beam central axis. Profiles were calculated
by extracting 1d slices from the 2d histograms through the central axis of the
open field in the cross-plane direction. Profiles were normalised to the response
calculated at the central axis. To simulate the e↵ect of the geometrical mismatch
between the plastic scintillating fibres and the underlying photodiode pixels, dose
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profiles were also simulated in an idealised PSA geometry using a 0.4⇥ 0.4mm2
fibre cross-sectional area. Throughout the remainder of this paper, profiles sim-
ulated using the true 0.5 ⇥ 0.5mm2 fibre area and the idealised 0.4 ⇥ 0.4mm2
area will be referred to as the “uncorrected” and “corrected” simulation profiles,
respectively.
8.3 Results and discussion
8.3.1 Line spread and modulation transfer functions
The experimentally measured and simulated LSFs, normalised to the peak re-
sponse at the detector central axis, are illustrated in Figure 8.4. Due to the
experimentally di cult nature of measuring the detector LSF in the MV energy
range, there is significant noise in the measured response at distances more than
approximately 5–10 mm away from the central axis. A median filter was used to
help improve upon this noise without a↵ecting the overall shape of the experi-
mental LSF. The experimentally measured and simulated MTFs are illustrated
in Figure 8.5 and were calculated by taking the Fourier transform of the LSFs
shown in Figure 8.4.
The simulation LSF and MTF were calculated using optical transport param-
eters that were obtained from the manufacturer or the literature where possible.
Information concerning the Rayleigh scattering length in plastic scintillator and
the optical nature of the fibre surfaces were not provided; therefore a range of
potential values (between 1   50mm, see also Chapter 7) was investigated to
empirically validate these parameters against the measured data. It was found
that a Rayleigh scattering length on the order of ⇡ 1mm resulted in optimal
agreement with measurements when specifying the EMA to act as a pure optical
absorber with zero reflectivity.
Interestingly, it was found that the introduction of a 0.5 mm thick layer of air
inserted at the contact surface between the PSA and the photodiode plane dras-
tically improved agreement with the measured results. In an idealised geometry
without the air gap present, the simulated LSF was narrower and, consequently,
the MTF was increased across all spatial frequencies. The value of f50 (the spatial
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Figure 8.4: Comparison of the experimentally measured LSF and simulated LSFs
calculated with and without a 0.5 mm air gap between the scintillator and pho-
todiode plane. LSFs were normalised to their peak values at the detector central
axis. For clarity, only every third data point has been plotted for each curve.
frequency at which the normalised MTF assumes a value of 0.5) for the experi-
mental MTF was 0.12 mm 1. Values for the simulation MTFs with and without
the 0.5 mm air gap present were and 0.13 and 0.18 mm 1 respectively.
While e↵orts were made to reduce the presence of air between the scintillator
and photodiode during measurements, it is certainly reasonable to expect a small
air gap to be present. Only a minimal amount of pressure was applied to the
scintillator to maintain close contact with the photodiodes so as not to damage
either component of the detector. This data has also been shown in Figures
8.4 and 8.5 to demonstrate the potential improvements in spatial resolution that
may be realised by further optimising the combined PSA-EPID detector design.
There are, however, several additional factors that may also contribute towards
a decrease in the measured MTF at higher spatial frequencies, relative to that
simulated without an air gap. One potential factor is whether the EMA itself
is truly 100% absorptive. Light leakage through the EMA would cause optical
cross-talk, which would also contribute towards a decreased MTF. The imaging
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panel itself may also have a thin protective coating that could behave like an
air gap and allow optical spread between the scintillator and photodiodes. Such
factors are worthy of additional investigation.
Another aspect of the PSA’s design that is worthy of further investigation
is the orientation of individual fibres with respect to the incident primary x-ray
beam. The PSA prototype described in this study used parallel fibres in line
with the primary beam’s central axis. However as a means of improving spatial
resolution when using imagers with thick scintillators, others have suggested a
so-called ‘focussed’ fibre geometry whereby the individual fibres are uniquely
angled to match the o↵-axis divergence exhibited by clinical linear accelerator
beams [24,41]. Sawant et al. have estimated that beam divergence through a non-
focussed 40 mm thick segmented array of crystal scintillators may cause losses
in the MTF up to 15% in the periphery of a 40⇥ 40 cm2 field [24]. Noting the 30
mm thickness of the PSA prototype used in this study, it is reasonable to assume
that improvements in both imaging and dosimetry performance may be realised
by moving towards a focussed geometry.
8.3.2 Field size response
The field size output factors measured using the reference water-equivalent Ma-
triXX ionisation chamber array and the prototype PSA EPID are shown in Fig-
ure 8.6. Field size factors simulated using the MC model are also shown for
comparison. Error bars for each set of data have been included, though for the
experimental measurements they were smaller than the markers used to illustrate
the data.
The maximum percent di↵erence between the MatriXX and PSA EPID mea-
surements was 0.86% and occurred for the smallest field size (2⇥2 cm2). The close
agreement between these measurements demonstrates the near water-equivalent
response of this prototype detector. The maximum percent di↵erence between
the simulated and measured PSA-EPID field size factors was 1.0% and occurred
for the 3 ⇥ 3 cm2 field size. This close agreement between the simulation data
and the experimental measurements serves as validation for the field size response
simulated using the MC model.
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Figure 8.5: Comparison of the experimentally measured MTF and simulated
MTFs calculated with and without a 0.5 mm air gap between the scintillator and
photodiode plane. MTFs were calculated from the LSFs shown above in Figure
8.4.
8.3.3 Relative dose profiles
Uncorrected and corrected relative dose profiles measured using the prototype
PSA-EPID and simulated with the MC model are shown in Figures 8.7 and 8.8
respectively. The significant variations in the measured and simulated response
within the open field region of the uncorrected profiles stems from an unavoidable
geometrical mismatch between the PSA fibres and the photodiode pixel array.
Due to di↵erences in the plastic fibre and a-Si photodiode areas, optical photons
confined to a single fibre may in fact be incident on multiple photodiode pixels. A
further complication exists with the physical prototype in that it is currently im-
practical to precisely align single rows or columns of fibres with rows or columns
of pixels. The net result of these e↵ects is that of quasi-periodic variations in
the response between neighboring pixels, despite being irradiated by a uniform
radiation field. The variation appears more regularly periodic in the simulation
data owing to the consistent and repetitive nature of the fibre/photodiode mis-
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Figure 8.6: Comparison of field size output factors measured using a MatriXX
array of ion chambers and the PSA-EPID. Simulated PSA-EPID field size output
factors are also shown over a smaller range of field sizes.
alignment in this geometry. The magnitude of signal variation is approximately
equal between the simulation and measured profiles for both field sizes studied.
This work investigated simple methods that may be applied to correct for this
element-to-element mismatching artifact. Experimentally, one approach is sim-
ply to apply a flood field correction to the raw image. Assuming an unchanging
detector setup, any observed variations in detector response due to a mismatch
between the scintillator and photodiode panel will also be present in a flood field
image. Therefore, applying the flood field correction will simply divide out this
variation in response and result in a smooth dose profile. Due to the computa-
tional burden of simulating a large flood field with optical transport in the PSA,
corrected dose profiles were instead simulated by changing the fibre cross-sectional
area to 0.4⇥ 0.4mm2, resulting in perfect fibre-to-photodiode alignment.
Undesirable consequences of this flood field correction approach however in-
clude the removal of the detector o↵-axis response due to changes in the incident
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Figure 8.7: Comparison of the uncorrected relative dose profiles measured using
the prototype EPID and simulated using the MC model for the (a) 5 ⇥ 5 and
(b) 10 ⇥ 10 cm2 open field sizes. Note the large signal variation in the open-
field region resulting from mismatching between the PSA and the underlying
photodiode array.
beam spectra at distances away from the central axis. Due to the generally softer
beam energy away from the central axis, dose profiles in water typically exhibit
a slight increase in response in this region (often referred to as the “horns” of the
profile). The corrected simulation profiles will retain the correct o↵-axis response
variations because no flood field correction was applied. While the corrected ex-
perimental and simulation profiles agree almost perfectly for the 5 ⇥ 5 cm2 field
size, the e↵ect of removing the dose horns through the application of the flood
field correction is more pronounced for the 10 ⇥ 10 cm2 field size. A  -index
comparison between the experimental and simulated profiles for these field sizes
quantitatively demonstrates this same e↵ect [53]. Using 2%/2mm criteria and a
relative dose threshold of 10%, 97.8% and 84.2% of data points passed for the
5⇥ 5 and 10⇥ 10 cm2 fields, respectively.
Because the incident x-ray energy spectrum is relatively uniform across the
5 ⇥ 5 cm2 field, the flood field correction approach to removing the variations
in response for the experimental profile is su cient. However, an alternative
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Figure 8.8: Comparison of the corrected relative dose profiles measured using the
prototype EPID and simulated using the MC model for the (a) 5 ⇥ 5 and (b)
10⇥ 10 cm2 open field sizes. The mismatching artifact present in the uncorrected
images was removed by applying a flood field correction to experimental images
and re-simulating the open field response using 0.4⇥ 0.4mm2 fibres to precisely
match the photodiode array. Subplots indicate a  -index analysis comparing the
experimental and simulated profiles with 2%/2mm criteria.
approach should be used for larger field sizes including the 10 ⇥ 10 cm2 field so
as not to remove the o↵-axis response. While the investigation of alternative
correction methods was beyond the scope of this study, others have reported
novel binning correction techniques to improve the spatial resolution of similar
thick, segmented scintillator detectors [31]. While those authors used a photodiode
array with a significantly higher resolution than the detector used in this study,
the impact of using similar binning techniques to correct for the mismatching
artifact with this detector will be the subject of future investigation.
8.4 Conclusions
This study reports the first experimental measurements taken using a novel,
second-generation water-equivalent EPID employing an array of plastic scintillat-
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ing fibres. Measurements were used firstly to characterise the detector’s response
and secondly to empirically validate a Monte Carlo model of the prototype based
on simulations quantifying the detector’s spatial resolution and dose response. As
hypothesised, the prototype EPID exhibited a water-equivalent non-transit dose
response that matched measurements performed using a MatriXX ion chamber
array. Simulation results of the detector’s line spread function and modulation
transfer function suggest the presence of a thin air gap between the scintillator
and photodiode array possibly present during the measurements. Future work
will endeavor to improve upon the quality of images acquired using this second-
generation prototype by investigating methods to correct for the artifact intro-
duced by scintillator fibre and photodiode pixel misalignment. Furthermore, the
Monte Carlo model will be used to investigate potential configurations to further
optimise the imaging and dosimetric response of a next-generation prototype.
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Conclusions
The investigations contributing to this thesis have taken several steps forward in
the pursuit to develop a next-generation device capable of simultaneous imaging
and dose verification in radiotherapy. While recent studies have reported on high
e ciency detectors for megavoltage (MV) imaging, the prototype EPID devel-
oped, optimised and evaluated in this work represents the first high e ciency
MV imager to be physically constructed that also exhibits a demonstrated water
equivalent response. Furthermore, the Monte Carlo (MC) model of the proto-
type EPID developed and validated here provides a valuable tool for ongoing
optimisation of next-generation prototypes.
As a foundation upon which to develop a MC model of the prototype EPID,
models of a clinical 6 MV photon source (Chapter 3) and a standard copper
plate/phosphor screen a-Si EPID were first developed and experimentally vali-
dated. While previous studies have reported similar models, the model devel-
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oped here is the first to characterise optical photon transport self-consistently
with x-ray and electron transport in the standard EPID by using the Geant4
MC toolkit. Results further confirmed that although simulating optical trans-
port is necessary to predict the EPID point spread function and hence imaging
performance, energy deposition in the phosphor screen is an accurate surrogate
for predicting EPID dose response to large fields in non-transit (Chapter 4) and
transit (Chapter 5) configurations.
Characterising the imaging and dosimetry performance of the prototype EPID
constitutes the first experimental demonstration reported in the literature of indi-
rect MV x-ray detection using a segmented low-density scintillator (Chapter 6).
Results demonstrating its water-equivalent response in non-transit and transit
configurations were perhaps of greatest relevance considering the goal of develop-
ing a novel EPID suitable for applications in dosimetry as well as imaging. While
images acquired with this first-generation prototype were of an inferior quality
relative to images acquired with a standard EPID, they were nonetheless capa-
ble of visualising gross anatomical features in an anthropomorphic phantom and
several opportunities for imaging performance optimisation were identified.
Having benchmarked the initial prototype array of plastic scintillating fibres,
a second-generation prototype was developed using fibres that were longer and
narrower in an attempt to improve sensitivity and spatial resolution. A MC model
based on the dimensions of the second-generation prototype was developed and its
sensitivity to a range of geometrical and optical transport parameters was studied
to determine an optimised configuration (Chapter 7). Simulation of the extra-
mural absorber that surrounds each fibre in the prototype array was found to be
critically important for simulations predicting the detector modulation transfer
function (MTF) and open field dose response. Element-to-element mismatch be-
tween scintillating fibres and photodiode pixels was also found to be important,
causing the MTF to decrease at high spatial frequencies and introducing quasi-
periodic variations in open field dose profiles. Measurements performed using the
second-generation prototype further demonstrated its water-equivalent response
and were used to validate the MC model (Chapter 8). A simple method to im-
prove upon the quasi-periodic profile response resulting from element-to-element
mismatch was also demonstrated to be suitable for small fields.
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Future work
Ongoing optimisation of the prototype EPID is required to continue improving
upon its imaging performance. For this type of detector to be used clinically for
simultaneous imaging and dose verification, its performance as an imager should
ideally match or exceed current commercially available a-Si EPIDs. The results
presented in this thesis confirm that the water equivalent dose response remains
una↵ected by changes in the optical properties of the plastic scintillator fibres.
Therefore, further improvements in imaging performance may be realised through
optimisation of select optical properties (such as the optical yield, for example)
without a↵ecting the dose response. Opportunities for continued design optimisa-
tion also include the fabrication of fibres with still narrower physical dimensions
to improve upon spatial resolution. Post-processing methods to correct images
exhibiting element-to-element mismatch artifacts, including those referenced in
Chapter 8, should also be investigated.
One particular design that warrants detailed investigation in future studies
is the use of an optical coupling agent between the scintillator array and the
photodiodes to maximise light detection. The discovery that the presence of air
between the scintillator and photodiodes reduces the detector MTF (Chapter 8)
suggests that optical coupling may o↵er further improvements in imaging perfor-
mance. The exploration of alternative cladding materials with di↵erent optical
properties is also warranted to investigate whether there is scope to decrease op-
tical signal loss in the plastic scintillator fibres beyond that which is present in
the current design. Another avenue for future work is the use of geometrically di-
vergent scintillator arrays designed to match the divergence exhibited by clinical
linear accelerator beams. A potential disadvantage to this design is that such a
detector would exhibit optimal performance at a fixed distance from the accelera-
tor target. Nevertheless the likely improvements in spatial resolution that would
result by accounting for beam divergence in this manner are worthy of further
exploration.
Ultimately, the feasibility of developing a novel MV imaging device with a
water-equivalent dose response has been demonstrated through this work. On-
going e↵orts to optimise the design of the existing prototype for radiotherapy
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imaging and dosimetry will now be able to progress at an accelerated rate by
taking advantage of the validated MC model. It is anticipated that through
these e↵orts and the development of advanced fabrication techniques, a next-
generation EPID may be realised with the ability to serve as an essential clinical
tool for comprehensive radiotherapy treatment verification.
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Appendix – Abstracts from conference
presentations
This appendix contains, in chronological order, the abstracts for work presented in
the form of posters and oral presentations at conferences throughout candidature.
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Appendix
Towards the development of a comprehensive model of an
electronic portal imaging device for advanced
radiotherapy applications
S. Blake, P. Vial, L. Holloway and Z. Kuncic
Oral presentation at the Cancer Research Network Symposium for Postgraduate
Students in Sydney, Australia – December, 2010
Background: Electronic portal imaging devices (EPIDs) are of major sig-
nificance to the field of radiation oncology due to their applications to external
beam megavoltage (MV) radiotherapy. Approximately half of all cancer patients
receive radiotherapy during treatment, the majority of which is delivered exter-
nally. The amorphous silicon (a-Si) flat panel EPID shows enormous promise
for its use as a 2-dimensional dosimeter due to its large, high-resolution detec-
tor area and real-time acquisition capabilities. As a dosimeter, it would serve to
verify accurate treatment delivery and to indicate when treatment adaptations
may be advantageous. This work represents the first stage of an ongoing study to
investigate the physical processes occurring within EPIDs, including the e↵ects
of optical scattering on image quality and dosimetry.
Methods: Data from the Phase-space database for external beam radiother-
apy (International Atomic Energy Agency, IAEA) was used with the Geant4
software toolkit to construct a Monte Carlo model of a Siemens Primus linear
accelerator (linac) 6 MV photon source. Dose profiles and percent depth dose
(PDD) curves were extracted from simulations of dose in water and compared
to experimental measurements. A preliminary EPID model was developed to
incorporate both high energy radiation and optical photon transport.
Results: Mean agreement in dose profiles inside the open beam was within
0.5%. Mean agreement in PDD curves beyond depth of dose maximum was within
1.1% (local percent di↵erence). The radiation transport of both high energy and
optical photons were visualized in the EPID simulation. Further work is under
way to experimentally validate the EPID model.
252
Conclusions: The comparison of simulated dose in water with measurements
indicates that the IAEA phase-space represents an accurate model of a linac
source. We have demonstrated the feasibility of developing a comprehensive EPID
model incorporating both high energy and optical physics.
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Towards the development of a comprehensive model of an
electronic portal imaging device using Geant4
S. Blake, P. Vial, L. Holloway and Z. Kuncic
Poster presentation at the Engineering and Physical Sciences in Medicine and the
Australian Biomedical Engineering Conference (EPSM-ABEC) annual meeting in
Melbourne, Australia – December, 2010
Objective: This work represents the first stage of an ongoing study to inves-
tigate the physical processes occurring within electronic portal imaging devices
(EPIDs), including the e↵ects of optical scattering on image quality and dosime-
try. The objective of this work was to develop an initial Monte Carlo model of a
linear accelerator (linac) beam and an EPID. The ability to simulate the radia-
tion transport of both high energy and optical photons in a single Monte Carlo
model was tested.
Methods: Data from the Phase-space database for external beam radiother-
apy (International Atomic Energy Agency, IAEA) was used with the Geant4
toolkit to construct a model of a Siemens Primus linac 6 MV photon source.
Dose profiles and percent depth dose (PDD) curves were extracted from simula-
tions of dose in water and compared to experimental measurements. A prelimi-
nary EPID model was developed to incorporate both high energy radiation and
optical photon transport.
Results: Agreement in dose profiles inside the open beam was within 1.6%.
Mean agreement in PDD curves beyond depth of dose maximum was within
6.1% (local percent di↵erence). The radiation transport of both high energy and
optical photons were simulated and visualized in the EPID model. Further work
is required to experimentally validate the EPID model.
Conclusions: The comparison of simulated dose in water with measurements
indicates that the IAEA phase-space may represent an accurate model of a linac
source. We have demonstrated the feasibility of developing a comprehensive EPID
model incorporating both high energy and optical physics in Geant4.
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Modelling of a radiotherapy linac beam and portal imager
using Geant4: A feasibility study
S. Blake, P. Vial, L. Holloway and Z. Kuncic
Oral presentation at the 5th Student Research Symposium of the ACT/NSW
Branch of the Australasian College of Physical Scientists and Engineering in
Medicine in Sydney, Australia – December, 2010
Introduction: This work represents the first stage of an ongoing study to
investigate the physical processes operating within electronic portal imaging de-
vices (EPIDs), including the e↵ects of optical scattering on image quality and
dosimetry. The objective of this work was to develop a Monte Carlo (MC) model
of a linear accelerator (linac) beam and an EPID using the Geant4 MC toolkit[1].
We tested the capability of Geant4 to model both the high energy and optical
physics relevant for EPIDs, which have not previously been modelled simultane-
ously.
Methods: A preliminary EPID model was developed to incorporate high
energy and optical photon transport. Data from the IAEA Phase-space database
for external beam radiotherapy was used with Geant4[2] to build a Siemens
Primus linac 6 MV source model. To benchmark the quality of this phase-space
(phsp) source, relative dose profiles and percent depth dose (PDD) curves were
extracted from simulations of dose in water and compared to measurements with
a CC13 compact ionization chamber (IC). Uncertainty in the mean energy de-
posited along the beam central axis was calculated using the method described
by Walters et al.[3]
Results: Mean agreement in dose profiles inside the open beam was within
1.6%. Mean agreement in PDD curves beyond depth of dose maximum (dmax)
was within 1.0% (local percent di↵erence). Latent uncertainties in the energy
deposited along the beam central axis using the phsp files are between approxi-
mately 1–3%. The radiation transport of both high energy and optical photons
were simulated and visualized in the EPID model.
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Discussion: The comparison of simulated dose in water with measurements
indicates that the IAEA phsp may represent an accurate model of a linac source.
To exclude dose-volume e↵ects inherent in IC measurements, agreement between
simulation and experimental data was only evaluated within the open field of the
beam (profiles) and beyond dmax (PDDs). To further benchmark the linac source
model, work is required to experimentally validate the energy deposited outside
of the open field (profiles) and within the build-up region (PDDs).
Conclusions: We have demonstrated the feasibility of developing a compre-
hensive EPID model incorporating high energy physics in Geant4. Future work
will include refining and testing the optical physics in our model to optimize
imaging and dosimetry capabilities.
References:
1. Agostinelli S, Allison J, Amako K, et al. Geant4–a simulation toolkit.
NIMA 2003;506:250.
2. Corte´s-Giraldo MA, Quesada JM, Gallardo MI, and Capote R. Geant4 In-
terface to Work with IAEA Phase-Space Files,2009.
3. Walters BR, Kawrakow I, Rogers DW. History by history statistical esti-
mators in the BEAM code system. Med Phys 2002;29:2745.
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Developing a model of an electronic portal imaging device
using Geant4
S. Blake, P. Vial, L. Holloway, P. Greer and Z. Kuncic
Oral presentation at the 1st GEANT4 Australian School and User Workshop in
Wollongong, Australia – April, 2011
Introduction: Electronic portal imaging devices (EPIDs) are silicon-based
detectors that are used regularly in radiotherapy for imaging and, more recently,
dosimetry. This work forms part of an ongoing study[1,2,3] to investigate the
physical processes operating within EPIDs, including the e↵ects of optical scin-
tillation and scattering on image quality and dosimetry. The objective of this
work is to develop and benchmark a preliminary Monte Carlo (MC) model of a
linear accelerator (linac) beam and an EPID using the Geant4 MC toolkit[4].
We tested the capability of Geant4 to model both the high energy and optical
physics relevant for EPIDs, which have not previously been modelled simultane-
ously.
Materials and methods: A preliminary linac and EPID model was devel-
oped to incorporate both high energy and optical photon transport. Data from
the IAEA Phase-space database for external beam radiotherapy was used with
Geant4[5] to build a Siemens Primus linac 6 MV source model. Phase-space
(phsp) files for five square-shaped beam field sizes were used (3⇥3, 5⇥5, 10⇥10,
15 ⇥ 15 and 20 ⇥ 20 cm2). To benchmark the quality of these phsp sources, rel-
ative dose profiles and percent depth dose (PDD) curves were extracted from
simulations of dose in water and compared to measurements taken using a CC13
compact ionization chamber (IC). Uncertainty in the mean energy deposited along
the beam central axis was calculated using the method described by Walters et
al.[6] Latent uncertainty in the IAEA phsp files has been estimated using the
method described by Sempau et al.[7]
Results: The radiation transport of both high energy and optical photons
were simulated and visualized in the EPID model. Mean agreement in dose
profiles inside the open beam was within 1.6% when benchmarking the linac
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source model. Furthermore, mean agreement in PDD curves beyond depth of dose
maximum (dmax) was within 1.0% (local percent di↵erence). Latent uncertainties
in the energy deposited along the beam central axis using the phsp files are within
1–3%.
Conclusions: We have developed a preliminary EPID model incorporating
both high energy and optical physics in Geant4. The comparison of simulated
dose in water with measurements indicates that the IAEA phsp may represent an
accurate model of a linac source. To further benchmark the linac source model,
work is required to experimentally validate the energy deposited outside of the
open field (profiles) and within the build-up region (PDDs). Future work will
also include refining and testing the optical physics in our model to optimize
imaging and dosimetry performance. This performance may be characterized
by simulating the Point Spread Function, Modulation Transfer Function, and
Detective Quantum E ciency of the EPID in this model.
References:
1. P. Vial et al. Phys. Med. Biol. 54, 7151-69 (2009).
2. H. Gustafsson et al. Med. Phys. 36, 5665-74 (2009).
3. P. Greer et al. Med. Phys. 34, 4389-98 (2007).
4. Geant4 Collaboration (S. Agostinelli et al.), Nucl. Instrum. Meth. Phys.
Res. A 506, 250-303 (2003).
5. M. Cortes-Giraldo et al., Geant4 Interface to Work with IAEA Phase-Space
Files.
6. B. Walters et al., Med. Phys. 29, 2745-52 (2002).
7. J. Sempau et al. Phys. Med. Biol. 46, 1163-86 (2001).
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Self-consistent Monte Carlo simulation of x-ray and
optical photon transport in electronic portal imaging
devices
S. Blake, P. Vial, L. Holloway, P. Greer and Z. Kuncic
Oral presentation at the International Workshop on Recent Advances in Monte
Carlo Techniques for Radiation Therapy in Montreal, Canada – June, 2011
Purpose: To self-consistently model x-ray and optical photon transport
within an indirect-detection electronic portal imaging device (EPID) using Monte
Carlo (MC) methods and to quantify the e↵ect of optical scatter on the output
signal.
Materials and Method: A generic indirect-detection EPID model was de-
veloped using the Geant4 MC toolkit. The EPID was modeled as a series of
uniform slabs with thicknesses and material properties obtained from published
literature. The standard Geant4 electromagnetic and optical physics modules
were incorporated into the model to self-consistently simulate both x-ray and op-
tical photon transport relevant for indirect-detection EPIDs. Preliminary model
response was investigated using simulations of a narrow monoenergetic beam of
1 MeV photons normally incident on the EPID surface. The beam width was
equal to the photodiode pixel pitch of 0.4 mm, generating a line of radiation
incident on the EPID surface. Particle hits and energy deposition were scored
in the gadolinium oxysulfide scintillator and amorphous silicon photodiode lay-
ers. Optical and x-ray photons were scored separately in the photodiode layer to
measure their relative e↵ects on the output signal. Line spread functions (LSFs)
were generated to indicate the distribution of hits and energy deposited across
the scintillator and photodiode planes.
Results: Preliminary LSFs have been generated for energy deposition events
scored in the scintillator and optical photon hits scored in the photodiode. Cur-
rent work involving the validation of optical transport within this model will be
presented.
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Conclusions: Initial LSF simulations suggest a small but non-negligible con-
tribution of optical photon scatter to the output EPID signal. Modeling of
optical photon transport may therefore be important when simulating imager
performance for an indirect-detection EPID. Validation of the optical transport
modeling is required to more accurately quantify imager LSFs.
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An investigation into optical photon transport e↵ects on
electronic portal imaging performance using Geant4
S. Blake, P. Vial, L. Holloway, P. Greer and Z. Kuncic
Oral presentation in the Young Investigators Symposium at The 2011 Joint Amer-
ican Association of Physicists in Medicine (AAPM)/Canadian Organization of
Medical Physicists (COMP) annual meeting in Vancouver, Canada – August,
2011
Purpose: To develop a comprehensive Monte Carlo (MC) model of an indirect-
detection electronic portal imaging device (EPID) that can self-consistently quan-
tify the e↵ect of optical blur on the output signal.
Method and Materials: A model of an indirect-detection EPID was de-
veloped using the Geant4 MC toolkit. The EPID was modeled as a series of
uniform slabs with thicknesses and material properties obtained from published
literature. The model also included a slab of solid water backscatter material
directly beyond the EPID rear housing. The standard electromagnetic and opti-
cal physics Geant4 modules were incorporated into the model to simultaneously
simulate both high energy and optical photon transport relevant for indirect-
detection EPIDs. A narrow, monoenergetic beam of 1 MeV photons was used to
generate a line of radiation normally incident on the EPID surface. The beam
width was equal to the pixel pitch of 0.4 mm used for scoring particle hits and
energy deposition in the gadolinium oxysulfide scintillator and amorphous sili-
con photodiode layers. Optical and gamma photons were scored separately in
the photodiode layer to measure their relative e↵ects on the output signal. Line
spread functions (LSFs) were generated indicating the distribution of hits and
energy deposited across the scintillator and photodiode planes.
Results: The LSFs for optical photon hits in the photodiode array and energy
deposition events in the scintillator had a FWHM of approximately 4.7 mm and
0.82 mm, respectively. This indicates a significant increase in image blurring due
to optical photon scatter.
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Conclusions: Our results indicate that modeling optical photon transport
may be important when simulating imager performance for an indirect-detection
EPID. Further analysis of calculated LSFs, including determination of the detec-
tor modulation transfer function, is required to further quantify imager perfor-
mance.
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Preliminary investigation of optical photon transport in
electronic portal imaging devices
S. Blake, P. Vial, L. Holloway and Z. Kuncic
Poster presentation at the Engineering and Physical Sciences in Medicine and the
Australian Biomedical Engineering Conference (EPSM-ABEC) annual meeting in
Darwin, Australia – August, 2011
Objective: To quantify the e↵ect of optical photon transport on the output
signal of an indirect-detection electronic portal imaging device (EPID) using the
Geant4 Monte Carlo (MC) toolkit.
Methods: The Geant4 MC toolkit has been used to develop a model of a
generic indirect-detection EPID based on geometrical data and material proper-
ties obtained from published literature. X-ray and optical photon transport were
modeled self-consistently within the EPID using the Geant4 electromagnetic
and optical physics modules. Narrow beams of 1 MeV monoenergetic x-rays,
normally incident on the EPID surface, were used in a preliminary investigation
of the detector response. The beam width was equal to the photodiode pixel
pitch of 0.4 mm. Line spread functions (LSFs) of energy deposition events and
photon hits were scored in the gadolinium oxysulfide scintillator and amorphous
silicon photodiode layers. X-ray and optical photons were scored separately to
measure their relative e↵ects on the output signal.
Results: The full width at half maximum (FWHM) and full width at tenth
maximum (FWTM) of the LSF scoring energy deposited in the scintillator are
0.82 mm and 1.16 mm respectively. The FWHM and FWTM of the LSF scoring
optical photon hits in the photodiode are 0.94 mm and 2.10 mm respectively.
Conclusions: Preliminary results suggest a small but non-negligible contri-
bution of optical photon scatter to the output EPID LSF signal. Modeling optical
photon transport may therefore be important when simulating indirect-detection
EPID imaging performance. Validation of the optical transport modeling param-
eters is required to more accurately quantify EPID LSFs.
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Monte Carlo investigation of optical photon transport
e↵ects on electronic portal imaging device dosimetric
response
S. Blake, P. Vial, L. Holloway, P. Greer and Z. Kuncic
Oral presentation at the 6th Student Research Symposium of the ACT/NSW
Branch of the Australasian College of Physical Scientists and Engineering in
Medicine in Sydney, Australia – December, 2011
Introduction: Amorphous silicon (a-Si) electronic portal imaging devices
(EPIDs) have been demonstrated to be suitable for radiotherapy dosimetry appli-
cations due in part to their high spatial resolution and real-time data acquisition
capabilities. Such EPIDs indirectly detect radiation by means of a Gd2O2S:Tb
phosphor screen that converts incident radiation into optical photons that are
detected by the a-Si photodiode array. The phosphor screen improves the detec-
tion e ciency of the EPID; however it results in an over-response to low energy
radiation when compared to more water equivalent dosimeters. Many previous
studies using Monte Carlo (MC) methods to model the dosimetric response of
a-Si EPIDs have not fully accounted for the transport of optical photons within
these detectors. The goal of this work was to develop a MC model of an a-Si
EPID that could self-consistently simulate both x-ray and optical photon trans-
port and to thereby investigate the e↵ects of optical photon transport on EPID
dosimetric response.
Methods: A model of an indirect-detection a-Si EPID was developed using
the Geant4 MC toolkit. The EPID was modeled as a series of uniform slabs with
thicknesses and material properties based on specifications from the manufacturer
of a research detector used in this study. The standard electromagnetic and
optical physics Geant4 classes were incorporated into the model. Phase-space
data for a 6 MV Elekta Synergy photon source was used to generate static open
fields (5 ⇥ 5 and 10 ⇥ 10 cm2) incident on the EPID surface. Optical photon
absorption events were scored in the a-Si photodiode layer. Experimental EPID
images were also obtained by exposing a research EPID to Elekta Synergy 6 MV
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photon beams for the aforementioned open field sizes. Normalized simulation
profiles scoring the optical photons absorbed in the photodiode were compared
to normalized profiles extracted from experimental EPID images.
Results: Local percent di↵erence (LPD) between the normalized simulation
profiles scoring optical photon absorption events in the photodiode and the nor-
malized experimental EPID images was calculated within the open field region
for each field size studied. The mean and maximum LPDs were 0.23% and 2.8%
respectively for the 5 ⇥ 5 cm2 open field and 1.7% and 5.9% respectively for the
10⇥ 10 cm2 field.
Conclusions: A MC model of an a-Si EPID that self-consistently simu-
lates x-ray and optical photon transport within the detector was developed using
Geant4. Preliminary results comparing normalized profiles scoring optical pho-
ton absorption events in the photodiode to normalized profiles extracted from
experimental images indicate mean agreement within the open field region of less
than 2%. Similar investigations of dosimetric EPID response to larger field sizes
are underway. Furthermore, to better quantify optical photon transport e↵ects
in this model current work is focussing on scoring energy deposition events in the
phosphor layer and comparing resulting profiles with those reported in this study.
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Monte Carlo modeling of optical photon transport e↵ects
on electronic portal imaging device dosimetric response
S. Blake, P. Vial, L. Holloway, P. Greer and Z. Kuncic
Oral presentation at the Electronic Patient Imaging 2012 (EPI2k12) conference
in Sydney, Australia – March, 2012
Introduction: Amorphous silicon (a-Si) electronic portal imaging devices
(EPIDs) have been demonstrated to be suitable for radiotherapy dosimetry ap-
plications due in part to their high spatial resolution, real-time data acquisition
capabilities and resilience to radiation-induced damage. Commercially available
a-Si EPIDs, however, contain a number of non water-equivalent components that
complicate their use for dosimetry. Such EPIDs indirectly detect radiation by
means of a gadolinium oxysulfide phosphor screen that converts incident radia-
tion into optical photons that are detected by the a-Si photodiode array. While
this phosphor screen is used to improve the detective quantum e ciency of the
EPID, it results in an over-response to low energy radiation in comparison to
more water equivalent dosimeters. Previous studies have used Monte Carlo (MC)
simulation methods to model the dosimetric response of a-Si EPIDs. However,
the majority of these studies have not fully accounted for the transport of optical
photons within these detectors. The goal of this work was to develop a MC model
of an a-Si EPID that could self-consistently simulate both x-ray and optical pho-
ton transport relevant for indirect-detection EPIDs. This model was then used to
investigate the e↵ects of optical photon transport on EPID dosimetric response.
Methods and Materials: A model of an indirect-detection a-Si EPID was
developed using the Geant4 MC toolkit. The EPID was modeled as a series
of uniform slabs with thicknesses and material properties based on specifications
from the manufacturer of a research detector used in this study. The standard
electromagnetic and optical physics Geant4 classes were incorporated into the
model. Phase-space data for a 6 MV Elekta Synergy photon source was used
to generate a static open 10 ⇥ 10 cm2 field incident on the EPID surface. En-
ergy deposition events were scored in the gadolinium oxysulfide phosphor layer
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and optical photon absorption events were scored in the a-Si photodiode layers.
Experimental EPID images were also obtained by exposing a research EPID to
Elekta Synergy 6 MV photon beams for the 10⇥ 10 cm2 open field. Normalized
cross-plane profiles scoring energy deposition events in the phosphor and opti-
cal photons absorbed in the photodiode were compared with normalized profiles
extracted from experimental EPID images.
Results: Local percent di↵erence (LPD) between the normalized simulation
profiles and the normalized experimental EPID profiles was calculated within the
open field region. The mean and maximum LPD were 1.5% and 5.6% respec-
tively between the simulation profile scoring optical photon absorption events
in the photodiode and the experimental profile. The mean and maximum LPD
were 1.1% and 3.3% respectively between the simulation profile scoring energy
deposition events in the phosphor and the experimental profile.
Conclusions: A MC model of an a-Si EPID that self-consistently simu-
lates x-ray and optical photon transport within the detector has been developed
using Geant4. Preliminary results comparing normalized profiles scoring opti-
cal photon absorption events in the photodiode and energy deposition events in
the phosphor to normalized profiles extracted from experimental images indicate
mean agreement within the open field region of less than 2%. Similar investiga-
tions of dosimetric EPID response to smaller and larger field sizes are underway.
Furthermore, to better quantify optical photon transport e↵ects in this model,
current work is focusing on evaluating potential di↵erences between the scoring
methods outside of the open field region of the beam.
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Sensitivity analysis of an electronic portal imaging device
Monte Carlo model to variations in optical transport
parameters
S. Blake, P. Vial, L. Holloway, A. McNamara, P. Greer and Z. Kuncic
Poster presentation at The 2012 American Association of Physicists in Medicine
(AAPM) annual meeting in Charlotte, NC USA – August, 2012
Purpose: To investigate the sensitivity of a Monte Carlo (MC) model of a
standard clinical amorphous silicon (a-Si) electron portal imaging device (EPID)
to variations in optical photon transport parameters.
Methods: The Geant4 MC toolkit was used to develop a comprehensive
model of an indirect-detection a-Si EPID incorporating x-ray and optical photon
transport. The EPID was modeled as a series of uniform layers with proper-
ties specified by the manufacturer (PerkinElmer, Santa Clara, CA) of a research
EPID at our centre. Optical processes that were modeled include bulk absorption,
Rayleigh scattering, and boundary processes (reflection and refraction). Model
performance was evaluated by scoring optical photons absorbed by the a-Si pho-
todiode as a function of radial distance from a point source of x-rays on an event-
by-event basis (0.025 mm resolution). Primary x-ray energies were sampled from
a clinical 6 MV photon spectrum. Simulations were performed by varying opti-
cal transport parameters and the resulting point spread functions (PSFs) were
compared. The optical parameters investigated include: x-ray transport cuto↵
thresholds; absorption path length; optical energy spectrum; refractive indices;
and the ’roughness’ of boundaries within phosphor screen layers.
Results: The transport cuto↵s and refractive indices studied were found
to minimally a↵ect resulting PSFs. A monoenergetic optical spectrum slightly
broadened the PSF in comparison with the use of a polyenergetic spectrum. The
absorption path length only significantly altered the PSF when decreased drasti-
cally. Variations in the treatment of boundaries noticeably broadened resulting
PSFs.
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Conclusion: Variation in optical transport parameters was found to a↵ect
resulting PSF calculations. Current work is focusing on repeating this analysis
with a coarser resolution more typical of a commercial a-Si EPID to observe if
these e↵ects continue to alter the EPID PSF. Experimental measurement of the
EPID line spread function to validate these results is also underway.
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Towards a Next-Generation Electronic Portal Device for
Radiotherapy Imaging and Dosimetry
S. Blake, P. Vial, L. Holloway, A. L. McNamara, P. B. Greer and Z. Kuncic
Oral presentation at the Cancer Research Network Symposium for Postgraduate
Students in Sydney, Australia – November, 2012
Introduction: Electronic portal imaging devices (EPIDs) are x-ray detectors
that have many clinical applications in radiation oncology. While optimized for
imaging uses, including verification of patient positioning prior to treatment,
EPIDs may also be used to verify the radiation dose delivered during radiotherapy
treatments. EPIDs use a phosphor screen to convert incident x-rays into optical
photons which are then detected by a photodiode array. Studies using Monte
Carlo (MC) simulations to model EPID response, however, often neglect optical
transport within these detectors. In this study a comprehensive MC model of
an EPID was developed to self-consistently simulate x-ray and optical transport,
and thereby investigate optical transport e↵ects on EPID response.
Methods: The Geant4 MC software toolkit was used to develop a model
of an EPID incorporating x-ray and optical transport. A clinical 6 MV photon
beam source was also developed and integrated into the model. This was vali-
dated using experimental images acquired with a research EPID at the Liverpool
and Macarthur Cancer Therapy Centres. Energy deposited in the phosphor and
optical absorption events in the photodiode were recorded in response to pho-
ton beams of varying size. Beam profiles were then normalized and compared to
quantify optical transport e↵ects within the detector. Recently the MC model has
been modified to incorporate CT images, enabling a patient/phantom geometry
to be positioned in the beam line (transit configuration).
Results: More than 94% of all data points for the simulated EPID dose
profiles agreed with experimental measurements. Di↵erences in model response
resulting from optical transport were not found to be statistically significant.
Conclusions: Optical photon transport contributed a negligible change in
EPID dosimetric response for a non-transit configuration. Current work is inves-
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tigating optical transport e↵ects in transit dosimetry, as well as next-generation
EPIDs utilizing di↵erent materials to optimize their use for radiotherapy dosime-
try applications.
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Towards a Next-Generation Electronic Portal Device for
Dual-Mode Imaging and Dosimetry
S. Blake, P. Vial, L. Holloway, A. L. McNamara, P. B. Greer and Z. Kuncic
Poster presentation at the 20th Australian Institute of Physics Congress in Syd-
ney, Australia – December, 2012
Introduction: Amorphous silicon (a-Si) electronic portal imaging devices
(EPIDs) are flat panel x-ray detectors that have found many clinical applications
particularly in radiation oncology. They are most frequently used for patient
imaging in image-guided radiotherapy to verify patient positioning prior to treat-
ment. More recently, EPIDs have also been demonstrated to be suitable for
dosimetry applications, such as to verify the radiation dose delivered during ra-
diotherapy treatment[1]. EPIDs employ a metal plate and phosphor scintillator
screen to indirectly detect x-rays and thereby increase their e ciency. X-rays and
electrons interact in the phosphor to generate optical photons which are then ab-
sorbed by an a-Si photodiode array. Optical photons are absorbed by individual
photodiode pixels, leading to a charge buildup that can be read out to form a
digital image. Many studies using Monte Carlo (MC) simulations to simulate
EPID response have made simplifying assumptions regarding optical transport
within the detectors. In most cases, the dose deposited in the phosphor is the
quantity used to predict dose response and optical transport is either empirically
corrected for or neglected, e.g. [2]. In this study, a comprehensive MC model of
an a-Si EPID was developed to investigate optical transport e↵ects on dosimetric
response. This is the first EPID model to self-consistently model both x-ray and
optical photon transport.
Methods: The Geant4 MC radiation transport toolkit was used to develop
a detailed model of a research EPID. Electromagnetic and optical physics classes
were used to simulate radiation transport in the EPID. Material and optical
properties were based on information provided by the manufacturer or literature
values. A model of a clinical 6 MV photon beam source was also developed
and integrated into the simulation. To validate the model, experimental images
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were acquired using the research EPID under the same irradiation conditions.
Histograms scoring the 2d spatial distribution of energy deposition and optical
absorption events (0.4 ⇥ 0.4mm2 resolution) were scored in the phosphor and
photodiode planes, respectively. These histograms were then normalized and
compared to evaluate the e↵ects of optical photon transport within the detector.
Histograms were also compared with experimental images to observe di↵erences
in agreement between scoring methods. Initial simulations were performed in a
non-transit dosimetry configuration – that is, with nothing between the radiation
source and the EPID. Recently the MC model has been modified to enable a
transit dosimetry configuration with a phantom based on a DICOM computed
tomography image set positioned in the beam line.
Discussion and conclusions: Optical photon transport was found to con-
tribute a non-negligible amount of signal towards the EPID response for irradia-
tions in non-transit dosimetry. Optical scatter, predominantly within the phos-
phor layer, acted to slightly broaden dose profiles relative to those obtained by
scoring energy deposited in the phosphor layer. Improved agreement with ex-
perimental images was obtained when scoring optical absorption events. Current
work is investigating the impact of optical transport on EPID response for transit
dosimetry.
References:
1. Mans A, et al. Catching errors with in vivo EPID dosimetry. Med. Phys.
2010;37(6)2638-44.
2. Siebers JV, Kim JO, Ko L, Keall PJ, Mohan R. Monte Carlo computa-
tion of dosimetric amorphous silicon electronic portal images. Med. Phys.
2004;31(7)2135-46.
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Towards the development of a novel EPID for
simultaneous imaging and dosimetry in radiotherapy
S. Blake, A. L. McNamara, P. Vial, L. Holloway, P. Greer and Z. Kuncic
Oral presentation at the 7th Student Research Symposium of the ACT/NSW
Branch of the Australasian College of Physical Scientists and Engineering in
Medicine in Sydney, Australia – December, 2012
Introduction: Amorphous silicon (a-Si) electronic portal imaging devices
(EPIDs) are x-ray detectors that have realized many clinical applications in ra-
diation oncology. Commercially available EPIDs use a metal plate and phosphor
screen to convert incident x-rays into optical photons which are then detected by
an a-Si photodiode array. While this detection scheme optimizes image contrast
and noise properties, the high atomic number materials result in a non water-
equivalent dosimetric response. By replacing the metal plate/phosphor screen
with an array of water-equivalent plastic scintillating fibers, it is hypothesized
that the EPID may be used to simultaneously image the patient while verifying
the radiation dose delivered during radiotherapy treatments.
In this study, the imaging and dosimetric capabilities of a research EPID were
evaluated for both the standard clinical configuration and the proposed configu-
ration which employed a prototype plastic scintillator array (PSA). In addition,
a comprehensive Monte Carlo (MC) model of the a-Si EPID was developed to
self-consistently simulate x-ray and optical transport within the standard and
prototype EPID configurations. This model will facilitate the optimization of
the proposed design and thereby play an important role in the development of a
next-generation EPID capable of simultaneous imaging and dosimetry in radio-
therapy.
Methods: The imaging performance of the standard and prototype EPIDs
was evaluated experimentally by acquiring images of a QC-3V phantom to quan-
tify the resulting contrast-to-noise ratio (CNR) and spatial resolution of each
configuration. The dosimetric response of the standard and prototype EPIDs
was evaluated experimentally by measuring field size response in non-transit and
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transit geometries. Dosimetric response was compared to that of an ion chamber
in solid water to determine the water-equivalency of each configuration.
The Geant4 MC toolkit was used to develop a model of an EPID incorporat-
ing electromagnetic and optical transport. A clinical 6 MV photon beam source
was developed and integrated into the model. The model may also incorporate
clinical computed tomography images to create a patient/phantom geometry po-
sitioned in the beam line. The energy deposited in the phosphor/PSA was scored
to approximate EPID response in each configuration.
Results: Experimental images acquired using the QC-3V phantom indicate
that the prototype EPID configuration has decreased CNR and spatial reso-
lution relative to the standard configuration. Measurements and simulations
have, however, demonstrated that the prototype configuration responds in an
approximately water-equivalent manner whereas the standard configuration over-
responds to low energy radiation relative to an ion chamber.
Conclusions: The prototype EPID employing a PSA responds in an approx-
imately water-equivalent manner, suggesting that images acquired using such a
detector may be useful for applications in dosimetry. The decreased CNR and
spatial resolution of the prototype configuration may be improved upon by opti-
mizing the design of the PSA, in part through the use of MC simulations. Ongoing
investigations are using the MC model to quantify optical transport e↵ects within
the PSA on detector response in the prototype configuration.
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Investigation of optical transport within a novel plastic
scintillator imaging device
S. Blake, A. L. McNamara, P. Vial, L. Holloway, P. Greer and Z. Kuncic
Oral presentation at the 2nd Geant4 Australian School and Monte Carlo Work-
shop in Wollongong, Australia – April, 2013
Purpose: Amorphous silicon (a-Si) electronic portal imaging devices (EPIDs)
are x-ray detectors frequently used in radiotherapy imaging and dosimetry ap-
plications. Standard EPIDs employ a copper plate and Gd2O2S:Tb phosphor
screen to convert x-rays into optical photons that may be detected using an array
of a-Si photodiodes. This indirect-detection system optimizes the EPID sensi-
tivity to incident x-rays, however the high atomic number materials cause a non
water-equivalent response that is not ideal for dosimetry. An alternative config-
uration that replaces the copper and phosphor screen with a low-density plastic
scintillator is under ongoing investigation by our group[1]. This plastic scintil-
lator exhibits a water-equivalent response, albeit with a reduced x-ray detection
e ciency that necessitates the use of a thick scintillator. In this study, Monte
Carlo (MC) simulations were used to characterize optical transport within two
alternate configurations of this novel EPID, employing either a single block of
plastic scintillator or a segmented array of plastic scintillating fibers.
Methods: Geant4 was previously used to develop and experimentally vali-
date a model of a standard a-Si EPID[2]. In the present study, the EPID model
was modified by replacing all of the components above the a-Si photodiode layer
(including the copper plate and phosphor screen) with a layer of plastic scintil-
lator. The plastic scintillator geometries are based on experimental prototypes
currently under investigation by our group. One design utilises a 15 ⇥ 15 cm2
block of plastic scintillator with uniform thicknesses ranging from 1–50 mm. A
second design utilises a 15⇥15 cm2 segmented array of plastic scintillating fibers,
each having a cross-sectional area of 1 ⇥ 1mm2 and 15 mm thickness. Mate-
rial properties were based on specifications provided by the manufacturer of the
experimental prototypes. The standard Geant4 electromagnetic and optical
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physics classes were used. Energy deposited in the scintillator and optical pho-
tons absorbed by the a-Si photodiode were separately scored to quantify optical
transport e↵ects on detector response. The detector imaging performance was
evaluated for each design by using a point source of monoenergetic x-rays (0.1 –
10 MeV) to calculate the x-ray detection e ciency, point spread function (PSF)
and modulation transfer function (MTF). Dosimetric response was investigated
for each design by using phase-space files of 6 MV x-ray beams with varying field
size to calculate field size factors and relative beam profiles.
Results: Simulations of the EPID PSF demonstrated noticeable signal blur-
ring from optical scattering within the plastic scintillator. Increased blurring
was observed for thicker blocks of plastic scintillator and the optical scattering
resulted in dose profiles that were distinctly rounded with very wide penumbral
regions. The blurring was, however, significantly reduced in the segmented array
design and the relative dose profiles had much steeper penumbrae. Validation
of optical transport parameters against experimental measurements is currently
under investigation.
Conclusions: Explicit modelling of optical transport is important when using
MC simulations to predict the response of novel EPIDs incorporating thick plastic
scintillators. The segmented array of plastic scintillating fibers greatly limits
the lateral spread of optical photons over the unsegmented block, resulting in
improved spatial resolution and steeper penumbrae in dose profiles. Further work
is required to validate the EPID models against measurements taken with the
experimental prototypes.
References:
1. P. Vial et al., “TH-C-BRA-11: First Experiments of a Prototype Device for
Simultaneous Imaging and Dose Verification in Radiotherapy,” Med. Phys.
39, 4002 (2012).
2. S. Blake et al., “Characterization of optical transport e↵ects on EPID
dosimetry using Geant4,” in press. Med. Phys. (2013).
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Monte Carlo simulation of electromagnetic and optical
transport within a-Si electronic portal imaging devices
S. Blake, A. L. McNamara, P. Vial, L. Holloway, P. Greer and Z. Kuncic
Poster presentation at the International Conference on the Use of Computers in
Radiation Therapy in Melbourne, Australia – May, 2013
Purpose: Amorphous silicon (a-Si) electronic portal imaging devices (EPIDs)
are x-ray detectors frequently used in radiotherapy imaging and dosimetry ap-
plications. Standard EPIDs employ a Gd2O2S:Tb phosphor screen to convert
x-rays into optical photons albeit with a non water-equivalent response. In this
study, Monte Carlo (MC) simulations were used to characterize optical transport
within the standard EPID and a novel EPID that improves the water-equivalent
response by replacing the phosphor screen with a plastic scintillator array (PSA).
Methods: The Geant4 MC toolkit was used to develop a-Si EPID mod-
els (standard and novel configurations) incorporating electromagnetic and optical
transport. Energy deposited in the phosphor/PSA and optical photons absorbed
by the a-Si photodiode were compared to quantify di↵erences in simulated re-
sponse. The imaging performance and dosimetric response of each configuration
was investigated using a point x-ray source and open field x-ray beams, respec-
tively. Patient/phantom CT images were recently integrated into the model for
transit dosimetry simulations.
Results: Simulations of the standard EPID point spread function demon-
strated noticeable signal blurring from optical scattering within the phosphor
screen. This blurring was not noticeable in open field beam profiles at the stan-
dard EPID pixel size of 0.4 mm. Characterization of optical transport in the
novel EPID is currently under investigation.
Conclusions: Explicit modelling of optical transport may be important when
using MC simulations to predict EPID imaging performance. Electromagnetic
transport alone may, however, su ce when predicting EPID dose response to
open fields. Further work is required to evaluate optical transport e↵ects in the
novel EPID configuration.
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Characterising optical photon transport in novel
electronic portal imaging devices employing plastic
scintillator
S. Blake, A. L. McNamara, P. Vial, L. Holloway, P. Greer and Z. Kuncic
Oral presentation at the Geant4 2013 International Users Conference in Bor-
deaux, France – October, 2013
Background: Amorphous silicon (a-Si) electronic portal imaging devices
(EPIDs) are x-ray detectors frequently used in radiotherapy for patient imaging.
Interest in using EPIDs for dosimetry is growing, however, due to their high 2d
spatial resolution and real-time readout capabilities[1]. Standard EPIDs use a
copper plate and gadolinium oxysulfide phosphor screen to convert x-rays into
optical photons that are detected with an array of a-Si photodiodes. While this
configuration results in high x-ray detection e ciency, the high atomic number
materials cause a non water-equivalent response that is not ideal for dosime-
try[1,2]. A novel configuration that replaces the copper and phosphor screen
with a 2d array of water-equivalent plastic scintillator (PS) fibres is under ongo-
ing investigation by our group[2]. This study uses Monte Carlo (MC) simulations
to characterise optical transport in this prototype EPID and model its dosimetric
response to megavoltage (MV) photon beams.
Methods: The Geant4 MC toolkit[3] was previously used to develop and
experimentally validate a model of a 6 MV clinical photon beam and standard
a-Si EPID[4]. This model was modified by replacing the components above the
photodiode layer with two separate PS geometries. First, a simple PS block with
variable thickness was used with the x-ray source to calculate EPID dose profiles.
Optical transport in the PS was characterised by varying optical transport pa-
rameters and observing any resulting e↵ects on the profiles. Reference scattering
(µ) and absorption (l) lengths were taken to be 2 cm and 3.5 m respectively from
manufacturer specifications. Second, a realistic model of the PS fibre array was
developed to simulate the response of the prototype EPID. The array consisted
of 150 ⇥ 150 optically isolated fibres, each measuring 1 ⇥ 1mm2 in area and 15
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mm in length.
Results: Dose profiles simulated for select values of µ and l (15 mm thick
PS block and 5 ⇥ 5 cm2 x-ray beam) are shown in Figure 1. A profile simulated
using the PS fibre array with reference µ and l is shown for comparison. The
percentage di↵erence between each PS block profile and the reference profile is
also shown. Since l is much greater than the PS thickness, varying l did not a↵ect
profile shapes. As µ is on the order of the PS thickness, profiles were sensitive
to changes in this parameter. Increasing µ acted to broaden dose profiles. This
e↵ect was greater for thicker scintillators and larger field sizes. The PS fibre array
drastically reduced lateral optical scatter, resulting in a flatter profile.
Figure 1: (Upper) Relative dose profiles simulated for select values of µ and ⌧ .
(Lower) Percentage di↵erence relative to reference profile with µ = 2 cm and
⌧ = 3.5m.
Conclusions: Geant4 has been used to develop a MC model of a novel EPID
incorporating PS detectors. A preliminary characterisation of optical transport
in a PS block demonstrates dose profile sensitivity to variations in the optical
scattering length. Ongoing work involves validation of the optical transport pa-
rameters and the EPID model’s dosimetric response against experimental mea-
surements. Simulations and measurements of the EPID line spread function will
also be used for further model validation.
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Towards a next-generation electronic portal device for
simultaneous imaging and dose verification in
radiotherapy
S. Blake, P. Vial, L. Holloway and Z. Kuncic
Oral presentation at The 2014 American Association of Physicists in Medicine
(AAPM) annual meeting in Austin TX, USA – July 2014
Purpose: This work forms part of an ongoing study to develop a next-
generation electronic portal imaging device (EPID) for simultaneous imaging
and dose verification in radiotherapy. Monte Carlo (MC) simulations were used
to characterize the imaging performance of a novel EPID that has previously
been demonstrated to exhibit a water-equivalent response. The EPID’s response
was quantified in several configurations and model parameters were empirically
validated against experimental measurements.
Methods: A MC model of a novel a-Si EPID incorporating an array of
plastic scintillating fibers was developed. Square BCF-99-06A scintillator fibers
with PMMA cladding (Saint-Gobain Crystals) were modelled in a matrix with
total area measuring 150 ⇥ 150mm2. The standard electromagnetic and optical
physics Geant4 classes were used to simulate radiation transport from an angled
slit source (6 MV energy spectrum) through the EPID and optical photons reach-
ing the photodiodes were scored. The prototype’s modulation transfer function
(MTF) was simulated and validated against experimental measurements. Several
optical transport parameters, fiber lengths and thicknesses of an air gap between
the scintillator and photodiodes were investigated to quantify their e↵ects on the
prototype’s detection e ciency, sensitivity and MTF.
Results: Simulated EPID response was more sensitive to variations in geom-
etry than in the optical parameters studied. The MTF was particularly sensitive
to the introduction of a 0.5 – 1.0 mm air gap between the scintillator and photo-
diodes, which lowered the MTF relative to that simulated without the gap. As
expected, increasing the fiber length increased the detector e ciency and sensi-
tivity while decreasing the MTF.
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Conclusions: A model of a novel water-equivalent EPID has been developed
and benchmarked against measurements using a physical prototype. We have
demonstrated the feasibility of this new device and are continuing to optimize
the design to achieve an imaging response that warrants the development of a
next-generation prototype.
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A next-generation EPID for simultaneous imaging and
dosimetry in radiotherapy
S. Blake, P. Vial, L. Holloway and Z. Kuncic
Oral presentation at EPI2k14 - The 13th International Conference on Electronic
Patient Imaging in Aarhus, Denmark – September 2014
Summary: A novel prototype electronic portal imaging device (EPID) has
been characterised experimentally for imaging and dosimetry applications in ra-
diotherapy. A Monte Carlo (MC) model of the prototype has also been devel-
oped for ongoing detector optimisation. The prototype EPID exhibits a water-
equivalent dose response and simulations of the modulation transfer function
have identified geometrical and optical transport parameters that are important
for maintaining spatial resolution.
Introduction: A novel EPID with a water-equivalent dose reseponse has
been designed for simultaneous imaging and dose verification applications in ra-
diotherapy. This work presents an updated prototype based on a previously char-
acterised first-generation water-equivalent detector[1]. The first measurements
taken with this prototype are reported along with a preliminary characteristion
of the detector performance based on MC simulations using a model of the de-
tector prototype. Measurements were used both to experimentally characterise
the prototype’s imaging and dosimetric response and to empirically validate the
MC model, which will be used for ongoing detector optimisation.
Methods and Materials: To facilitate a water-equivalent dose response
and thereby render the prototype EPID more suitable for applications in dosime-
try, a plastic scintillating fibre array (PSA) was used in place of the metal
plate/phosphor screen in standard amorphous silicon (a-Si) EPIDs. The MC
model, developed using Geant4, is based on the prototype’s design and incorpo-
rates an array of 0.5⇥0.5⇥30mm3 (width ⇥ height ⇥ length) scintillating fibres
with total area measuring 150 ⇥ 150mm2 (Figure 2). This array was placed in
direct contact with the a-Si photodiode panel, which has a nominal pixel pitch
of 0.4mm (the impact of fibre and a-Si pixel mismatch was investigated using
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the model). Experiments were performed using a clinical 6 MV photon beam to
measure the prototype PSA-EPID’s modulation transfer function (MTF), field
size output factors and relative dose profiles for static, open fields. These quanti-
ties were likewise simulated using the MC model. The fibre cross-sectional area,
extra-mural absorber (EMA) and optical transport parameters were varied in the
MC model to investigate their impact on detector performance.
Figure 2: (a) Photo of the second-generation prototype array of plastic scintillat-
ing fibres. The individual fibre components and dimensions are illustrated in the
schematic, (b).
Results: Field size response and relative dose profiles demonstrated a water-
equivalent PSA-EPID dose response (Figure 3). Measured and simulated field
size response and profiles agreed within statistical and experimental uncertain-
ties. Dose profiles exhibited quasi-periodic variations that resulted from element-
to-element mismatch between the scintillating fibres and underlying photodiode
pixels. This mismatch also reduced the MTF for high spatial frequencies. When
the MC model was used to precisely match scintillating fibres to the underly-
ing pixels, the quasi-periodic variation in profile response was eliminated and
the MTF was increased for high spatial frequencies. Removal of the EMA sur-
rounding each scintillating fibre caused a severe decrease in the simulated MTF,
highlighting the importance of minimising optical cross talk between fibres in
maintaining spatial resolution. Of the optical transport parameters investigated,
only the Rayleigh scattering length had a quantifiable impact on the simulated
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MTF, where increases in this parameter over the range 1 50mm caused a slight
increased in the MTF.
Figure 3: Field size output factors measured using a water-equivalent MatriXX
array of ion chambers with solid water buildup are compared to those measured
and simulated using the PSA-EPID prototype and MC model.
Discussion: The dose response exhibited by this prototype PSA-EPID gives
support that a water-equivalent EPID may be developed to be better suited for
clinical dosimetry applications than current commercially available portal im-
agers. Since its value is not precisely known for plastic scintillator, the Rayleigh
scattering length may be treated as a “free” parameter to empirically tune sim-
ulated MTFs to measurements. A recent study by El-Mohri et al. has proposed
novel binning algorithms to correct element-to-element mismatch artefacts and
the application of these methods to our prototype is currently under investiga-
tion[2].
Conclusion: A novel water-equivalent EPID has been characterised experi-
mentally for imaging and dosimetry applications in radiotherapy. A MC model
has also been validated and simulation results suggest that further improvements
in detector performance may be realised through ongoing detector optimisation.
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